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Abstract 
The major reservoirs for most influenza A virus subtypes are wild aquatic birds, 
especially ducks. However, they are typically resistant to the effects of the infection and 
usually do not develop clinical disease. In contrast, some influenza viruses cause severe 
illness or even death in susceptible hosts like chickens and turkeys. Paradoxically, 
infection of primary duck cells results in rapid cell death, whereas in chicken cells, death 
occurs less rapidly. Duck cells produce fewer infectious virions in comparison with the 
longer surviving chicken cells. In order to understand this variation in infectious virus 
production, chicken and duck embryo fibroblast cells (CEF and DEF) were infected with 
low pathogenic avian H2N3, and the viruses produced from the two hosts ware 
characterised. Infectious virus production from chicken cells was significantly greater 
than that observed from duck cells, from 8±48 hr after infection. Influenza matrix gene 
and protein expression, analysed by quantitative real time PCR and western blotting of 
culture supernatants, showed comparable levels between species at 8 and 24 hr post 
infection. These findings led to investigation of virus budding and morphology following 
infection of duck and chicken cells with the virus. Differences in morphology of released 
virions were observed. Budding viruses from duck cells were elongated, while chicken 
cells produced almost spherical virions. There was a similar clear difference in virus 
morphology in the duck and chicken culture supernatants. Spherical viruses were 
observed in chicken supernatants while duck cell supernatants contained pleomorphic 
virions. No differences between any genes of chicken± and duck±derived viruses were 
found, suggesting that host cell determinants might be responsible for such variations in 
virus morphology. DEF cells showed extensive production of filamentous or short 
filament virions following infection with filamentous (equine H3N8) and non±filamentous 
(avian H2N3) virus strain, respectively. This was observed even after actin disruption 
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with cytochalasin D (Cyt.D). CEF cells infected with equine H3N8 virus produced 
extensive filamentous virus, which decreased markedly after disruption of actin with 
Cyt.D, whereas, following infection with H2N3, spherical virions were observed in the 
presence or absence of the actin inhibitor. Cells were also transfected with green 
fluorescent protein ± microtubule-associated protein 1A/1B-light chain 3 (GFP±LC3) 
expression vector and then infected or mock infected with avian H2N3. Short filaments 
were observed from untransfected and transfected duck cells, while spherical and short 
filaments were observed from untransfected and transfected chicken cells, respectively. 
Filamentous virus formation could be enhanced as a result of autophagy which is more 
marked in duck cells than chicken cells. Further studies such as studying the structure of 
chicken and duck fibroblast cell membranes, the use of other drugs that inhibit actin in a 
mechanistically different way, and the role of other cellular proteins in modulating virus 
morphology should be considered. 
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1.1 Influenza 
Influenza, commonly known as the ൏flu, is an acute febrile viral illness that affects the 
respiratory tract of birds and mammals. It usually occurs between autumn to spring and 
appears in epidemic form in humans which spreads in a specific community and 
sometimes in pandemic form causing high levels of mortality and economic losses 
(Timbury, 1997). In humans, it has been documented that epidemic ൏flu is responsible for 
3±5 million typical infections and 250,000 to 500,000 fatal cases each year (WHO, 2011).  
New influenza viral strains may be generated over time causing sudden pandemic 
outbreaks which spread easily among humans especially infants, elderly, and 
immunocompromised persons (Timbury, 1997, Smith et al., 2001). Several pandemic 
outbreaks have been recorded and the most significant is the so±called ³Spanish flu´, 
which occurred in 1918, killing more than 30 million people around the world. Other 
significant outbreaks were in 1957 (Asian flu), and in 1968 (Hong Kong flu); but they 
were less severe than the 1918 pandemic avian influenza (Horimoto and Kawaoka, 2001, 
Horimoto and Kawaoka, 2005). 
 
1.2 Avian influenza 
The first description of avian influenza (AI) was in Italy in 1878 when researchers 
differentiated a disease of poultry from other diseases with high mortality rates 
(Alexander and Brown, 2009). The disease is highly contagious for poultry and 
DVVRFLDWHGZLWKKLJKPRUWDOLW\,WZDVQDPHG³IRZOSODgXH´DQGLWZDVLQLWLDOO\FRQIXVHG
with fowl cholera (avian pasteurellosis). In 1880, according to the clinical and 
pathological properties, the disease was differentiated from fowl cholera and called 
Typhus exudatious gallinarum. In 1901, scientists determined that a virus causes the 
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disease, and in 1955, the classical fowl plague virus was confirmed to be a type A 
influenza virus based on the presence of type±specific ribonucleoprotein (Lupiani and 
Reddy, 2009).  The first isolation of influenza A virus from free±living wild ducks was in 
1972 and at that time, numerous surveillance studies showed that wild birds including 
free±flying and shore birds are the natural hosts for all influenza A subtypes (Slemons et 
al., 1974).  
 
1.3 Influenza viruses  
Influenza viruses belong to the ³2UWKRP\[RYLULGDH´ family and are classified into five 
different genera: influenza A, influenza B, influenza C, Thogotovirus, and Isavirus 
(Cheung and Poon, 2007). They were initially isolated from pigs in 1931 and later from 
humans in 1933 (Shope, 1931, Smith W., 1995, Juozapaitis and Antoniukas, 2007). The 
most serious types that cause dangerous outbreaks with high morbidity and mortality are 
influenza A viruses because they mutate more rapidly and have a wider range of hosts 
(Khanna et al., 2008). Influenza A viruses infect animals, including birds, pigs, horses, 
whales, seals, and also humans (Ito and Kawaoka, 2000, Reperant et al., 2009). Type B 
and C are generally found in humans, in addition to some mammals like seals, with less 
severity than influenza A. The infection is usually associated with a common cold±like 
illness, particularly in children (Greenbaum et al., 1998, Osterhaus et al., 2000). Wild 
aquatic birds of the order of Anseriformes (ducks, geese and swans) and Charadriformes 
(gulls, terns, surfbird and sandpiper) are considered to be the natural reservoir of all types 
of influenza A viruses. In these hosts, viral replication occurs mainly in the 
gastrointestinal tract, and to a lesser extent in the respiratory tract. The infected birds 
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generally have no apparent signs of illness, but with some exceptions after infection with 
highly pathogenic avian influenza viruses (Munster et al., 2007). 
The main differences between the three main types of influenza viruses (A, B and C) are 
outlined in table 1.3±1. 
 Influenza A Influenza B Influenza C 
Number of gene segments 8 8 7 
Surface glycoproteins HA and NA HA and NA HEF (Haemagglutinin±Esterase±Fusion) 
Host range 
Wide range of hosts 
(humans, pigs, horses, 
whales, seals and birds) 
Humans and seals Mainly humans (also found in swine) 
 
Table 1.3±1 Comparison of major properties of influenza viruses, adapted from Cheung and Poon 
(2007) 
 
1.3.1 Structure and molecular biology of influenza A virus  
Influenza viruses are roughly spherical with a size of around 100 nm or filamentous in 
shape, often in excess 300 nm in length (Bouvier and Palese, 2008). Morphological 
structure is known to be affected by several viral proteins (HA, NA, M1, and M2), in 
addition to the nature of the host cells (Cheung and Poon, 2007).  
Influenza viruses are enveloped with surface glycoprotein spikes and a segmented RNA 
genome of negative sense (complementary to mRNA). RNA of influenza A virus is 
organized into 8 segments, in total around 13600 nucleotides long (Hoffmann et al., 
2001). These are the polymerase basic (PB1 and PB2), the polymerase acidic (PA), 
haemagglutinin (HA), nucleoprotein (NP), neuraminidase (NA), matrix (M), and non±
structural (NS) genes (Samji, 2009).  
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Each viral segment contains non±coding regions at both 5´ and 3´ ends. The 5´ terminus 
RIHDFKLQÀXHQ]D$YLUDO51$VHJPHQWKDVFRQVHUYHGQXFOHRWLGHVDQGWKH´ terminus 
has 12. The extreme ends are conserved among all segments, and this is followed by a 
segment±specific noncoding region (Hoffmann et al., 2001). These unique noncoding 
regions (U12 and U13) contain the promoter components, which are important for the 
initiation of transcription and replication as they are recognized by the polymerase 
complex consisting of PB1, PB2, and PA proteins (Hsu et al., 1987, Coloma et al., 2009). 
In between these highly conserved noncoding regions and the long central coding region 
of each gene there are additional untranslated regions (UTRs) at both 5´ and 3´ ends. 
Specific nucleotides and the UTRs and terminal coding regions act as the viral packaging 
signal (Hutchinson et al., 2010). Figure 1.3±1 shows the typical structure of influenza 
viral RNA. 
 
 
Figure 1.3±1 Schematic diagram of a typical influenza viral RNA segment. 
A large open reading frame (green box) which represents the coding region is flanked by short untranslated 
region (UTRs) (black lines) containing terminal promoter sequences (blue boxes) that form the polymerase 
binding site. Those sequences are comparable between all genome segments and all virus subtypes. 
Specific nucleotide segments (red wedges), which overlap the UTRs and the terminal coding regions act as 
viral packaging signal. Figure adapted from Hutchinson et al. (2010).    
 
Influenza A viral gene segments are known to encode at least ten proteins which are the 
RNA polymerase complex proteins (PA, PB1, and PB2), surface glycoproteins (HA, and 
NA), nucleoprotein (NP), matrix proteins (M1 and M2), and nonstructural proteins (NS1, 
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NS2) (Samji, 2009, Wang and Taubenberger, 2010). In addition, PB1±F2 and a new viral 
protein (N40) which is translated from segment 2 have been recently identified in some 
influenza A virus isolates (Chen et al., 2001, Wise et al., 2009). Moreover, two more 
proteins, PA-X and M42 which are translated from segment 3 and 7, respectively, have 
been recently found (Jagger et al., 2012, Wise et al., 2012) (Figure 1.3±2).  
 
 
Figure 1.3±2 Genomic structure of influenza A virus. 
RNA segments (in nucleotides) shown in positive sense and their encoded proteins (in amino acids). The 
lines at the 5´ and 3´ termini represent the coding regions. The PB1 segment encodes three proteins, two of 
them (PB1 and N40) translated from ORF 0, and PB1±F2 protein translated from ORF 1. The M2, M42 and 
NEP/NS2 proteins are encoded by spliced mRNAs (the introns are indicated by the V±shaped lines). Figure 
modified from (David M. Knipe, 2007, Jagger et al., 2012, Wise et al., 2012). 
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Each viral RNA segment is surrounded by nucleoprotein (NP) forming ribonucleoprotein 
(RNP) and encapsidated by one copy of trimeric polymerase (PB1±PB2±PA complex) 
which is essential for viral replication (Digard et al., 1999). The lengths of the rod±like 
RNPs are varied (30±100 nm) and correlate with the length of each viral segment (Noda 
and Kawaoka, 2010). By longitudinally and transversally sectioning budding virions of 
different virus strains, a study has shown that the eight RNPs are highly organized in a 
distinct pattern; a central segment is surrounded by seven segments of different lengths 
(Noda et al., 2006). Such an organization is also observed in the isolated virion (Calder et 
al., 2010). The structural organization of viral ribonucleoprotein can be seen in figure 
1.3±3.  
 
Figure 1.3±3 Structure of influenza virus ribonucleoprotein (vRNP). 
Green spheres represent NP monomers, and the black line shows the associated single±stranded vRNA 
molecule. Influenza RNP folds into a double±helical hairpin structure. A short duplex formed between the 
5´ and the 3´ ends provides the binding site for the heterotrimeric RNA±dependent RNA polymerase. 
Figure adapted from Portela and Digard (2002). 
 
Four virus proteins (PB2, PB1, PA, and NP) are responsible for virus transcription and 
replication of the viral genome in the nuclei of infected cells. PB1±F2 protein plays a role 
in pro±apoptotic activity, while N40 protein, which is encoded by the same gene (PB1), 
Firas Al ?Mubarak 2014                                                                        Chapter 1: Introduction and Aims 
30 
 
interacts with the polymerase complex in the cellular environment but does not contribute 
to transcription function (Wise et al., 2009). PA-X protein has been shown to modulate 
host response and viral virulence (Jagger et al., 2012). Haemagglutinin (HA or H) plays a 
role in virus attachment to the host cell and subsequent fusion with cell membranes, while 
neuraminidase (NA or N) supports the release of viruses from the host cell surface by 
hydrolyzing sialic acid from glycoproteins which helps to release the progeny virus 
particles from host cells (McCauley and Mahy, 1983, Odagiri, 1992). Non±structural 
protein 1 (NS1) has a major role in inhibition of host immune response via limitation of 
interferon (IFN) production (Hale et al., 2008). NS2 (also called nuclear export protein or 
NEP) plays a role in the export of RNPs from the nucleus to the cytoplasm during viral 
replication, in addition, it also regulates virus transcription and replication processes 
(Robb et al., 2009). Matrix protein 1 (M1), the major structural protein, is the dominant 
protein in determining virus morphology and also plays an important role in virus 
assembly and budding (Rossman and Lamb, 2011). Matrix protein 2 (M2) is the ion 
channel that regulates the pH, and is responsible for virus uncoating, the step that follows 
virus entry into the host cell (Holsinger et al., 1994). In addition, this protein also plays 
an important role in membrane scission in the last stage of virus life cycle (Roberts et al., 
2013). Matrix protein 42 (M42) can functionally replace M2 and support efficient 
replication in null M2 influenza viruses (Wise et al., 2012). Table 1.3±2 summarizes the 
length of each viral segment and the function of protein(s) encoded by each segment.  
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Table 1.3±2 Influenza A virus gene segments, their proteins and functions. Modified from Bouvier and 
Palese (2008). Typical gene and protein sizes shown, though strain variation occurs. 
 
 
Segment 
Segment 
length in 
nucleotides 
Encoded 
protein(s) 
Protein  
length in 
amino acids 
Protein function 
1 2341 PB2 759 
Polymerase subunit; plays a role in RNA 
replication by mRNA cap recognition 
2 2341 
PB1 757 
Polymerase subunit; RNA elongation during 
replication 
PB1±F2 87 
 
Pro±apoptotic activity 
N40 718 
 
Polymerase complex interaction 
3 2233 
PA 716 
 
Polymerase subunit; endonuclease activity 
PA-X 252 
 
modulates the host response and viral virulence 
4 1778 HA 550 
Major surface antigen, receptor binding and fusion 
activities, main target for neutralizing antibodies 
5 1565 NP 498 
 
RNA binding protein; nuclear import regulation 
6 1413 NA 454 
Minor surface glycoprotein for neutralizing 
antibodies; sialic acid activity, cleavage of progeny 
virions from host cell receptors and virus release 
7 1027 
M1 252 
Major component of virion; RNA nuclear export 
regulation, viral assembly and budding 
M2 97 
Ion channel for controlling pH during virus 
uncoating and HA synthesis (viral release) 
M42 99 functionally replace M2 in M2-null viruses 
8 890 
NS1 230 
Interferon antagonist protein; regulation of host 
gene expression 
NEP 121 
 
Control export of RNP from nucleus 
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The viral envelope is made of a lipid bilayer which is derived from the host cell¶VSODVPD
membrane. Three surface viral antigens are embedded in the lipid bilayer: the HA spike, 
which has a rod like±shape, represents approximately 80% of the total surface proteins; 
the NA spike, which is almost mushroom±shaped, represents 17%; with minor 
components of M2 represented by few molecules (only 16 to 20 molecule per virion) 
(Schroeder et al., 2005, Nayak et al., 2009). Underneath the lipid bilayer, the M1 protein 
forms a layer that separates the viral segments from the virus membrane. Inside the 
virion, 8 segments of different length are associated with the nucleocapsid protein (NP) 
and three large proteins (PB1, PB2, and PA). NEP is also associated with the virus but in 
low amounts (Cheung and Poon, 2007). Figure 1.3±4 illustrates the typical structure of 
influenza A virus. 
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Figure 1.3±4 Schematic diagram of influenza virus A particle.  
The RNA is segmented and each segment encodes one or more proteins. The segments are not identical in 
length (ranging from 2341 to 890 nucleotides). The longest segment encodes PB2 protein and the shortest 
encodes NS protein. The RNA segments are coated with nucleoprotein forming ribonucleoprotein (RNP), 
and a small amount of transcriptase (polymerase complex) represented by PB1, PB2, and PA is also 
associated with it. The haemagglutinin (HA), neuraminidase (NA), and M2 proteins are inserted into the 
host±derived lipid envelope. The matrix (M1) protein underlies the lipid envelope.  A nuclear export 
protein (NEP) is also associated with the virus.  
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Both NA and HA genes encode surface glycoproteins and influenza A virus can be 
classified into several subtypes according to the antigenic diversity of those surface 
antigens. There are 18 HA and 11 NA subtypes described as H1±H18 and N1±N11 with 
amino acid sequences differing by 30% or more between subtypes (Hampson and 
Mackenzie, 2006). Of those subtypes, 16 HA (HA1±HA16) and 9 NA (NA1±NA9) 
circulate in waterfowl and two of HA and NA (HA17±HA18 and NA10±NA11) have 
been isolated from bats (Tong et al., 2012, Tong et al., 2013). The most frequently 
circulating subtypes of influenza A viruses in the human population are H1N2, H3N2 and 
H1N1 (Nelson and Holmes, 2007).  
In addition, many different subtypes have been generated over time because of the 
genetic reassortment (antigenic shift). In the last few years, humans have been infected 
with swine and bird flu in different parts around the word, raising concerns for public 
health for humans as well as for pork and poultry production worldwide (Metzgar et al., 
2010, Van-Tam and Sellwood, 2010). 
 
1.3.2 Replication of influenza A viruses 
1.3.2.1 Virus attachment and entry 
The first step of viral replication is virus attachment to its host cell through N±acetyl 
neuraminic (sialic) acid, a nine±carbon acidic monosaccharide (Couceiro et al., 1993). 
The most common linkages of sialic acids are Į  DQG Į  OLQNDJH ZLWK ZKLFK
influenza viruses have the affinity to bind. The different sialic acid linkages can be one 
factor in host specificity. Both types of receptors are wide spread in many organs in 
chickens, ducks, cats, and pigs (Kuchipudi et al., 2009, Nelli et al., 2010, Trebbien et al., 
2011, Wang et al., 2013); with a dominant expression of  SA  ĮGal in the respiratory 
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tissues of humans including epithelial cells in the nasal mucosa,  paranasal sinuses, 
pharynx, trachea, bronchi and bronchiolesZKLOH6$Į*DOLVRFFDVLRQDOO\GHWHFWHGLQ
the nasal mucosa and on the non±ciliated cuboidal bronchiolar cells at the junction 
between the respiratory bronchiole and alveolus (Shinya et al., 2006). 
Once a host cell is infected with influenza virus, the HA glycoprotein is produced as a 
precursor, HA0, which is cleaved into two subunits (HA1 and HA2) by host serine 
proteases before virus particles become infectious (Klenk and Garten, 1994). The H1 
portion contains the antigenic sites (the receptor binding domain), while the H2 portion 
mediates fusion of the virus envelope and cell membranes (Figure 1.3±5)  (Steinhauer, 
1999). Virulent and avirulent avian influenza A viruses can be differentiated by the 
sequence of a few basic amino acids at the point where the HA0 is cleaved (cleavage 
site); the so±called cleavage sequence (Zambon, 1999).  
 
 
Figure 1.3±5  Schematic structure of HA of influenza A virus.  
The HA0 monomer of approximately 560 amino acid length is cleaved into HA1 and HA2 at the cleavage 
site (yellow). Fusion peptide (blue) mediates fusion of the virus envelope and cell membranes. TM: 
transmembrane domain.  
 
The virus enters the host cell via receptor (clathrin) mediated endocytosis at the inside 
face of the plasma membrane forming an endosome (Rust et al., 2004). Although other 
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endocytic routes (non±clathrin±dependent) may provide additional entry pathways, the 
endocytic pathway seems to be the most common (Sieczkarski and Whittaker, 2002). The 
endosome has a low pH of around 5 to 6, which induces a conformational change in 
HA0, displaying the HA2 fusion peptide. This fusion peptide inserts itself into the 
endosomal membrane and mediates the fusion of the viral envelope with the endosomal 
membrane, reviewed in Stegmann (2000). This mechanism is not only important for 
inducing the conformation change in HA0, but also opens up the M2 ion channel during 
fusion of viral and endosomal membranes, allowing the virion interior to become acidic 
which releases the vRNP from M1. This permits WKH Y513 WR HQWHU WKH KRVW FHOO¶V
cytoplasm, reviewed in Pinto and Lamb (2006).  
 
1.3.2.2 Transcription, replication and protein synthesis 
Transcription and replication occur inside the nucleus. Because of the negative sense of 
the viral genome, the viral RNA is copied into positive sense mRNA by the polymerase 
complex to act as a template for the production of the viral RNAs. The polymerase 
complex responsible for viral transcription and replication is formed by PB1, PB2, and 
PA. The viral RNA transcription is catalyzed by the RNA dependent RNA polymerase. 
The mRNA acquires a 5´ FDSSHGSULPHULQDSURFHVVNQRZQDV³FDSVQDWFKLQJ´7KH3%
protein has a role to capture this primer from host mRNA. The cap is cleaved by PA 
endonuclease into short sequence which is polymerized by RNA dependent RNA 
polymerase PB1.The resultant positive sense viral mRNA is exported to the cytoplasm 
through nuclear pores to start viral translation by ribosomes (Figure 1.3±6). Positive 
sense viral mRNA also serves as a template to produce the negative sense RNA that is 
packaged into new virions (Bouloy et al., 1978, Swayne, 2008).    
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Figure 1.3±6 Cap±snatching transcription mechanism of influenza A virus polymerase.  
The polymerase complex (PB1, PB2, and PA) is localized in the nucleus of infected host cell. The PB2 subunit 
steals short 5´ capped host mRNA molecule (black). The cap is cleaved by PA endonuclease into a short 
fragment (10±15 nucleotides) which is used to initiate polymerization by RNA dependent RNA polymerase of 
the PB1 subunit using viral RNA as a template (green), resulting in capped, polyadenylated, chimeric mRNA 
molecule (black and green). The resultant molecule is exported to the cytoplasm via nucleus pores for translation 
into viral proteins. Figure adapted from Boivin (2010). 
 
Polymerase basic (PB1 & PB2), nonstructural (NS1 & NS2), NP, PA, and M1 proteins 
are synthesized in the host cell cytoplasm then transported to the nucleus to participate in 
matrix and nonstructural splicing, transcription and replication. Surface glycoproteins 
(HA and NA) are synthesized by ribosomes and then enter the endoplasmic reticulum 
(ER), where they are glycosylated, and then folded in the Golgi apparatus. These proteins 
are incorporated in the cell membrane and assembled with vRNP complex, (reviewed in 
Sidorenko and Reichl (2004)).  Matrix 2 (M2) protein is modified by palmitoylation and 
it also plays a part in membrane association (Grantham et al., 2009). 
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1.3.2.3 Virus packaging, budding and release 
Influenza progeny virions are not infectious unless they have all eight genome segments 
(Bancroft and Parslow, 2002). Formation of new vRNP complexes from the newly 
synthesized PB1, PB2, PA, NP, and NS2 proteins occurs in the nucleus of the infected 
host cell. M1 proteins catalyze the transport of vRNP to the cytoplasm after forming M1±
vRNP complexes. Nuclear export of vRNA complexes is directed by NEP protein and the 
nuclear export signal (NES) carried by NP proteins and inhibited by the M1 proteins. 
Consequently, newly synthesized vRNA accompanied by M1 proteins are unable to 
penetrate into the nucleus again (Portela and Digard, 2002). 
Two models for the packaging of the segmented influenza A virus genome have been 
identified: random and segment specific packaging (Hutchinson et al., 2010). In the 
random model, the segments of the viral genome are distinguished from cellular RNA 
and also non±genomic viral RNAs and then integrated into a new virion; however, this 
mechanism does not distinguish between different segments. In this case, the possibility 
of the formation of fully infectious virus might be through chance by acquiring 8 
different segments, or by packaging with more segments than the minimum. Conversely, 
in a mechanism of the specific packaging model, one copy of each viral segment is 
specifically selected producing fully infectious virus, (cited by Bancroft and Parslow 
(2002)). 
The final step of viral replication is budding and release. Budding occurs at the apical 
plasma membrane of the host cell, possibly initiated by the accumulation of M1 protein at 
the cytoplasmic side of the lipid bilayer. The protein complexes represented by M1 
interact with the cytoplasmic tail of envelope proteins (M2, HA, and NA proteins). This 
interaction leads to the formation of a bud and assembly site in the cellular membrane 
(Bouvier and Palese, 2008). The most important step occurring before the new virion 
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leaves the plasma membrane is the cleavage of sialic acid residues by NA from 
glycoproteins and glycolipids to facilitate release of virus particles into the extracellular 
medium (Palese et al., 1974). In addition, the cytoplasmic tail of M2 protein facilitates 
virion scission and is also required for filamentous particle formation (Roberts et al., 
2013). 
 
1.3.2.4 The role of cell polarity on virus assembly and morphology 
Cell polarity is a characteristic feature in many cell types, in particular epithelial cells, 
which enables them to perform specialized functions. Cytoskeleton proteins, in particular 
the actin, play a dominant role in establishment and maintenance of this feature. 
Differences  in the structure and organisation of actin cytoskeleton exhibit differences in 
the level of cell polarity. Cell polarity was shown to play an important role in determining 
influenza virus morphology, in particular, the filamentous form. Polarized epithelial cells 
produce high levels of filamentous virus while non-polarized fibroblasts were found to 
support the production of spherical virions (Roberts and Compans, 1998). The assembly 
of filamentous virions, but not the spherical, requires an intact actin cytoskeleton because 
filaments grow by incorporating multiple lipid raft domains in cell membrane. Disruption 
of actin cytoskeleton with actin inhibitors leads to aggregation of lipid raft domains into 
annuli surrounding actin cores. This blocks the production of filamentous virions but the 
spherical viruses are not affected because of the much smaller raft domains necessary for 
the formation of a single virus particle (Simpson-Holley et al., 2002).  
The stages of influenza virus replication start from attachment of the virus onto host cells 
and end with the release of the progeny particles (Figure 1.3±7). 
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Figure 1.3±7 Life cycle of influenza viruses.  
Stages involved in the replication process are:  
1. Attachment to host receptor and entry to host cell via endocytosis. 
2. Virus uncoating and releasing RNPs to the cytoplasm. 
3. Transcription and translation of viral RNA. 
4. Replication of viral RNA. 
5. Production of nucleoprotein, non-structural, matrix, polymerase acidic, and polymerase basic proteins. 
6. Production of envelope proteins (surface glycoproteins HA and NA, and M2) and their transportation to 
cell membrane. 
7. Viral RNPs packaging and assembly. 
8. Virion budding and release from the cell membrane.  
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1.4 Pathogenicity of influenza A viruses 
According to the pathogenicity and severity of the disease in chickens, avian influenza A 
viruses can be classified into two pathotype groups: highly pathogenic avian influenza 
(HPAI) and low pathogenic avian influenza (LPAI). The mortality rates of the poultry 
flocks infected with HPAI viruses may reach to 100%, while infection with LPAI cause 
only milder and primarily respiratory disease (Capua and Alexander, 2009).  
In HPAI viruses, the region that encodes the cleavage site of the surface glycoprotein 
(HA) molecule contains multiple basic amino acids (arginine and lysine) which allows 
cleavage of the HA molecule by cellular endogenous proteases widely distributed 
throughout the cells of the body (Wood et al., 1993, Senne et al., 1996). This molecular 
structure is important in determining the virulence of these strains because it allows the 
virus to replicate in a considerably broader tissue range, causing widespread damage in 
tissues and death of the bird, with a mortality rate approaching 100% (Kim et al., 2009, 
Adams and Sandrock, 2010). The most pathogenic subtypes of avian influenza are 
restricted to subtypes H5 and H7 (Hampson and Mackenzie, 2006). On the other hand, 
LPAI viruses have only one basic amino acid (arginine) in the cleavage site of the HA 
molecule. This limits the site for the viral cleavage by host proteases such as trypsin±like 
enzymes, and as a consequence, the replication process occurs in limited tissues and 
organs, particularly in respiratory and digestive tracts, causing only mild disease 
(Alexander, 2000). LPAI viruses which cause asymptomatic or low pathogenic infection 
may mutate and convert to HPAI viruses through an adaptation process after infection of 
poultry (Mundt et al., 2009). This also reflects the importance of the role of wild birds as 
a primary source of zoonotic introduction of influenza and spreading the pandemics 
(Causey and Edwards, 2008). 
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1.5 Genetic variations 
During influenza viral replication, genetic variations occur frequently. This is due to the 
structure of the viral RNA (segmented) and the low fidelity of the RNA dependent RNA 
polymerase which generates replication errors during virus life cycle (Zambon, 1999, 
Zambon, 2001). Consequently, influenza A viruses can undergo recurrent antigenic 
changes (Shors, 2009). The resultant change in structure allows the virus to evade 
neutralizing antibody, the main mechanism of protective immunity against influenza 
infection. Such changes may lead to the creation of a new virus strain distinctive from 
those previously circulating viruses (Zambon, 1999, Smith et al., 2001).  
 
1.5.1 Antigenic shift  
Antigenic shift is a result of reassortment and it occurs when two or more different 
influenza A viruses subtypes infect a single cell simultaneously. Because influenza A 
viruses are segmented, it is possible to produce new viruses with a variety of segment 
combinations by the acquisition of entirely new gene segments. The newly assembled 
progeny virions may have mixed genes from the two parent viruses (Holmes et al., 2005, 
Nelson et al., 2008). Genome segmentation therefore confers evolutionary advantages by 
allowing genetic reassortment. This may result in the emergence of new subtypes which 
may be more pathogenic than the original parent viruses and may be associated with 
pandemics (Neumann et al., 2009b, Van-Tam and Sellwood, 2010).  
Pigs are thought to have an important role in reassortment because of their ability to 
become infected with different types of influenza A viruses (avian and human viruses), 
and thus they act as an intermediate host, or ³PL[LQJ YHVVHO´ (figure 1.5±1). The new 
reassortant strain may cause a pandemic or panzootic because the hosts (humans or birds) 
Firas Al ?Mubarak 2014                                                                        Chapter 1: Introduction and Aims 
43 
 
have little or no immunity against it (Smith et al., 2001, Van-Tam and Sellwood, 2010). 
Such a scenario happened recently in April 2009 where a swine origin H1N1 virus 
originated from a triple reassortant, composed of genes from avian, porcine and human 
virus origin (Michaelis et al., 2009).  
 
 
 
 
Figure 1.5±1 Schematic diagram of the antigenic shift process.  
Both avian and human influenza A strains co±infect WKHSLJ¶Vrespiratory tract cells where the reassortment 
may occur. The new virus strain is released and can infect humans and also spread from person to person. 
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As a consequence of such genetic changes, many pandemic outbreaks have been 
UHFRUGHG7KHPRVWVHYHUHRXWEUHDNZDVLQZKLFKLVNQRZQDVµ6SDQLVKIOX¶; Asian 
and Hong Kong flu occurred in 1957 and 1968 respectively (Timbury, 1997). The very 
recent global outbreak is named swine flu or 2009 flu pandemic which is caused by a 
H1N1 subtype which derived from triple reassortment of human, avian and swine viruses 
(Trifonov et al., 2009). 
 
1.5.2 Antigenic drift 
Genetic change in influenza A virus also occurs by µDQWLJHQLFGULIW¶. This is due to the 
accumulation of point mutations over time, which results from a lack of proofreading 
mechanism in the RNA polymerase, leading to incorrect ribonucleotide insertions during 
replication (Zambon, 1999, Adams and Sandrock, 2010). Such changes occur 
progressively over a period of time accompanied by a gradual change in surface 
glycoproteins (HA and/ or NA). The accumulation of basic amino acids in the HA gene 
product  may result in the transition of low pathogenic viruses to high pathogenic forms 
(Adams and Sandrock, 2010). The newly created viruses can escape immunity acquired 
after infection or vaccination and cause seasonal epidemic influenza, in humans, which 
usually occurs in winter every year and can infect the same person multiple times (figure 
1.5±2). As a result of this, influenza vaccines must be updated each year with changes in 
the circulating influenza viruses to achieve the best match with the circulating strain 
possible (Chen and Deng, 2009). These changes can be confirmed by phylogenetic 
analysis of H and N gene sequences (Hampson and Mackenzie, 2006). Influenza viruses 
produced as a result of antigenic drift are usually not changed much in their virulence in 
comparison with those produced from antigenic shift (Timbury, 1997). However, such 
viral gene mutations may play a role in virus evolution and spread. 
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Figure 1.5±2 Schematic diagram of antigenic drift process.   
This occurs when the genes encoding viral surface antigens undergo progressive mutation which leads to 
antigenic changes in the protein. Such changes allow the newly formed viruses to infect the host because of 
the absence of the specific antibodies against the altered surface antigen. 
 
1.6 Host range and cell receptors 
Influenza A viruses൏ subtypes have been isolated from an expansive range of hosts 
including avian and mammalian species. The avian host range includes both wild aquatic 
and terrestrial birds particularly ducks, geese, and chickens. The mammalian host range 
includes humans, pigs, and horses (Webster, 1998, Adams and Sandrock, 2010). The host 
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specificity of each type of influenza virus is mainly determined by differences in the host 
cell receptors (Naeve et al., 1984).  
There are two main types of host cell receptors with which influenza viruses have the 
affinity to bind. The linkage between neuraminic acid and the sugar (galactose) 
determines whether influenza virus binds to avian or mammalian cells (Figure 1.6±1). 
Avian influenza viruses preferentially bind to the neuraminic DFLG Į  JDODFWRVH
receptors while mammalian influenza viruses bind to neuraminic DFLG Į 
galactose(Auewarakul et al., 2007, Pillai and Lee, 2010).  
 
Figure 1.6±1 Overview of receptor predilections of avian and mammalian influenza viruses.  
 
Nelli et al (2010) showed that both receptors are present extensively in different organs in 
pigs, providing evidence why such mammals can act as mixing vessels for human and 
avian influenza virus. These two types of receptor are also distributed in many organs in 
chickens and ducks (Kuchipudi et al., 2009). The presence of these receptors on the same 
cells of the host may provide the environment for genetic reassortment and the production 
of new viruses by antigenic shift that may be more virulent than the original viruses. 
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Genomic mutations of avian influenza viral HA may play a role in changing the affinity 
of receptor binding from sialic acid± ĮJDODFWRVHWRVLDOLFDFLG± ĮJDOactose, which 
leads to extension of the viral host range (Yu et al., 2011). 
Figure 1.6±2 shows the natural reservoirs of influenza A viruses and how transmission 
occurs between hosts, which might lead to increase virulence after mixing in the pig.  
 
 
 
 
Figure 1.6±2 The reservoir of influenza A viruses.  
Wild aquatic birds are the natural reservoir for all influenza A subtypes. Avian influenza A viruses are 
frequently transmitted to domestic fowl from the natural wildlife reservoirs, and also to pigs from domestic 
fowl. Pigs can be frequently infected from human and domestic fowls, and virus reassortment can occur in 
pigs between avian, swine and human influenza A viruses. Influenza A viruses from pigs can also infect 
KXPDQV3LJVDFWDV³PL[LQJYHVVHO´ IRULQfluenza A viruses. Transmission of influenza A viruses can be 
either frequent (solid lines), or occasional (dotted line). Figure adapted from Maw et al. (2008) 
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1.7  Pathological findings 
Avian influenza A viruses can be classified into two fundamental groups: high and low 
pathogenic viruses, based on the severity of infection.  In seasonal and acute outbreaks of 
low pathogenic viruses in chickens, the major areas affected with pathological lesions are 
the respiratory and urogenital systems. These pathological lesions include pulmonary 
congestion, air saculitis, pneumonia, congestion of the ovary, and hemorrhagic ovarian 
follicles. During the latter stages of outbreaks, gross or histologic lesions which are 
identified within the urinary system include visceral urate deposition, nephritis, renal 
tubule necrosis, and swollen kidneys (Swayne and Slemons, 1994).  
In contrast, during infection with high pathogenic viruses in chickens, the pathological 
lesions are more prominent in comparison with low pathogenic viruses. The lesions may 
also involve the intestine, liver, spleen, and the brain. The major lesions are congestion 
and neuronal degeneration in brain tissues and severe congestion, edema and hemorrhage 
in lung tissues. The main pathological findings in the liver, spleen, and kidneys are 
hyperemia, cell degeneration and necrosis (Vascellari et al., 2007). 
 
1.8 Mode of transmission  
All influenza A subtypes can be transmitted in two main ways: inhalation of 
contaminated aerosols and by direct contact. Many studies have shown that inhalation of 
aerosol and infectious respiratory droplets play an essential role in the spread of the 
disease (Tellier, 2009, Tellier, 2006). Transmission by contact may occur directly from 
the infected persons or animals or indirectly by touching contaminated tissues and 
surfaces (Collier and Oxford, 2006, Tellier, 2006, Van-Tam and Sellwood, 2010).  
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Persons who are in contact with infected birds may be infected with the highly 
pathogenic strains (Khanna et al., 2008). Such transmission could happen in wet markets 
where live birds are sold, leading to direct close contact with infected poultry, via feather 
plucking and preparation of poultry for consumption, as well as poultry slaughtering 
facilities, commercial poultry farms, and eating of raw or poorly cooked animal parts 
(Paul Tambyah and Leung, 2006, Ma et al., 2008).  
Transmission between birds usually occurs by the faeco±oral route which is the 
predominant means of spread in wild  bird reservoirs (University Jawa State, 2010). The 
stability of avian influenza viruses in water supplies may spread the infection to other 
birds such as shore birds and also to aquatic mammals such as seals and whales 
(Stallknecht et al., 1990). Mallard ducks are of great interest because they are widely 
distributed and can travel large distances carrying the viruses from one region to another 
(Achenbach and Bowen, 2011). Transmission also occurs through inhalation of 
respiratory secretions contaminated with influenza virus particles (Zambon, 1999).  
 
1.9 Clinical signs and symptoms  
1.9.1 Clinical signs and symptoms in humans  
Generally signs and symptoms appear directly after the incubation period which is 24 to 
48 hr after being exposed to infection, but sometimes they may take four days to appear 
(Van-Tam and Sellwood, 2010). The severity of symptoms varies with virus subtype. A 
person who is infected with the disease starts to spread the viruses to other people one 
day prior to the beginning of symptoms and remains infectious for five to seven days 
(Collier and Oxford, 2006, Van-Tam and Sellwood, 2010). The typical symptoms of 
influenza A in people include fever (38ÛC or more), rhinitis, runny nose, cough, 
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headache, myalgia (muscle pain), body aches especially joints and throat, nasal 
congestion, chills, tiredness, watering eyes, loss of appetite, weakness and general 
discomfort, diarrhoea or vomiting (especially in children) (Collier and Oxford, 2006, 
Van-Tam and Sellwood, 2010). The common symptoms (fever, headache and fatigue) are 
caused by the secretions of large amounts of cytokines, including interferons and 
interleukins which are produced from influenza infected cells (Hampson and Mackenzie, 
2006).  
 
1.9.2 Clinical signs in birds 
The incubation period of influenza A in birds extends from one to seven days followed by 
the appearance of clinical signs (University Jawa State, 2010). The main clinical signs 
which appear in poultry infected with HPAI include decreased food and water 
consumption, loss of appetite, sudden drop in egg production, rales, sinusitis, ruffled 
feathers, excessive lacrimation, respiratory signs, cyanosis of the head and skin 
(purplish±blue coloring), edema of the face and head, diarrhea and nervous system 
disorders, including loss of the ability to walk and stand. The birds can be markedly 
depressed and sudden death of large number of poultry is common (Peiris et al., 2007, 
Neumann et al., 2009a). Other signs include sneezing, coughing, blood tinged oral and 
nasal discharges, loss of egg pigmentation and shell less eggs (University Jawa State, 
2010). Usually HPAI viruses cause significant mortality in chickens but are typically 
benign in ducks and geese with some exceptions of highly pathogenic avian H5N1 which 
may cause dark green diarrhea, anorexia and sometimes neurological signs (Neumann et 
al., 2009a). 
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Infection of poultry with LPAI is usually subclinical (asymptomatic), however, it may 
cause decreased egg production and mild respiratory signs (University Jawa State, 2010).  
 
1.10 Laboratory diagnosis 
Laboratory diagnosis is important to detect and confirm influenza virus infection either in 
the case of seasonal outbreaks or in a pandemic (Dwyer et al., 2006). Laboratory 
investigations should confirm the suspected cases and differentiate them from flu±like 
diseases which may be caused by other respiratory viruses including adenovirus, 
picornaviruses, SDUDLQÀXHQ]D YLUXVHV UHVSLUDWRU\ V\QF\WLDO YLUXVHV rhinovirus, and also 
by bacterial agents such as chlamydia, legionella and mycoplasma (Allwinn et al., 2002, 
Patrick and Richard, 2003). 
Many diagnostic techniques for influenza virus infection have been used and are 
classified into direct and indirect techniques. The direct methods include direct detection 
of viral particles, rapid antigen detection such as immunofluorescence techniques, and 
Enzyme Linked Immunosorbent Assay (ELISA). The indirect methods involve 
conventional and rapid cell culture, eggs or animal inoculation for growing and also 
typing of the viruses. +HQ¶V eggs are usually used for such propagation (Dwyer et al., 
2006, Khanna et al., 2008). 
Further investigations of influenza virus have been done by nucleic acid testing (RT±
PCR), and serological diagnostic tests (complement fixation (CF), haemagglutination 
inhibition (HI), and neutralization tests). All of these diagnostic tests have different 
sensitivity rates with some advantages and disadvantages (Dwyer et al., 2006). RT±PCR 
is generally more sensitive and specific and is not time consuming. It provides accurate 
detection, and facilitates the typing and subtyping of influenza viruses (Ellis et al., 1997). 
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In addition, multiplex PCR can be used to detect the infection by including a universal 
primer set in one amplification reaction, to determine the presence of more than one 
genome segment in the same reaction (Hoffmann et al., 2001, Ellis and Zambon, 2002). 
Furthermore, quantitative RT±PCR (qRT±PCR) is considered the more sensitive and 
accurate method for influenza A virus detection and quantitation. This test is usually used 
for the detection of viral M gene, the most conserved gene for all influenza A virus 
subtypes (Spackman and Suarez, 2008).  
Serological tests, particularly haemagglutination inhibition and complement fixation are 
not only used for detection of infection, but also to determine the KRVW¶V response to 
influenza vaccination (Prince and Leber, 2003). 
Influenza viruses can be isolated by using cell culture techniques whereby a specimen is 
inoculated in a live culture system and the virus is then detected after a given period of 
incubation. Madin Darby Canine Kidney (MDCK) cells are frequently used to detect viral 
replication by observing the cytopathic effects (CPE) on infected cells (Dwyer et al., 
2006). Embryonated KHQ¶s eggs, 10 to 12 days old, are also used to grow and isolate 
influenza virus by inoculating the amniotic cavity with the specimen. It usually requires 3 
days or more to grow the viruses inside the eggs before harvesting (Wang and 
Taubenberger, 2010). 
 
1.11 Treatment 
Treatment of influenza infection using antiviral medication plays an important role in 
modulating disease severity and in prevention and management of the disease. There are 
two main antiviral classes for influenza: adamantanes (M2 blockers), and neuraminidase 
inhibitors (Hurt et al., 2006). 
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1.11.1 M2
 
blockers 
M2 protein plays an essential role in virus uncoating, the process that follows virus entry. 
It is activated by the low PH of endosome prior HA mediated fusion; however, this 
mechanism can be inhibited using effective M2 blockers (Wharton et al., 1994). 
Amantadine (Symmetrel®) and rimantadine (Flumadine®) were the first effective drugs 
licensed for influenza treatment (Montalto et al., 2000). They inhibit viral replication 
during the early stage of infection by preventing H+ protons from flowing into the inner 
part of the virion through the M2 ion channel, thereby preventing viral uncoating, a 
process necessary for release of the transcriptionally active ribonucleoprotein complex 
for transport to the nucleus (Figure 1.11±1). As a consequence of the M2 blocking, viral 
RNA is not released to the cytoplasm of infected cell (Suzuki et al., 2003). 
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Figure 1.11±1 Inhibition of influenza virus uncoating.  
Amantadine (green bars) blocks the M2 ion channel preventing H+ protons from entering the inside of the 
virion. Viral RNP is not released from matrix protein 1, which therefore stops viral replication. 
 
In 1966, the Food and Drug Administration (FDA) approved amantadine for prophylaxis, 
and then in 1976, it started to administer this anti±viral for adults and children from one 
year and older. Rimantadine was then approved in 1993 by FDA for prevention of the 
disease in adults and for prophylaxis in children more than one year of age (Montalto et 
al., 2000). These two antiviral medications, in particular amantadine, are not widely used 
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because of their side effects on the central nervous system and the high incidence of drug 
resistance (Hayden et al., 1981, Du et al., 2012). Mutations in the viral M gene which 
happens through a single amino acid substitution in the M2 transmembrane domain can 
cause resistance to amantadines, and the resistant virus isolates can be transmitted to 
susceptible contacts. This potential of drug resistance limits the use of this drug for the 
treatment of influenza (Hay et al., 1986, Moscona, 2005).   
 
1.11.2 Neuraminidase inhibitors 
Neuraminidase is a glycoprotein expressed on the surface of influenza virus. It helps the 
progeny viral particles to be released from a host cell by cleaving the terminal neuraminic 
acid (sialic acid) residues from HA receptors on the cell membrane (Figure 1.11±2). This 
supports the spread of the new viral particles from the host cell to the uninfected 
surrounded cells (Air and Laver, 1989). Neuraminidase inhibitors are effective against all 
influenza viruses through inhibiting the release of virions from the host cell (Thorlund et 
al., 2011).  
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Figure 1.11±2 Mechanism of action of neuraminidase inhibitors.  
(A) Neuraminidase function during influenza virus replication cycle. (B) Neuraminidase inhibitors block 
the replication of the virus, preventing the release of virions from the surface of infected cells. Adapted 
from Moscona (2005). 
 
Two main neuraminidase inhibitors Zanamivir (Relenza®) and oseltamivir (Tamiflu®) 
have been approved to limit the severity and spread of influenza infections. They were 
first introduced in 1999 by the FDA for the treatment of uncomplicated acute influenza 
(Montalto et al., 2000). Both drugs are also effective for preventing the spread of the 
disease (chemoprophylaxis). These drugs are preferable to the M2 blockers because of 
their wider effectiveness (effective against influenza A and B), in addition to the absence 
of nervous system side effects (Gubareva et al., 2000). Other antivirals, Peramivir and 
laninamivir have been recently introduced in Japan (Thorlund et al., 2011).  
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1.12 Immunity and host response 
1.12.1 Innate immunity and viral strategies to avoid the innate response 
The first line of host defense against influenza virus infection is the innate immune 
response, and it is activated within a few hours of infection. There are three major 
components used by the host: antigen presenting cells (APCs), pattern recognition 
receptors (PRRs), and cytokines (Kreijtz et al., 2011).  
The main function of APCs is the engulfment of foreign particles through phagocytosis, 
as well as the production of inflammatory cytokines such as interferons. In addition, they 
have a role to ingest and breakdown the pathogen to clear the infection. Interferons 
produced from these cells can stimulate dendritic cells (DCs) resulting in enhancement of 
antigen presentation to CD4+ and CD8+ (helper) T cells which further promote the 
adaptive immune response (Kreijtz et al., 2011).  
Influenza virus infection can be recognized by some PRRs such as toll like receptors  
(TLRs), retinoic inducible gene±I (RIG±I), melanoma differentiation±associated gene 5 
(MDA5), as well as NOD±like receptors (NLR). These receptors recognize pathogen±
associated molecular patterns (PAMPs), in addition NLR can also recognize the activity 
of the virus replication strategy (Pang and Iwasaki, 2011).  
Of the 11 TLRs known, TLR±3 and TLR±7 have been shown to play an important role in 
recognizing double±stranded and single±stranded viral RNA, respectively. Both RIG±I 
and MDA5 have been shown to bind double stranded RNA. Signaling by these receptors 
leads to  production of inflammatory cytokines from infected host cells including 
interferon (IFN), tumor necrosis factor (TNF), and macrophage inflammatory protein 
(MIP) released by natural killer (NK) cells (Alexopoulou et al., 2001, Lund et al., 2004, 
McGill et al., 2009). These cytokines have such a strong antiviral activity that they can 
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kill virus±infected cells and limit viral replication. Such immunity is a starting point of 
the cellular immune response to limit viral replication and viral load (Achdout et al., 
2003).  
Although the host organism develops sophisticated antiviral responses in order to defeat 
emerging viruses following infection, influenza viruses can avoid or subvert these 
responses by evolving various immune evasion strategies to replicate efficiently. This 
involves binding of influenza virus proteins to various components of the innate immune 
system leading to their inhibition. For example, NS1 protein plays an important role to 
block interferon production by inhibiting RIG-I receptor signaling. In addition, PB2 and 
PB1-F2 limit the production of IFN-ȕ through the association with mitochondrial 
antiviral signaling protein (MAVS) (van de Sandt et al., 2012). Recently, a study has 
shown that autophagy which is considered an important defence process against influenza 
A infection, is manipulated by the virus itself via the interaction of M2 with the essential 
autophagy protein, Microtubule±associated protein 1A/1B±light chain (LC3). This 
interaction subverts autophagy and promotes the relocalization of LC3 to the plasma 
membrane in virus±infected cells. This could provide suitable resources for viral budding 
and to enhance the stability of filamentous viruses (Beale et al., 2014).  
 
1.12.2 Adaptive immune response 
The adaptive immune response represents the second line of host defense. It consists of a 
cellular response represented by T lymphocytes, and a humoral response which is 
represented by specific antibodies produced by B lymphocytes. 
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1.12.2.1 Cellular immune response 
During infection, CD4+ and CD8+ T lymphocytes may be induced. Antigen presenting 
cells (dendritic cells, macrophages, and monocytes) express the major histocompatibility 
complex class II (MHC II) on their surfaces. When the virus has been engulfed, a 
lysosome containing digestive enzymes combines with the phagosome to process the 
antigens. The processed antigens combine with the MHC II proteins forming an MHC II±
antigenic peptide complex and are presented on the surface of the APC. Helper T cells 
(CD4+) recognize the displayed antigen and bind to the complex. T helper cells are 
divided into several subsets including Th1 and Th2. Th2 cells produce cytokines which 
further promote the humoral response (Soghoian and Streeck, 2010). In contrast, Th1 
cells promote the development of cellular immunity via stimulation of CD8+ 
lymphocytes. Some viral peptides are expressed on major histocompatibility complex 
class I (MHC I) of antigen±presenting cells. In this case, peptides are transported to the 
endoplasmic reticulum where they associate with MHC I, then this complex 
(peptide/MHC I) is transported via the Golgi apparatus to the plasma membrane.  CD8+ 
cells (cytotoxic T cells) recognise this complex as abnormal resulting in the activation of 
these cells which eventually lyse virus±infected cells (Yewdell et al., 1985).   
 
1.12.2.2 Humoral immune response (antibody response) 
Humoral immunity (antibody based) is a specific type of immune response which helps to 
eliminate disease and also prevents reinfection in hosts previously exposed to the same 
strain (Hampson and Mackenzie, 2006). Antibodies against HA have been shown to 
increase host resistance to influenza. They bind to the trimeric globular head of the HA 
and inhibit virus attachment and entry. The virus can be neutralized by facilitating 
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phagocytosis (Kreijtz et al., 2011). Antibodies against NA are not protective but may 
limit the spread of infection by inhibiting NA enzymatic activity (Hampson and 
Mackenzie, 2006). Both proteins have high sequence differences and antigenic variations 
between subtypes. Thus protection provided by humoral immunity is type and subtype 
dependent and is not effective against different HA and NA subtypes or newly emerging 
viruses after antigenic shift and antigenic drift, even among healthy young adults. This is 
the main reason that influenza vaccines should be updated annually to generate humoral 
immunity against the HA molecule of the newly emerging viruses. Antibodies against M2 
might have an impact on virus neutralization, but to a limited extent in comparison with 
antibodies against HA and NA (Suarez and Schultz-Cherry, 2000, Chen and Deng, 2009). 
The main antibody types secreted following influenza infection are the mucosal 
antibodies (IgA), and the circulatory antibodies (IgM and IgG). All have a major role in 
virus neutralization and clearance (Mazanec et al., 1995). 
The humoral immune response in poultry which follows natural infection includes 
systemic and mucosal antibody production. The circulatory antibody response is 
measured by the production of immunoglobulin M (IgM) after 5 days of infection. The 
immunoglobulin Y (IgY), which is equivalent to the mammalian IgG in terms of 
function, but slightly different in structure, is detected shortly after. The antibodies target 
surface viral proteins (HA, NA, and M2) that are of importance for protection from 
disease (Suarez and Schultz-Cherry, 2000). 
 
1.12.3 Acquired immunity 
Although vaccination in poultry is possible and effective, it may cause some concerns. It 
poses problems for international trade, as animals with positive antibodies against 
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influenza either due to vaccination or infection may not be imported to many countries. In 
addition, if vaccination is not administered correctly, it may allow the virus to mutate and 
spread the infection (Savill et al., 2006).  
Haemagglutinin (HA) antigen is considered the main component in vaccines which 
stimulate virus neutralizing antibodies. Most current influenza vaccines used for poultry 
contain inactivated virus, and are produced through a series of chemical and physical 
processes. Such vaccines are very effective in inducing antibody against highly 
pathogenic influenza without causing any dangers because the virus cannot replicate (Rao 
et al., 2009).  
Many other kinds of influenza vaccines have been introduced recently by applying 
reverse genetic technology, such as fowl±pox recombinant vaccines (Suarez and Schultz-
Cherry, 2000). DNA vaccines have received much attention to induce protective immune 
responses. Polyvalent DNA vaccines have also been developed recently since they elicit 
broad protection against different H5N1 sublineages in poultry (Rao et al., 2009).  
Vaccine immunogenicity is enhanced by the use of adjuvants which regulates the 
adaptive immune response. Adding an adjuvant triggers the immune system non±
specifically to become more sensitive to the vaccine (Atmar and Keitel, 2009). 
Adjuvanticity (the effect of adjuvant) can be measured by comparing the immunogenicity 
of vaccine containing adjuvant, with vaccine without adjuvant. Most adjuvants that have 
been used worldwide are aluminum salts, followed by MF59 and AS03. Although 
adjuvants play a role in improving vaccine immunogenicity, they can cause adverse 
reactions ranging from slight to moderate. However, no serious reactions have been 
reported, indicating that the use of adjuvanted vaccines is generally safe (Kohhei T. and 
Ishii, 2012).  
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1.13   Differences in influenza infection outcome between chicken and ducks 
Aquatic birds such as ducks are considered to be the major natural reservoirs of all 
recognized subtypes of influenza A viruses (Webster et al., 1992) in which the virus is 
maintained in a low pathogenic form. LPAI viruses usually cause asymptomatic infection 
in those birds, and they replicate mainly in their epithelial cells of the digestive tracts 
following a faeco±oral route of transmission. Large amounts of virus are shed in faeces of  
reservoirs which contaminates the environment for prolonged periods of time (Webster et 
al., 1978). In contrast, when LPAI viruses are transmitted to domestic poultry such as 
chickens, turkeys and quail, subclinical infection or mild respiratory signs are typically 
observed (Pillai et al., 2010). In addition, in experimentally infected ducks, most HPAI 
virus infections are non±lethal and produce subclinical or no clinical signs (Shortridge et 
al., 1998, Kishida et al., 2005, Jeong et al., 2009). In contrast, HPAI viruses infecting 
chickens (naturally and experimentally) are very lethal causing high mortality rate 
reaching to 100% of the animals, often within 2 days. 
Paradoxically, Kuchipudi et al. (2011) observed that duck cells undergo rapid cell death 
following in vitro infection with H2N3 viruses, while cell death occurs less rapidly after 
infection in chicken cells. This study also showed that the number of infectious virions 
produced in chicken cells was significantly higher than the number of infectious virions 
produced from duck cells. However there was no significant difference between virus 
RNA output measurements from the two species.  
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1.14 Hypothesis 
The different outcomes of H2N3 infection in chicken versus duck cells, which are 
accompanied by a reduction in infectious virus titre from duck cells, may be due to 
changes in virus morphology, defects in the viral structure, or host cell factors.  
 
1.15 Aim and objectives 
The overall aim was to study the molecular and morphological differences between 
influenza viruses grown in chicken and duck cells in vitro. The aim was achieved by the 
following objectives: 
1. To determine the difference in infectivity of viruses produced from chicken and duck 
cells at different time points and also to monitor viral RNA replication and protein 
synthesis by absolute real time PCR and western blotting, respectively. 
2. To determine the differences in the viral budding and morphology between chicken 
and duck cells via electron microscopy, and also to examine virus morphology in culture 
supernatants of both cell types. 
3. To investigate the molecular changes of an avian influenza A virus cultured on 
chicken and duck embryo fibroblasts by whole genome sequencing. 
4. To determine the influence of the host cell on virus morphology by growing viruses 
with different morphology on MDCK, chicken, or duck cells. 
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Chapter 2 
General Materials and Methods 
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2.1 Introduction 
This chapter describes the general materials and methods that were used in the study. 
Further specific methods are described in the appropriate chapters thereafter.  
 
2.2 Virus production and titration 
2.2.1 Viruses 
Two LPAI influenza A subtypes were used in this study: avian influenza H2N3 
(A/mallard duck/England/7277/06) and equine influenza H3N8 
(A/equine/Newmarket/5/03) that were kindly provided by Dr Ian Brown (AHVLA) and 
Dr Debra Elton (Animal Health Trust), respectively. They were grown in allantoic fluid 
of embryonated KHQ¶V eggs to propagate the viruses.  
 
2.2.2 Virus propagation 
Influenza viruses are efficiently propagated in the laboratory, which has allowed them to 
be widely studied. Embryonated chicken eggs are efficient and commonly used for this 
purpose (Stanley, 1944, Veeraraghavan and Sreevalsan, 1961, Monto et al., 1981). This 
method is still being used for vaccine production and diagnostic purposes.  
Viruses used in this study were propagated in fertile KHQ¶V eggs provided by Henry 
Stewart & Co. Ltd, UK. Eggs were produced from Dekalb white hens, which 
were originally selected from the light Sussex strain. Working virus concentration was 
prepared by diluting the stock virus 1:2000 for H2N3 and 1:200 for H3N8 in 'XOEHFFR¶V
phosphate buffer saline (DPBS, Invitrogen) containing 2% tryptose phosphate broth 
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solution (Sigma) and 1% antibiotics (100 U/ mL penicillin and 100 ug/ mL streptomycin, 
Invitrogen). The number of virus passages of both strains is unknown; however, the 
available information assumes that it is relatively low passage. 
The fertilized eggs were incubated for 8 days and 10 days (for H2N3 and H3N8, 
respectively) at 37.5Û& WKHQ LQRFXODWHG with the virus. At the end of this period of 
incubation, the embryos were candled using an Egg±Lume Candling Lamp in a dark 
room and the air sacs were outlined with a pencil in order to determine the site for 
injection. Eggs without developing embryos were discarded. After wiping the egg surface 
with ethanol, a small hole was made in the shell at the site of injection with a specific 
drill without damaging the shell membranes, and a second hole was made above the air 
sac to alleviate the pressure during inoculation. A hypodermic syringe (1 mL) fitted with 
a fine needle was used for virus inoculation. The needle was passed through the hole in 
the egg shell, through chorioallantoic membrane, and the virus (0.1 mL) was injected in 
the allantoic cavity, which is filled with allantoic fluid. The hole was carefully sealed 
with wax or tape, and the eggs were placed at 37.5Û&IRUhr.  Figure 2.1±1 shows the 
structure of the embryonated egg and the specific site of inoculation. 
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Figure 1.1±1 Inoculation of influenza virus into chicken embryo. 
A healthy embryo was inoculated with 0.1 µl of virus in to the allantoic cavity as indicated with a syringe. 
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Eggs were candled again 24 hr after inoculation, in the dark room, in order to discard any 
embryos killed by the inoculation procedure. 7KHHPEU\RVZHUHFKLOOHGDWÛ&IRUmin 
or overnight before harvesting the virus at 48 hr post±inoculation. The top of the egg 
shell (at the air sac) was carefully opened using scissors, and the flap of the shell was 
removed by tweezers. Allantoic fluid was then carefully aspirated with a disposable 
pipette. The harvested viruses were clarified at 1000 xg for 5 min, aliquoted into small 
tubes, and then stored frozen at ±80Û&XQWLOIXUWKHUXVH  
 
2.2.3 Virus titration  
2.2.3.1 Primary cell culture 
Embryo fibroblast cells were extracted from 8 day old chickens provided by Henry 
Stewart & Co. Ltd, UK, and 10.5 day old Pekin duck embryos provided by Cherry Valley 
Farms Ltd (Rothwell, Lincs, UK). The egg shell was opened and the embryo was pulled 
out with a sterile blunt ended curved forceps and placed in a Petri dish and rinsed with 
PBS (Invitrogen). The head, limbs and internal organs were removed, and the bodies 
were transferred to a new petri dish containing PBS. The embryos were minced and 
digested in 0.25% trypsin in dissociation medium (DM) (F12 Hams + 1% penstrep + 
1.5% fungizone) at 37ƕC for 1 hr. Large undigested tissue pieces were removed using a 
cell strainer and the remaining suspension was centrifuged at 400 x g for 5 min. Cells 
were seeded into cell culture flasks (Nunc) and maintained in 'XOEHFFR¶V PRGLILHG
(DJOH¶V PHGLXP DMEM) containing 10% fetal calf serum (FCS) (Invitrogen) and 
supplemented with 1% antibiotics (100 U/mL penicillin and 100 ug/mL streptomycin) 
(Invitrogen).  
Firas Al ?Mubarak 2014                                                                      Chapter 2: Materials and Methods 
69 
 
2.2.3.2 Cell line 
Madin Darby canine kidney (MDCK) cells were used for the determination of infectious 
virus production from chicken and duck fibroblasts, and for immunofluorescence 
experiments (Chapter 3 and 6). 
 
2.2.3.3 Sub±culturing of cells 
Confluent monolayers of cells were washed three times with pre±warmed PBS and 
trypsinised with pre±warmed 0.5% and 1% trypsin/EDTA solution (Invitrogen) in PBS 
for primary and MDCK cells, respectively. Cells were incubated at 37ƕC until they 
detached from the flask surface, then trypsin was neutralised using pre±warmed DMEM±
Glutamax containing 10% FCS and 1% antibiotics. The cell suspension was centrifuged 
at 400 xg for 5 min and the supernatant was discarded. The cell pellet was re±suspended 
in DMEM±Glutamax supplemented with 10% FCS and 1% antibiotics, and then 
inoculated into new plates after cell counting.    
For later use, cells were frozen at ±196ƕC in liquid nitrogen. Freezing solution was 
prepared using DMEM±Glutamax supplemented with 50% FCS and 10% dimethyl 
sulphoxide (DMSO) (Sigma). Cell±freezing solution was aliquoted into 1.8 mL cryovials 
and put in Mister Frosty containing isopropanol and stored at ±80ƕC for 24 hr, prior to 
moving to liquid nitrogen.    
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2.2.3.4 Cell counting  
Cells were counted using the microscope chamber slide (haemocytometer). The slide has 
two chambers, each divided into 9 large squares. Each square has the same dimensions 
and accommodates 10±4 mL of cell suspension (Figure 2.2±1 A). The cell suspension was 
first diluted enough to be uniformly distributed and not overlapping. The slide mirror±
like polished surface and its cover slip were cleaned gently using lens paper and 70% 
ethanol. A volume of 10 microlitres of the diluted cell suspension was mixed thoroughly 
with 10 µl of 0.4% trypan blue in microcentrifuge tube, and incubated for a few minutes. 
Ten microlitres of the mixture was gently loaded onto the edge of the cover slip and 
allowed to distribute under the cover slip by capillary action. The slide was placed under 
the light microscope stage, and the viable cells (unstained with trypan blue) were counted 
using the x10 objective lens. Cells were counted in four large squares (top left, top right, 
bottom left, and bottom right) and the centre square. Cells touching lines were included 
on two sides only (see figure 2.2±1 B). The concentration of viable cells per millilitre was 
calculated using the following formula: 
Number of viable cell in top left square = A 
Number of viable cell in top right square = B 
Number of viable cell in bottom left square = C 
Number of viable cell in bottom right square = D 
Number of viable cell in centre square = E 
The total number of viable cells = A+B+C+D+E = F 
Average number of viable cell per square = F/5 = G 
Dilution factor = final volume of sample (cell volume + Trypan Blue) / cell volume = H 
Concentration of viable cells per millilitre = G x H x 104  
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Figure 2.2±1 Haemocytometer Cell Counting Chamber.  
(A) Diagram showing the dimensions of a haemocytometer grid when viewed under the microscope. The 
slide consists of 9 large squares, and cells were counted in the five labelled squares. (B) Diagram showing 
one of the largest squares. To ensure consistency of counting, cells that crossed the edges were counted in 
two sides only (indicated by transparent circles), while those located on the other sides were excluded 
(indicated by red circles). Dead cells (indicated by blue circles) were also excluded.   
 
2.2.3.5 Determination of multiplicity of infection (MOI) 
Confluent monolayers of MDCK cells in T75 flasks (Nunc) were split with trypsin and 
seeded to a 96 well plate (Nunc) at a seeding density of approximately 5000 cells per cm2 
in DMEM with 10% FCS, and 1% penicillin/streptomycin (P/S). The plates were 
LQFXEDWHGDWÛ&XQWLOWKH\were 100% confluent (usually after 24 hr). The medium was 
removed and cells were rinsed three times with PBS. The cells were infected with 50 µl 
of each virus dilution in triplicate using serum free infection media (DMEM/F±12, 
Invitrogen) supplemented with 2% Ultroser G (Pall Biosepra), 1% antibiotics, and 500 
ng/mL TPCK trypsin (Sigma±Aldrich), and incubated initially for 2 hr.  They were then 
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washed thoroughly three times with PBS followed by addition of 50 µl fresh infection 
medium to each well. At 6 hr post±infection, cells were washed three times with PBS and 
fixed with cold (4ƕC) 1:1 acetone±methanol. The plates were then kept in the fridge with 
PBS or TBS until they were stained (2.2.3.6). 
In practice, if a plaque assay is used, the MOI used in this study was at least 3. For 95% 
infection, the proportion of cells uninfected (P0) = 0.05. The multiplicity of infection (m) 
can be calculated using the formula for the Poisson distribution as follows:  
P0 = e-m = 0.05 
m = 3 
 
2.2.3.6 Immunocytochemical staining  
Detection of influenza viral protein expression was carried out by using the Envision + 
system±HRP (DAB; DAKO, Ely, UK) for immunocytochemical staining. The fixed cells 
were first blocked with peroxidase block for 40 min at room temperature, and then 
washed three times with 1x TBS±T. The cells were then incubated with a primary mouse 
monoclonal antibody to influenza nucleoprotein (NP) (Abcam, UK) for 50 min at room 
temperature. After washing three times with TBS±T, the cells were incubated with 
peroxidase labelled anti±mouse IgG antibody for 50 min at room temperature. During 
incubation time, substrate±chromogen solution was prepared by mixing 1 drop of DAB 
chromogen to 1 mL of substrate buffer, according to the manufacturer instructions. Cells 
were washed three times and incubated with the solution for 5 min, and then were rinsed 
with water and examined under the microscope. The amount of virus that produced 95±
100% positive cell labelling for NP was established as MOI of 1.0.  
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2.2.3.7 Virus infection of cells 
Cells were seeded in flat culture well plates (Nunc) at a seeding density of 5000 cells/cm2 
in DMEM containing 10% FCS, 100 U/mL penicillin and 100 µg/mL streptomycin. The 
plates were incubated at 37ƕC until cells became 100% confluent.  The cells were rinsed 
twice ZLWK3%6DQG WKHQ LQIHFWHGZLWKYLUXV LQ VHUXPIUHH+DP¶V LQIHFWLRQPHGLD
containing 2% Ultroser G (Pall Biosepra, Portsmouth, UK), 500 ng/mL TPCK Trypsin 
(Sigma±Aldrich Ltd.) and antibiotics. The plates were incubated at 37ƕC for 2 hr to allow 
virus attachment. The cells were rinsed three times with PBS, and then a fresh infection 
media was added to all the wells. They were then further incubated up to 48 hr. 
Supernatants were collected either for viral RNA extraction or for virus titration. 
 
2.3 Viral RNA Extraction and quantification 
Extraction of viral RNA from chicken and duck culture supernatants was performed 
using a QIAamp viral RNA purification kit (Qiagen) following the manufactureU¶V 
instructions (Appendix IV). The concentration of purified RNA was determined using 
NanoDrop8000 spectrophotometer (Thermoscientific, UK) by UV absorption. Eluted 
viral RNA samples were stored at ±Û&XQWLOIXUWKHUXVH
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3.1 Summary 
In this chapter, comparisons of infectious virus production, viral RNA production, and 
matrix protein expression were made following infection of chicken and duck embryo 
fibroblasts (CEF and DEF) with avian LPAI H2N3 (A/mallard duck/England/7277/06). 
DEF cells produced significantly lower numbers of infectious viruses compared to CEF 
cells. This difference was observed at 24 to 48 hr post infection. Influenza matrix gene 
expression, analysed by absolute real time PCR on culture supernatants, was comparable 
between species at 8 and 24 hr post infection. Matrix protein expression of viruses 
produced from both cells at 8 and 24 hr post infection was measured by western blotting. 
No significant difference in viral M protein expression was detected. These findings 
suggest that neither replication of viral RNA nor inefficient virus budding is responsible 
for the lower infectious virus production from duck cells. Other factors such as 
differences in the molecular structure of virions could have an impact in decreasing virus 
infectivity. 
 
3.2  Introduction 
Various laboratory in vitro models have been widely employed for studying influenza 
virus infection. Both organ and tissue cultures have been shown to support the growth of 
influenza virus. Avian organ cultures such as chicken embryo tracheal cultures are very 
sensitive to influenza infection and they have been used for the propagation of viruses 
(Blaskovic et al., 1972). Human organ cultures such as nasal polyps have been shown to 
support the growth of both human and avian influenza strains (Suptawiwat et al., 2010). 
In addition, other mammalian organ cultures such as hamster trachea were also used for 
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studying virus infection and metabolic activity following infection with different 
influenza viruses (Reeve et al., 1978).  
Cell cultures are a good model to study influenza virus isolation and determination of 
virus titre. Madin Darby Canine Kidney (MDCK) cells are the most efficient cell system 
for this purpose because of the high susceptibility to infection and the production of high 
virus titres (Reina et al., 1997, Li et al., 2009). In addition, avian cell cultures such as 
CEF and DEF cells made from 10±day old chicken embryos and 12±day old Pekin duck 
embryos, respectively,  have also been used to study influenza virus infection and host 
responses (Liang et al., 2011). 
 
3.2.1 Cytopathic effect 
The growth of viruses in cell culture is often associated with microscopically visible 
morphologic changes in the infected cells. These changes are referred to as cytopathic 
effect (CPE) of the virus, and they consist of cell rounding and detachment from the 
surface, disorientation, swelling, shrinking, necrosis, and vacuolization. Examples of CPE 
caused by influenza A virus are shown in Figure 3.2±1. Influenza virus infection, in 
particular infection with highly pathogenic strains, causes death of infected tissue culture 
cells (Daidoji et al., 2008). Apoptotic (programmed) cell death following influenza virus 
infection plays a major role in tissue damage during infection (Brydon et al., 2005), and 
is usually associated with low yields of infective virus particles (Takizawa et al., 1993, 
Kuchipudi et al., 2011).  
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Figure 3.2±1 Cytopathic effects caused by influenza A virus.  
Different cytopathic changes following infection of embryo fibroblasts with H2N3 virus for 24 hr are 
shown. Chicken cell culture (A) shows some swelling cells and vacuole formation while duck cell culture 
(B) shows cells rounding and detaching from the surface (indicated by arrows). Uninfected control chicken 
and duck cells (C and D) show no evidence of CPE.  
 
3.2.2 Measurement of virus production in infected cells 
3.2.2.1 Focus forming assay  
Focus forming assays are widely used to determine the virus concentration.  Madin Darby 
canine kidney (MDCK) cells are often used for this purpose because of their high 
susceptibility to infection with most influenza A strains (Gaush and Smith, 1968, 
Govorkova et al., 1999). In this method, cell monolayers are infected with serial dilutions 
of the virus and incubated for about 8 hr. Detection of infected cells is determined by 
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immunostaining technique using a virus±specific primary antibody such as an NP specific 
monoclonal antibody, and then the infected cells can be easily observed using either 
fluorescently or enzyme (e.g. horse radish peroxidase, HRP) labelled secondary 
antibodies (Figure 3.2±2). Results are expressed as Focus Forming Unit (FFU) per 
microlitre.  
 
Figure 3.2±2 Immunocytochemical staining of MDCK cells.  
Cells are infected with unknown concentration of influenza A virus for 8 hr. Infected cells (dark brown) can 
be easily differentiated from uninfected cells (unstained). 
 
3.2.2.2 Quantification of viral gene expression by qRT±PCR 
Quantitative reverse transcription polymerase chain reaction (qRT±PCR) enables 
quantification of gene expression and RNA copy number measurements (Heid et al., 
1996).  It allows exponential amplification of RNA sequences to be detected and 
measured as the reaction progresses in real time. This technique is based on the reaction 
of fluorescent molecules with the amplified DNA to produce a fluorescent signal (Figure 
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3.2±3). The main fluorescent chemistries that have been used are DNA binding dyes 
(such as SYBR green) and fluorescently±labelled sequence specific primers or probes 
(such as TaqMan).  
 
 
 
Figure 3.2±3 Graphical representation of real±time PCR data. Cycle number is shown on the X±axis, 
and the amplification of fluorescence is shown on y±axis. Exponential phase represents the period of time 
where the PCR product is approximately doubled each cycle. Non±exponential plateau phase (cycles 30±
40) starts when one or more PCR component becomes limited. The number of cycles at which the 
fluorescent signal becomes detectable is called Threshold cycle (Ct).  
 
Previous studies have described qRT±PCR methods to detect influenza A virus by 
amplifying a part of the matrix gene, the most conserved gene among all influenza A 
subtypes (Fouchier et al., 2000, Ward et al., 2004, Youil et al., 2004). This technique is 
considered to be faster and more sensitive in comparison with the other traditional 
isolation and quantification procedures (Fouchier et al., 2000).  
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3.2.2.3 Measurement of virus protein production from culture supernatants 
The final step of the influenza A life cycle is budding and release. M1 protein plays a 
critical role in this step, and it is impossible for virus budding to occur in the absence of 
this protein (Lohmeyer et al., 1979, Nayak et al., 2004). Therefore measurement of M1 
protein expression from culture supernatants is valuable to measure virion production 
from different host cells. Protein expression can be measured by western blotting, a 
widely accepted technique for visualization and identification of proteins. Western 
blotting was first documented by Towbin et al (1979), and has since become a routine 
technique for protein analysis. It is based on building up an antibody:protein complex 
using a specific primary antibody followed by detecting this complex using a labelled 
secondary antibody. The procedure involves electrophoretically separating proteins in an 
appropriate gel such as sodium dodecyl sulfate±poly acrylamide gel electrophoresis 
(SDS±PAGE) (Laemmli, 1970), and then the separated proteins are blotted onto a solid 
matrix such nitrocellulose membrane. Before immunological detection, membranes are 
blocked to prevent the non±specific binding (high background) of antibodies to the 
membrane surface. Immunological staining (Figure 3.2±4) is performed by incubating 
membranes with primary antibody targets for the specific protein. The produced 
protein:antibody complex is then exposed to conjugated secondary antibody such as 
HRP±linked, and the detected signal from the labelled secondary antibody is proportional 
to the amount of protein on the membrane.  
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Figure 3.2±4 Illustration of target protein detection in western blot.  
Specific antibody binds with the protein of interest on the blotted membrane. Enzyme± labelled secondary 
antibody interacts with protein±primary antibody, forming protein±primary antibody±secondary antibody 
complex. When this complex is exposed to an appropriate substrate, the enzyme drives a 
chemiluminescence reaction and produces a colour.  
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3.2.3 5HSOLFDWLRQRILQÀXHQ]D$LQFKLFNHQDQGGXFNFHOOFXOWXUHV 
Previous work showed that the number of infectious virions produced in CEF cells is 
significantly higher than the number of infectious virions produced from DEF cells, 
however there was no significant difference between virus RNA output measurements 
from the two cell types (Kuchipudi et al., 2011). The experimental aims of the work 
outlined in this chapter were to confirm these findings and additionally measure virus 
protein production to determine whether the decrease in virus protein expression may be 
responsible for the decreased infectivity of the virus.  
 
3.2.4 Hypothesis 
The reduction of infectious virus production from duck cells might be a consequence of 
disruption in RNA replication and decrease in the level of viral M1 protein expression. 
  
3.2.5 Aim and objectives 
To determine the difference in infectivity of viruses produced from chicken and duck 
cells. 
For this objective, culture supernatants of infected chicken and duck cells were collected 
at different times post±infection to detect infectious virus production at each time point. 
Viral RNA replication and protein synthesis were monitored by absolute real time PCR 
and western blotting, respectively. 
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3.3 Materials and methods 
3.3.1 Growth curves 
3.3.1.1  Infection of chicken and duck cells 
Monolayers of chicken and duck embryo fibroblast cells were grown in 24±well plates as 
described in (2.2.3.7). Cells were infected with the LPAI H2N3 (A/mallard 
duck/England/7277/06)  in triplicate at multiplicity of infection (MOI) of 1.0 in serum 
free media (infection media) supplemented with 2% Ultroser G (Pall Biosepra), 1% P/S, 
and 500 ng/mL TPCK trypsin (Sigma±Aldrich), and incubated initially for 2 hr. After 2 
hr, the cells were carefully washed three times with PBS followed by addition of fresh 
media. Supernatants were collected at 2, 4, 6, 8, 24, and 48 hr post infection and were 
stored at ±80ƕC until use.  
 
3.3.1.2 Virus infectivity assay 
Confluent MDCK cells grown on 96±well plates were infected in triplicate with virus 
collected from chicken and duck cells at each time point to measure the virus infectivity, 
which was expressed as focus forming units per µl. Immunological staining with 
influenza mouse anti±NP antibody was performed (as described in 2.2.3.6) to 
differentiate between infected and non±infected cells.  
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3.3.1.3 Focus forming units calculation  
Focus forming units (ffu) per microlitre of the virus were calculated. The well was 
divided into four equal parts (A1, A2, A3, and A4). Pictures were taken for each part of 
the well and all positively±stained cells were counted using image J software 
(http://imagej.en.softonic.com).   
Total number of positive cells in the well = A1+A2+A3+A4 = B 
Amount of undiluted virus used in the well = C (microlitres) 
The number of infective virus particles per microlitre = B/C 
 
3.3.2 Quantification of virus production (measurement of M gene copy number) 
RT±PCR was employed to quantify influenza virus matrix gene in culture supernatants as 
described before (Slomka et al., 2009). Viral RNA from culture supernatants of infected 
chicken and duck cells was extracted using QIAamp viral RNA purification kit (Qiagen) 
IROORZLQJWKHPDQXIDFWXUHU¶V LQVWUXFWLRQV$RQHVWHSDEVROute quantification of viral M 
gene expression was performed using SuperScript® III Platinum® One±Step qRT±PCR 
Kit ,QYLWURJHQ $ VHQVH SULPHU ¶±¶ 24±AGA TGA GTC TTC TAA CCG AGG 
TCG±47 and antisense primer 124±TGC AAA AAC ATC TTC AAG TCT CTG±100 
were used to amplify a 101 ESIUDJPHQWRI0JHQHDORQJZLWKDK\GURO\VLVSUREH¶±¶
74±FAM±TCA GGC CCC CTC AAA GCC GA±TAMRA±93 which anneals to a part of 
the amplicon amplified by the two primers. The master mix components were prepared in 
RNase±free conditions using the amounts of reagents in Table 3.3±1. 
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Table 3.3±1 Components and concentrations of one±step real±time PCR for M gene.  
Table showing list of components used to perform a one±step real±time PCR reaction. The volumes and 
concentrations of reagents were optimized as shown in the table. Enzyme mix consisted of SuperScript® III 
Reverse Transcriptase and a hot start Platinum® Taq DNA Polymerase. Reaction mix consisted of a 
proprietary buffer system, magnesium ions (Mg+), deoxyribonucleotide (dNTPs), and stabilizers.  
 
Seventeen microlitres of master mix was added to each required well (in triplicate) of the 
96±well plate (Thermo Scientific), followed by adding 3 µl of RNA sample (diluted 
1:300 or 1:500). Amplification and detection of specific amplicons was performed by 
using LightCycler® 480 (Roche). A relative standard curve was constructed using 5 
different dilutions (10,000 to 100,000,000 copy/µl) of M gene standards (a kind gift from 
Dr. Suresh Kuchipudi, The University of Nottingham, UK). These standard dilutions 
were prepared by cloning the amplified influenza M gene cDNA into the TOPO±TA 
cloning system followed by in±vitro transcription to produce M gene RNA (Kuchipudi, 
2010).  Quantitative RT±PCR conditions and cycling parameters for samples were as 
follows: one cycle at 50ƕC for 30 min, one cycle at 95ƕC for 2 min, and 40 cycles of 95ƕC 
for 15 s and 60ƕC for 1 min. M gene copy number was calculated using LightCycler® 480 
software release 1.5.0, and statistical analysis was done by using GraphPad Prism 
software, version 6.02. 
Component     Volume/reaction (µl) 
DEPC±treated water 4.4 
Enzyme mix 0.4 
Reaction mix (2X) 10 
RNase OUT (40 units/µl) 0.2 
Probe (used at final concentration of 0.2µM) 0.4 
Sense primer (used at final concentration of 0.4µM)   0.8 
Anti±sense primer (used at final concentration of 0.4µM) 0.8 
Template RNA 3 
Total                      20 
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3.3.3 Western blotting 
3.3.3.1 Samples of viruses 
Supernatants collected from chicken and duck cells infected with H2N3 at MOI 1.0 for 8 
and 24 hr were used. They were first centrifuged for 10 min at 1000 xg to remove cell 
debris. Samples were then either used directly or kept at ±80ƕC.  
 
3.3.3.2 SDS±PAGE 
Polyacrylamide Novex® 14% Tris±Glycine Mini Gels (Invitrogen) was used to detect M1 
protein from culture supernatants. Samples to be tested, 1 µl of chicken or duck virus 
supernatant was suspended in 5 µl of 2X Tris±glycine SDS sample buffer (Invitrogen) 
with 1 µl of 2X reducing agent (DTT, Invitrogen) and distilled water (to 10 µl) to lyse 
viral protein. The mixture was incubated at 95ƕC for 5 min, and then cooled and spun 
briefly. Ten microlitres of each sample along with a pre±stained protein marker 
(Invitrogen) were loaded into lanes. Samples were then electrophoresed in 1X Novex® 
Tris±Glycine SDS running buffer (Invitrogen) at 125 V until the final band of the samples 
had reached the bottom of the gel. Gels were then taken out from electrophoresis 
apparatus and washed briefly with electro±transfer buffer.  
 
3.3.3.3 Transfer 
Samples were transferred to a 0.2 µm Amersham Hybond ECL Nitrocellulose Membrane 
(GE Healthcare, Life Sciences) by wet blotting. Membrane was first submerged with 
100% methanol for 30 s, and then washed briefly with water. Tris±glycine gel, 
membrane, Hybond blotting paper (GE Healthcare, Life Sciences) and foam stacks 
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(Invitrogen) were pre±soaked in 100 mL of transfer buffer (1X Novex® Tris±Glycine 
Transfer buffer (Invitrogen) with 10% methanol) for about 15 min. Pre±wetted blotting 
paper was placed on three foam stacks followed by the gel. The membrane was then 
placed on the gel, and further blotting paper and foam stacks were placed on top. Air 
bubbles were removed after adding each layer using a serological pipette to push air 
bubbles outward. 7KHJHO³VDQGZLFK´ZDVSODFHGLQWKHWUDQVIHUFDVVHWWHDQGWKHQORaded 
to the transfer apparatus. Cold transfer buffer was poured into the apparatus, and the 
power supply was then set at 40V for 90 min.  
 
3.3.3.4 Immunological staining 
After transfer, the membranes were removed and rinsed briefly with ultrapure water. 
They were then treated with blocking buffer (5% skimmed dried milk in 1x TBS) for 50 
min at room temperature with gentle shaking. Without washing, membranes were then 
incubated with diluted primary antibody: a mouse monoclonal antibody to influenza M1 
protein (ABD Serotec) diluted 1:2000 with blocking solution and incubated at 4ƕC 
overnight. The membranes were washed 5 times with 1x TBS±T (10 min each time) with 
shaking. Following this step, HRP±linked anti±mouse IgG antibody (Cell Signaling 
Technology) diluted 1:2000 with blocking buffer was added and incubated for 1 hr at 
room temperature with gentle shaking. After 5 times washing, the membranes were 
subjected to ECL prime reagent (GE Healthcare, Life Sciences) to detect the antigen 
antibody complexes. The membrane was exposed to photographic film (GE Healthcare, 
Life Sciences) for about 10 s. The film was then processed with a SRX±101A Konica 
Minolta processer and protein molecular weight was marked on the film. M protein 
expression was determined by optical densitometry using Image J 1.47 software. 
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3.3.4 Statistical analysis 
All data were analysed using GraphPad Prism software, version 6.02. The data from 
infectious virus production in chicken and duck cells was compared using two±way 
ANOVA. The data from M1 gene and protein expressions were analysed using VWXGHQW¶V t 
test.  
 
3.4 Results 
3.4.1 Measurement of stock virus titre on MDCK cells 
MDCK cells infected with serial dilutions of H2N3 were stained with NP specific 
monoclonal antibody to influenza A. The lowest dilution that showed around 95% of 
positive cell was an MOI of 1.0 (Figure 3.4±1 A), and that dilution was used for the 
followed experiments. Uninfected cells showed no staining (Figure 3.4±1 B).  
 
Figure 3.4±1 Measurement of multiplicity of infection 1 (MOI 1.0) of H2N3 on MDCK cells.  
Cells infected with H2N3 and stained with a monoclonal antibody to virus nucleoprotein. (A) The lowest 
dilution of virus that infected 95±100% of cells was considered as MOI of 1.0. (B) Uninfected control cells 
did not show any staining with antibody. 
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3.4.2 Chicken and duck cell susceptibility to H2N3 
The effect of virus infection on chicken and duck cells was assessed by infection with 
H2N3. Comparable levels of infection were obtained following infection of the two cells 
with the virus at MOI of 1. Uninfected cells did not show any evidence of infection 
(Figure 3.4±2). 
 
Figure 3.4±2 Susceptibility of avian embryo fibroblasts to H2N3 influenza at MOI of 1. 
(A) Chicken and (B) duck cells show similar susceptibility to infection with the virus (8 hr post infection at 
MOI of 1.0). Cell infection is detected by immunostaining for viral nucleoprotein antigen to influenza A 
virus. (C) Chicken and (D) duck uninfected controls show no staining with antibody. 
 
3.4.3 Infectious virus production from chicken and duck cells  
To determine the level of infectious virus production at different time points, supernatants 
were collected from infected chicken and duck cells at 2, 4, 6, 8, 24, and 48 hr post 
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infection, and titrated on MDCK cells. The results showed a highly significant difference 
in the number of infectious viruses after 8 hr between infected chicken and duck cells 
(Figure 3.4±3). Chicken cells produced four± to five±fold more infectious virus, 24±48 hr 
post infection, than duck cells.  
 
 
Figure 3.4±3 Levels of infectious virus production in supernatants of infected chicken and duck 
embryo fibroblasts. Cells were infected with avian H2N3 at a MOI of 1.0 and supernatants collected at six 
different time points. The infectious viral titre was measured by titration on Madin Darby canine kidney 
(MDCK) cells. Significant differences (p<0.0001) in infectious virus production between species was 
detected at 24 and 48 hr post infection. Level of infectious viruses showed no difference between species 
following infection for 2, 4, 6, and 8 hr. Data shown represent the mean of triplicate wells with error bars 
showing SD. ffu, focus±forming unit. CEF: chicken embryo fibroblasts, DEF: duck embryo fibroblasts. 
 
3.4.4 Viral RNA production from chicken and duck cells  
To investigate whether the reduction of infectious virus production from duck cells was a 
consequence of the disruption of viral RNA replication, matrix gene copy number (M 
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gene) was measured using qRT±PCR technique on culture supernatants collected at 8 and 
24 hr post infection. M gene copy number of tested samples was calculated using the 
constructed standard curve with five dilutions of matrix gene RNA (Figures 3.4±4 and 
3.4±5). Viral RNA output (M gene) at the two time points (8 and 24 hr post infection) 
was comparable between infected chicken and duck cells (p>0.05).  
 
 
 
Figure 3.4±4 Standard curve for the calculation of M gene copy number. X axis represents M gene 
copy number which can be predicted using the average of Ct values (crossing points) on Y axis.  
 
 
 
 
Figure 3.4±5 Measurement of influenza A matrix gene copy number using real time PCR. Figure 
shows matrix gene copy number in culture supernatants of chicken cells (black bars) and duck cells (grey 
bars) infected with avian H2N3 for 8 hr (a) and 24 hr (b). Results did not show any significant difference in 
M gene production between host cells at the two time points following infection with the virus (p>0.05). 
Data shown represent the mean of triplicate wells with error bars showing SD. 
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3.4.5 Matrix protein expression in chicken and duck cell supernatants 
The level of viral M1 protein expression was determined following infection, using 
western blotting. Viral proteins were prepared from culture supernatants at 8 and 24 hr 
post infection. The amount of matrix protein production at the two time points, measured 
by the optical density, was similar between chicken and duck cell produced viruses 
(Figure 3.4±6 a and b).  
 
 
 
 
Figure 3.4±6 Western blot analysis of viral matrix protein.  
Viral protein, extracted from culture supernatants, and subjected to SDS±PAGE. (a) M protein expression 
from infected chicken and duck cells at 8 hr, and (b) at 24 hr. Quantitative analysis showed no difference in 
M protein expression between chicken cells (black bars) and duck cells (grey bars) at both time points (c 
and d; p>0.05). Data shown represent the mean of triplicate wells with error bars showing SD. 
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3.5 Discussion 
In this chapter, differences in the production of infectious virus from chicken and duck 
fibroblasts were studied. Results revealed that duck cells produced significantly less 
infectious virus than chicken cells, at 24 and 48 hr post infection. The number of 
infectious viruses in supernatants of chicken cell cultures was dramatically increased by 
increasing the time of incubation, in contrast, the production of infectious virus from 
duck cells did not increase greatly with further incubation. However, viral M gene RNA 
production was comparable between chicken and duck cells. Matrix protein expression 
(M1) was also similar in supernatants from chicken and duck cells. 
It is well known that influenza virus requires host cell factors and components to 
facilitate productive infection and to produce infectious progeny virions. Cell type and 
virus strain may play a role in supporting different levels of influenza virus replication. 
For example MDCK and Vero (African green monkey kidney) cells have different viral 
growth kinetics (Youil et al., 2004). In addition, different strains of influenza viruses 
target different cell types in cultured human airway epithelial cells because of the 
differences in cell receptors  (Matrosovich et al., 2004). In the current study, the same 
virus strain (avian H2N3) was used to infect the same cell type of chicken and duck. 
Interestingly, chicken and duck fibroblasts showed similar viral antigen expression of 
H2N3 based on antibody staining of cells for virus nucleoprotein expression. This 
suggests that the viral antigen expression on both cell types at a similar level. Therefore, 
the significant decrease in the number of infectious virions produced following infection 
of duck cells was not a consequence of a lower number of infected cells. The number of 
infectious viruses produced from duck cells was significantly lower than that produced 
from chicken cells at 24 and 48 hr post infection while it was similar between the two cell 
types at time point 2 to 8 hr post infections. This observation is associated with rapid cell 
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death which is induced to a greater degree in duck cells than in chicken cells following 
infection with influenza viruses (Kuchipudi et al., 2011). Cell death was also associated 
with low yields of infective virus particles following infection of HeLa cells with 
influenza virus (Takizawa et al., 1993).  
Supernatants collected at 8 and 24 hr post infection were used to determine viral M gene 
RNA production and viral matrix protein expression. The two time points were selected 
as representatives of a significant (24 hr) and non±significant (8 hr) difference in 
infectious virus production between chicken and duck cells. Influenza viral M gene 
production in the infected cell cultures at 8 and 24 post infection was comparable in 
chicken and duck cells virions. Further, matrix protein expression in culture supernatants 
at the two time points was also comparable between chicken and duck cells. The matrix 
protein of influenza A virus has been shown to play a major role in mediating the 
budding of virus±like particles (VLPs) in the absence of other viral proteins (Gomez-
Puertas et al., 2000, Latham and Galarza, 2001).  However, it would be interesting to 
measure the level of all viral proteins in culture supernatants using western blotting. In 
addition, immunofluorescence of budding viruses and electron microscopy of 
immunogold±labeled virions with monoclonal antibodies against viral surface proteins is 
important to evaluate VLPs formation (Latham and Galarza, 2001).  Moreover, further 
studies are required to measure the levels of the other viral RNA segments and the 
resultant protein expression associated with replication in chicken and duck cells. It is 
possible that the replication of one of the other segments is the rate limiting step for virus 
replication in duck cells. In addition, genetic factors such as mutations or deletions in 
some virus genes or the production of defective interfering viruses might have a role in 
decreasing virion infectivity following infection of duck cells with the virus. 
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4.1 Summary 
Differences in the cellular response to influenza A infection between chicken and duck 
embryo fibroblast (CEF and DEF) cells, with duck cells producing less infectious virus, 
have led to investigate virus assembly and morphology in chicken and duck fibroblasts 
following infection with avian H2N3. Cells were infected with a spherical H2N3 virus 
strain, and the differences in morphology of budding virions were observed.  Viruses 
budding from duck cells were elongated, while chicken cells produced almost spherical 
virions. This difference was also seen in viruses purified from the duck and chicken 
culture supernatants. Spherical viruses were observed in chicken supernatants while duck 
cell supernatants showed pleomorphic virions. These results suggest that factors such as 
differences in gene sequences of structural genes (M1, M2, HA, and NA) or host cell 
determinants might be the reason for the production of such variations in virus 
morphology.  
 
4.2 Introduction 
4.2.1 Influenza A virus morphology  
Influenza A viruses are not uniform in their morphological features. They have different 
shapes ranging from spherical to elliptical with about 100 nm in diameter to elongated or 
filamentous with a diameter reaching to more than several micrometres, and occasionally 
they are pleomorphic (Calder et al., 2010). They have two membrane±associated 
glycoproteins: haemagglutinin (HA), neuraminidase (NA), with small amount of matrix 
protein 2 (M2), which are embedded in a cell±derived lipid envelope. Beneath the lipid 
envelope, there is a matrix protein 1 (M1) layer. All these proteins play an important role 
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in virus morphogenesis (Palese and Shaw, 2007, Bouvier and Palese, 2008).  Diversity of 
virus morphology is thought to be a genetic trait, in particular the seventh segment (M) 
which encodes the matrix proteins plays a dominant role in determining virus shape 
(Roberts et al., 1998, Elleman and Barclay, 2004).  In addition, surface glycoproteins 
(HA and NA) have also been implicated to modulate virus shape (Jin et al., 1997, Zhang 
et al., 2000). Although genetic traits play a major role in determining morphology, these 
traits can be lost after serial passages in the laboratory (Chu et al., 1949, Ada et al., 1958). 
Non±viral factors are also involved in determining influenza A virus morphology. Newly 
isolated clinical strains usually contain a certain percentage of filamentous forms, while 
laboratory adapted viruses especially with many passages on eggs or cells, are almost 
spherical particles (Cox et al., 1980). Cellular factors such as cell polarity and actin 
cytoskeleton can play a major role in determining virus morphology (Sun and Whittaker, 
2007). Epithelial cells have been shown to produce more filamentous particles than 
fibroblasts and intact actin cytoskeleton is important for forming filamentous, but not 
spherical virions (Roberts and Compans, 1998, Simpson-Holley et al., 2002). 
Furthermore, endocytic trafficking regulator and its effector Rab11±family interacting 
protein 3 (Rab11±FIP3) are also required to support the formation of filamentous virions 
(Bruce et al., 2010).  
 
4.2.2 Electron Microscopy 
Electron Microscopy (EM) was first described by Ruska et al. (1939) for investigating the 
nature of viruses; however it is still used in different purposes, particularly in the field of 
virology (Goldsmith and Miller, 2009). It allows detection and classification of viruses 
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based on their structure and morphology, in addition to studies of virus pathogenesis and 
life cycle (Schramlova et al., 2010, Zhang et al., 2013). It can be employed for viewing 
pathogens (usually viruses) either by performing routine thin sections of tissue culture or 
by testing body fluids directly (Hazelton and Gelderblom, 2003).   
Thin tissue sectioning is considered a valuable method used in cells or tissues for virus 
detection and examining the effect of the virus on the host cell (Miller, 1986). In this 
technique, cells are usually grown and infected on plastic coverslips, followed by fixation 
with EM fixative buffer, such as 2±4% glutaraldehyde, then washing in buffers, and 
positive staining with 1% buffered osmium. The sample is then completely dehydrated 
with graded ethanol series and acetone followed by embedding in resin, ultrathin 
sectioning, and multiple staining incubations. Viruses can also be viewed in fluids using 
negative staining. Samples are first clarified to remove large particles (e.g. bacteria and 
cell debris) by centrifugation at a low speed and for diluted samples, ultracentrifugation is 
usually performed. Samples are adsorbed on coated grids and floated to allow negative 
staining such as Urenyle acetate or phosphotungstic acid (PTA) and examined under an 
electron microscope (Hazelton and Gelderblom, 2003, Goldsmith and Miller, 2009).  
Transmission electron microscopy (TEM) has had a major contribution in the discovery 
of many viruses and in the diagnosis of various virus infections. Although more sensitive 
molecular methods such as PCR and immunofluorescence have gradually replaced TEM, 
it remains essential for certain aspects in virology particularly in the diagnosis of 
unknown pathogens and also to study the cellular changes associated with viral infection 
(Roingeard, 2008). Transmission electron microscopy of influenza viruses has been used 
to study the morphology and the ultra±structural components of viruses (Noda et al., 
2006, Khanna et al., 2008), and for the detection of new virus strains (Kang et al., 2006). 
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TEM can be used to observe budding of influenza virions by ultra±thin sections, and also 
detection of virus morphology using negative staining of culture supernatants or body 
fluids (Bachi et al., 1969, Rodriguez Boulan and Sabatini, 1978, Wrigley, 1979, Nayak et 
al., 2009).  
 
4.2.3 Hypothesis 
The reduction in infectious virus titre from duck cells may be due to changes in virus 
assembly and morphology.  
 
4.2.4 Aim and objectives 
To determine the differences in influenza virus assembly and morphology in duck or 
chicken cells via electron microscopy.  
For this objective, chicken and duck cells infected with influenza virus were detected by 
electron microscopy to visualise the differences in viral budding and assembly. Culture 
supernatants were tested to compare the morphology of viruses produced from both cell 
types. 
 
4.3 Materials and Methods 
4.3.1 Viruses 
Avian influenza H2N3 A/mallard duck/England/7277/06 was used. This was grown in 
allantoic fluid of embryonated KHQ¶Veggs (as described in 2.2.2).  
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4.3.2 Virus infection and fixation of cells  
Chicken and duck embryo fibroblast cells (as described in 2.2.3.1) were grown on 
Thermanox Plastic Coverslips (13 mm in diameter) in 24±well plates in DMEM with 
10% FCS and 1% antibiotics, and then incubated at 37ƕC until confluent. The cells were 
then infected with H2N3 in serum±IUHH+DP¶VFRQWDLQLQJ8OWURVHU*QJmL 
TPCK trypsin and antibiotics at a multiplicity of infection (MOI) of 1.0 for 7 hr, or at a 
MOI of 0.1 for 24 hr. They were then fixed with EM fixative buffers (3% glutaraldehyde 
in 0.1M cacodylate buffer) at room temperature for 10 min, washed with cacodylate 
buffer, and stored at 4ƕC until TEM processing. 
 
4.3.3 Processing cells for transmission electron microscopy 
4.3.3.1 Preparing resin 
Resin used for cell infiltration and embedding was prepared by mixing 25 mL Araldite 
CY212 resin, 15 mL Agar 100 resin and 55 mL of dodecenylsuccinic anhydride (DDSA) 
in a tri±pour beaker. The mixture was stirred well, and then 2 mL dibutyl phthalate and 
1.5 mL DMP±30 were added and mixed. The beaker was covered with foil and incubated 
for 20 min at 60ƕC to eliminate air bubbles that formed during mixing. 
 
4.3.3.2 Cell dehydration and infiltration with resin 
Cultured cells were fixed with 1% aqueous osmium tetroxide for 30 min, and then 
washed with distilled water 5 x 1 min. Dehydration in graded ethanol series was 
performed using the following ethanol concentrations and times:   2 x 5 min 50% ethanol, 
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2 x 5 min 70% ethanol, 2 x 5 min 90% ethanol, followed by 3 x 10 min 100% ethanol. 
The coverslips were then transferred to glass vessels and infiltrated with 100% dried 
acetone for 2 x 5 min. The dried cells were infiltrated with resin in three steps: 30 min in 
1:3 resin:acetone mix, 1 hr in 1:1 resin : acetone mix, and then 3 x 1 hr in pure resin.  
The coverslips containing the cell layer were inverted on a capsule filled with fresh resin 
and then incubated in the embedding oven for 48 hr at 60ƕC. The resin block 
polymerized, and the coverslip was removed from the cells by immersing the block in 
liquid nitrogen and snapping the coverslip leaving the cells on the surface of the block. 
The resin block was removed from its plastic tube using a beam capsule press. Then the 
block was embedded in an eppendorf tube containing fresh resin so that the cell layer was 
nearest the bottom, and the sides of the tube were marked where the cell layer of the 
block was. Then it was polymerized as before.  
After polymerization, the cell layer was enclosed in a resin block. The layer was cut out 
of the block by sawing either side of it to give a disc of resin with the layer running 
through the middle. The disc was cut in half to form 2 semi±circles, and those were stuck 
onto the top of a blank resin block using super glue.  
 
4.3.3.3 Sample cutting 
The block±tissue was placed into a chuck of a Leica EM UC6 ultramicrotome system and 
tightened securely. A sharp knife was fixed on the stage of the microscope and gradually 
advanced to the front until it has almost touched the block. The block was the carefully 
trimmed several times until the tissue was being sectioned. The knife was then replaced 
with a fresh one attached with a plastic boat. The boat was filled with sterile water to the 
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level of the knife edge. The block was advanced by 0.5 µm and green±pink sections were 
cut and floated out onto the water. A drop of water was placed on a 3±
aminopropyltriethoxysilane (APES)±coated slide, and a section was removed from the 
boat using a fine paintbrush and placed on the drop of water on the slide. The slide was 
then placed on a hotplate to flatten out and dry the section, and then a few drops of 1% 
toluidine blue±O in 1% sodium borate were added, and the slide was placed again on the 
hotplate.  After 1 min, the slide was rinsed with distilled water and replaced on the 
hotplate to dry, and then was viewed under the light microscope. Once the cells were seen 
clearly, the area of interest was determined.  
The whole chuck holder (including the block) was removed and placed into the flat 
holder in place of the knife holder. The surface of the block was trimmed into a trapezium 
shape using a single±edged blade. The sample was then sectioned as above using a 
diamond knife. The sections this time were cut thinner (90 nm) and they appeared pale 
gold±silver in color. Sections were separated in the boat using a fine eyelash and flattened 
using chloroform vapour. Sections were picked up on G200HH 3.05 mm copper grids, 
100 HEX (TAAB). Using fine forceps, the grid was held dull side up and introduced to 
the water at an angle, and then was brought under the section and lifted clear of the water 
with the section on the upper surface. Grids were put in a labelled petri dish containing 
filter paper for 1 hr at room temperature for air drying. 
 
4.3.3.4 Sample staining 
A square of parafilm slightly smaller than a petri dish was prepared and attached to the 
bottom of the dish. Using a syringe and filter, 1 drop of ethanolic urenyle acetate was put 
on the parafilm, and the grid was then placed on the drop with the sample facing down. 
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Drops were then incubated in the dark for 5 min at room temperature. The grid was then 
retrieved from the drop with a pair of fine forceps and quickly dipped ten times in each of 
a series of three disposable beakers, the first beaker containing 50% ethanol and the other 
two containing sterile water.  It was then blotted on clean filter paper, and then a fresh 
piece of filter paper was slid between the forceps blades and also used to push the grids 
out of the forceps and onto a clean dry piece of filter paper on a petri dish. Using another 
clean petri dish, a square of parafilm was placed on the base, and by the use of syringe 
DQGILOWHUGURSRI5H\QROG¶V/HDG&LWUDWHZDVSXWRQWKHSDUDILOPThe grid was placed 
on the drop, and the dish was quickly covered and incubated in dark for 8 min at room 
temperature. It was then rinsed with sterile water and dried as above, and then placed in a 
clean labelled petri dish.  
 
4.3.4 Processing supernatants for electron microscopy 
Chicken and duck cells were grown in T75 flasks in DMEM with 10% FCS and 1% 
antibiotic at a seeding density of 2.5 x 106 cells per flask. They were incubated at 37ƕC 
until confluent. They were then infected with H2N3 in serum±free +DP¶V)containing 
2% Ultroser G, 500 ng/mL TPCK trypsin and antibiotics, at a MOI of 1.0. The flasks 
were initially incubated at 37ƕC for 2 hr. They were then rinsed three times with PBS, and 
5 mL of fresh infection media without Ultroser G and TPCK trypsin was added. The cells 
were then further incubated up to 24 hr. Viral supernatants were then harvested, and 
clarified by centrifugation at 500 xg for 10 min. They were then concentrated by 
Amicon® Ultra 100K NMWL (National Molecular Weight Limit) Centrifugal Filter 
Device (Millipore) at 3000 xg for 30 min. Virus concentration was confirmed by titrating 
with chicken red blood cells. Samples were then prepared for negative staining. Briefly, 
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10 µl of concentrated sample were absorbed to Formvar carbon support film 3.05 mm 
copper grids, 100 HEX (TAAB) and incubated for 1 min then the excess fluid was 
carefully wicked away using a filter paper. Ten microlitres of negative stain (2% 
phosphotungstic acid) were then added to the grid and incubated for 30 s, then removed 
with filter paper. Grids were then left to air dry for 30 min at room temperature.  
 
4.3.5 EM imaging 
Samples were imaged using Tecnai G212 Bio Twin Digital TEM system. Photographs 
were taken from different areas of the grid at a range of image magnifications.    
 
4.4 Results 
4.4.1 The morphology of avian H2N3 
Avian H2N3 viruses that were used to infect chicken and duck fibroblasts were visualized 
by negative stain transmission electron microscopy. Virions appeared spherical to slightly 
ovoid in shape of a diameter about 100 nm (Figure 4.4±1).  
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Figure 4.4±1 : Electron micrographs of negatively stained avian H2N3 virions grown in allantoic 
IOXLGRIKHQ¶V HJJV Spherical particles were detected after testing the allantoic fluid under transmission 
electron microscope. Scale bar 500 nm. 
 
4.4.2 EM imaging of infected chicken cells 
To observe the first generation of viruses produced from chicken fibroblasts, cells were 
infected at MOI of 1.0 and incubated at 37ƕC for 7 hr. The majority of cell membrane 
budding viruses showed spherical virus morphology with a diameter of about 100 nm 
(Figure 4.4±2). Very similar results were observed in the second viral generation which 
was obtained after infecting cells at MOI of 0.1 for 24 hr (Figure 4.4±3). 
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Figure 4.4±2 Budding influenza virus particles from infected chicken cells 7 hr post infection. 
Electron micrographs showing the presence of spherical virions budding from the surface of H2N3 infected 
chicken fibroblasts at MOI of 1.0 at 7 hr post infection (A, B, C, D and E) (indicated by arrows). 
Uninfected control (F) showed no virions. Scale bars 500 nm. 
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Figure 4.4±3 Budding influenza virus particles from infected chicken cells 24 hr post infection. 
Electron micrograph showing the presence of spherical virions budding from the surface of H2N3 infected 
chicken fibroblasts at MOI of 0.1 after 24 hr post infection (A, B, and C) (indicated by arrows). Uninfected 
control (D) showed no virions. Scale bars 500 nm. 
 
4.4.3 EM results of infected duck cells 
Two viral generations were also studied following infection of duck cells with the H2N3. 
The first generation was generated by infecting cells at MOI of 1.0 for 7 hr, while the 
second generation was observed following infection at MOI of 0.1 for 24 hr. Although 
the virus used to infect cells is spherical in shape, the majority of budding viruses were 
elongated over 500 nm length and almost filamentous up to few micrometres in length 
(Figure 4.4±4 and 4.4±5).  
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Figure 4.4±4 Budding influenza virus particles from infected duck cells 7 hr post infection.  
Electron micrograph showing the presence of numerous virions budding from the surface of H2N3 infected 
duck fibroblasts at MOI of 1.0 after 7 hr post infection. Most of the budding particles are elongated or short 
filaments (A, B, C and D) with some filamentous bundles (E) (indicated by arrows). Uninfected control (F) 
showed no virions. Scale bars 500 nm. 
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Figure 4.4±5 Budding influenza virus particles from infected duck cells 24 hr post infection.  
Electron micrograph showing the presence of elongated to filamentous virions budding from the surface of 
H2N3 infected duck fibroblasts at MOI of 0.1 after 24 hr post infection (A, B, and C) (indicated by arrows). 
Uninfected control (D) showed no virions. Scale bars 500 nm. 
 
4.4.4 EM results of culture supernatants 
To achieve a further overview of the variations in virion morphology between viruses 
grown in chicken and duck embryo fibroblasts, concentrated viruses from culture 
supernatants of infected cells were examined under the electron microscope at different 
magnifications (Figure 4.4±6 and 4.4±7). Morphological differences were clearly 
observed between the two cell supernatants. Viruses derived from chicken cells were 
almost spherical while those obtained from duck cells were elongated to pleomorphic 
with sizes similar to those budding from cells. Very similar results were observed after 
imaging the non±concentrated viruses (Figure 4.4±8). 
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Figure 4.4±6 Electron micrographs of concentrated and negatively stained virions released from chicken fibroblasts.  
Spherical particles were detected after testing culture supernatants of infected chicken cells under an electron microscope. Scale bars 500 nm. 
 Firas Al ?Mubarak 2014 Chapter 4: Electron Microscopy 
 
111 
 
 
Figure 4.4±7 Electron micrographs of concentrated and negatively stained virions released from duck fibroblasts.  
Pleomorphic particles were frequently observed after testing culture supernatants of infected duck cells under electron microscope. Scale bars 500 nm. 
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Figure 4.4±8 Electron micrographs of non±concentrated and negatively±stained virions released 
from chicken and duck fibroblasts.  
The figure showing non±concentrated viruses obtained from chicken (A, B and C) and duck (D, E and F) 
fibroblasts. Similar virus morphology with concentrated virions was observed. Chicken and duck cells 
produced spherical and pleomorphic virion shapes, respectively. Scale bars 500 nm 
 
 
 
 
Firas Al ?Mubarak 2014 Chapter 4: Electron Microscopy 
113 
 
4.5 Discussion 
Differences in virus morphology between chicken and duck fibroblasts following 
infection with avian H2N3 were studied using a transmission electron microscope. 
Results revealed that there is a clear difference in assembly of viruses from chicken and 
duck cells, and also in the morphology of viruses within culture supernatants. Longer 
virions were observed in duck cells compared with those budding from chicken cells. 
Viruses observed from culture supernatants of chicken cells were mostly spherical in 
shape with a similar diameter to the inoculum virions, while viruses produced from duck 
cells were slightly elongated or pleomorphic.  
Sample preparation processes may play a role in producing pleomorphic virus particles 
(Noda, 2011). Studies have shown that pleomorphic morphology is introduced during the 
storage of virions at 4ƕC after they are harvested (Choppin et al., 1961). In addition, virus 
morphology can be substantially disrupted by ultracentrifugation of non±fixed samples 
which results in production of irregular virions (Sugita et al., 2011). To avoid these 
possibilities, viruses were concentrated using an alternative method that should keep the 
virus shape without any changes. This method is based on the filtration of culture 
supernatants at a lower centrifugation speed. In addition, non±concentrated viruses were 
also tested under an electron microscope and no obvious differences to the concentrated 
samples were observed.  
It is well known that influenza A viruses exhibit different morphological structures. Most 
clinical isolates are predominantly filamentous (Chu et al., 1949), while the laboratory±
adapted strains are mostly spherical or elliptical (Kilbourne and Murphy, 1960). Matrix 
(M gene) which encodes two proteins (M1 and M2) has been shown to play an essential 
role in modulating filamentous versus spherical virus morphology (Hughey et al., 1995, 
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Bourmakina and Garcia-Sastre, 2003, Elleman and Barclay, 2004). In addition, viral 
morphology, genome packaging, and incorporation of NA and M1 into virions are also 
reported to be affected by changes in the amino acid sequences  (Burleigh et al., 2005) or 
deletion in the cytoplasmic tails of the other viral transmembrane proteins (HA, NA) (Jin 
et al., 1997, Zhang et al., 2000). Therefore, sequencing of these genes (M, HA, and NA) 
is important to determine whether the difference in virus morphology is accompanied by 
with some mutations or deletions in these genes during virus replication (see chapter 5).  
Cellular factors such as cell polarity and actin cytoskeleton network are important in 
determining the production of filamentous virions. Filamentous particles up to 30 µm 
can be observed on the surface of polarized cells following infection with a filamentous 
strain such as A/Udorn/72 virus while spherical or slightly elongated particles are usually 
detected from the infection of non±polarized cells (Roberts and Compans, 1998). 
However, duck fibroblast cells used in this study produced short filaments after infecting 
with spherical strain (H2N3) while chicken fibroblast cells produced only spherical 
virions. Intact actin of chicken and duck fibroblasts might have a potential role in 
determining virus morphology, particularly the filamentous form.  
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5.1   Summary 
Molecular differences between H2N3 viruses produced in chicken and duck cells were 
investigated. All the eight viral segments were amplified by one±step polymerase chain 
reaction (PCR) and sequenced directly. Six of the viral gene sequences (PA, HA, NA, M, 
NS, and NP) showed identical sequences in viruses produced by chicken and duck cells, 
but some differences in viral sequences were found in two of the polymerase (P) genes 
(PB1, and PB2). However, these differences were due to the production of non±specific 
PCR products rather than viral mutations, which was confirmed by cloning the PCR 
products using the TOPO® TA Cloning system, and also by loading a large volume of 
PCR products on agarose gel, enabling detection of the non±specific bands. Taken 
together, these results demonstrate that there is no difference between gene sequences of 
influenza viruses grown in chicken or duck primary cells. As a consequence, any 
differences in virus morphology, between chicken and duck grown viruses must be due to 
host cell factors. 
 
5.2 Introduction  
5.2.1 Genetics of influenza A virus 
The influenza A virus is lipid±enveloped with eight separate single±stranded RNA 
segments, which are the polymerase genes (PA, PB1, and PB2), haemagglutinin (HA), 
nucleoprotein (NP), neuraminidase (NA), matrix (M), and non±structural (NS) genes 
(Cheung and Poon, 2007). Each segment encodes one or more proteins. The polymerase 
protein complex (PB1±PB2±PA) encodes RNA±dependent RNA polymerase and is 
found as a heterotrimer within the whole virions or in the nuclei of infected host cells 
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(Detjen et al., 1987). In addition to the three polymerase subunits that are encoded by the 
three polymerase genes, PB1 also encodes two minor products: N40, which is N±
terminally truncated from the same PB1 protein reading frame (Wise et al., 2009) and 
PB1±F2, a short peptide expressed from open±reading frame 1 (McAuley et al., 2010). 
The NP with the polymerase complex forms the ribonucleoprotein (RNP) that each viral 
segment is associated with (Naffakh et al., 2008). The HA gene encodes the major 
surface protein which binds with the sialic acid of the host cell leading to virus uptake, 
while the NA gene encodes the enzymatic surface protein which is important for viral 
release at the end of virus replication. The seventh segment (M) encodes two proteins: 
M1 that lines the internal surface of the virus lipid membrane; and M2, which is the ion 
channel that mediates virus uncoating (Mitnaul et al., 2000). The shortest segment also 
encodes two proteins: NS1 which mediates evasion of the innate immune response and 
NS2 (also called nuclear export protein, NEP) that plays a role in exporting RNA from 
the nucleus into the cytoplasm (Iwatsuki-Horimoto et al., 2004).  
Every viral protein has specific binding sites that are essential in the virus life cycle, to 
facilitate production of a fully infectious virion. These domains have a role in each of the 
life cycle, including virus attachment, transcription, replication, nuclear import and 
export, packaging, budding and release. Mutations and deletions in any of influenza viral 
genes might affect virus replication and the production of a completely infectious virion. 
Figure 5.2±1 shows the main influenza A viral protein domains and their role in virus 
replication, pathogenicity and morphogenesis. 
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Figure 5.2±1 Domain organisation and structures of influenza A viral proteins.  
The figure shows a linear representation of the viral protein molecules. Numbers refer to the amino acid 
positions. PB1 protein (1) represents the core subunit of the polymerase complex as it interacts with both 
PB2 and PA proteins (2 and 3, respectively), which results in the production of a PA±PB1±PB2 complex 
which plays an essential role in viral RNA transcription and replication. In addition, PB2 forms the cap±
binding and putative RNA domains; and also a domain that bindVKXPDQLPSRUWLQĮ. NP protein (5) has a 
tail±loop binding site, which is important in NP±NP binding, in addition to the RNA binding site. NP is 
also incorporated into the polymerase complex via interaction with the PB2 protein. The HA protein (4) 
consists of two main parts; the HA1 subunit containing the sialic acid receptor±binding domain and the 
ectodomain HA2 subunit, which contains a fusion peptide that mediates the fusion of the virus envelope 
and endosomal membranes, and transmembrane (TM) domains, which interact with M1 at the end of the 
virus life cycle. There is a protease cleavage site between the HA1 and HA2 subunits characterised by a 
specific multibasic amino acid sequence. The biggest part of the NA protein (6) is the active site, which 
plays a role in cleaving the terminal sialic acid from the HA receptors on cell membranes. It also contains a 
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membrane domain that interacts with M1. The main structural component of the M1 protein (7) is the 
nuclear export protein (NEP) binding site, which is important in the nuclear export of ribonucleoprotein 
particles. The M2 protein (8) has three regions: the extracellular domain which is highly conserved 
between the different influenza in all known influenza strains, transmembrane domain which forms the 
core of the ion channel and is the target of anti±influenza drugs, and cytoplasmic domain, which plays a 
role in virus budding and assembly. The NS1 protein (9) can be divided into the N±terminal domain that 
binds double±stranded RNA and the C±terminal effector domain that binds multiple cellular proteins. NEP 
(10) is also divided into two regions; the N±terminal domain that binds the cellular protein Crm1, or 
exportin 1, which mediates the export of many proteins, and the C±terminal region which has been 
identified as pivotal for the M1 binding site. Figure assembled from (Kong et al., 2006, Boulo et al., 2007, 
Cady et al., 2009, Das et al., 2010, Du et al., 2012). 
 
5.2.2 Polymerase chain reaction and nucleotide sequencing 
The polymerase chain reaction (PCR) is an in vitro biochemical technique used to 
amplify a single copy of DNA, generating billions of specific sequences from a DNA 
template in a simple enzymatic reaction (Mullis, 1990). It has now became one of the 
most common molecular techniques used for a variety of applications such as detection 
and diagnosis of infectious diseases, identification by ³finger printing´, and DNA 
cloning for sequencing. It has frequently been used in the detection and screening of 
influenza A viruses (Pisareva et al., 1992, Fouchier et al., 2000). Viral mutations can also 
be detected using this technique (Liu et al., 2009). Sequencing of PCR amplification 
products can provide valuable information about the identity of a virus. The process of 
obtaining nucleotide sequence data from PCR reactions can be achieved through the use 
of a cycle sequencing reaction that utilizes Taq polymerase and dideoxynucleotides in 
the PCR reaction mixture (Innis et al., 1988). Removal of unincorporated primers and 
nucleotides from the PCR product is a necessary step before DNA sequencing. This can 
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be achieved by performing PCR purification by centrifugal ultrafiltration devices. While 
most of primer dimers are removed using such devices, large nonspecific amplicons (>50 
bp) will not be removed and they can interfere with DNA sequencing (Krowczynska and 
Henderson, 1992).   
 
5.2.3 Hypothesis  
The reduction in infectious influenza virus titre from duck cells and the variation in virus 
morphology may be due to defects or changes in the viral genome.  
 
5.2.4 Aim and objectives 
To investigate the molecular changes of influenza viruses cultured on chicken and duck 
embryo fibroblasts by whole genome sequencing.  
To achieve this objective, viral nucleotide and amino acid sequence alignment between 
viruses derived from chicken and duck fibroblasts will be performed to determine any 
differences which might have a role in decreasing viral infectivity and changing virus 
morphology. 6HTXHQFHVRISDUHQWYLUXVHVJURZQLQKHQV¶HJJVZLOODOVREHFRPSDUHG
with virus sequences following culture in chicken or duck cells.  
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5.3 Materials and Methods 
5.3.1 Polymerase chain reaction (PCR) 
Amplification of each gene segment of influenza virus was performed using One Step 
Super Script III RT±PCR kit (Invitrogen). Viral RNA was extracted from culture 
supernatant following the procedure described in chapter 2 (2.3). 
 
5.3.1.1 Oligonucleotide primers used in PCR  
Highly conserved sequences among several strains of H2N3 influenza A viruses were 
used to design the primers that were used for amplification (Appendix II). The influenza 
research data base (http://www.fludb.org/brc/home.do?decorator=influenza) was used for 
primer design of all viral genes together with another freely available software program 
(http://www.premierbiosoft.com/servlet/com.pbi.crm.clientside.FreeToolLoginServlet#) 
for checking the possibilities of primer dimer, cross dimer, and hair pin loops. Primers 
were designed to amplify all eight H2N3 viral segments in the genome. In order to 
amplify the whole virus genome, two or three sets of primers were designed for each 
gene (Table 5.3±1). All these primers were supplied by Eurofins WMG Operon, London, 
UK. 
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Table 5.3±1 Primers designed for RT±PCR amplification of the eight viral segments of H2N3 avian 
influenza A. Two or more sets of primers were designed for each gene to amplify and sequence the whole 
genome. Some non±influenza nucleotides were added in some primers (underlined) to ensure that the whole 
amplicon can be sequenced, to increase annealing temperature at 5'±end and also to decrease the possibility of 
primer dimer formation.  
Gene Forward primer Reverse primer Amplicon 
sizes(bp) 
PB2 PB2±53±For                                                       5'±ATCTAATGTCGCAGTCCCGCAC±3' 
PB2±2278±Rev                                                      
5'±TCGCTGTCTGGCTGTCAGTAAG±3' 2226 
PB2 PB2±1±For                                                         5'±CTCAGCGAAAGCAGGTCAA±3' 
PB2±106±Rev                                                        
5'±GGTCCACAGTGGTCTCTTAG±3' 106 
PB2 PB2±2233±For                                                   5'±AACGGAAACGGGACTCTA±3' 
PB2±2341±Rev                                                      
5'±TAGAGTAGAAACAAGGTCGT±3' 109 
PB1 PB1±25±For                                                       5'±ATGGATGTCAATCCGACTTTAC±3' 
PB1±2298±Rev                                                
5'±CTATTTCTGCCGTCTGAG±3'  2274 
PB1 PB1±1±For                                                         5'±CTC AGCAAAAGCAGG CAAA±3' 
PB1±120±Rev                                                  
5'± ATGGCTGTATGGAGGATCTC±3' 120 
PB1 PB1±2222±For                                                   5'± ACGGATTAAGAAGGAGGAGT±3' 
PB1±2341±Rev                                                
5'± AGAGTAGTAGAAACAAGACATT±3' 120 
PA PA±1±For                                                           5'±AGCGAAAGCAGGTACTGA±3' 
PA±2217±Rev                                                  
5'±TTTTGGACAGTATGGATAGC±3'  2217 
HA HA±1±For                                                          5'±AGCAAAAGCAGGGGTTATAC±3' 
HA±1711±Rev                                                       
5'±GCAGAGACCCATTAGAACAC±3' 1711 
HA HA±1366_For                                                    5'±TGGAGAATGAGAGGACA±3' 
HA±1778±Rev                                                       
5'±CTAGAGTAGTAGAAACAAGGGTGT-3' 413 
NP NP±1±For                                                           5'±AGCAAAAGCAGGGTAGATAA±3' 
NP±1525±Rev                                                  
5'±CTGCATTGTCTCCGAAGA±3' 1525 
NP NP±1356±For                                                     5'±TCAGACATGAGAACAGAAATCA±3' 
NP±1565±Rev                                                  
5'±TAGAGTAGTAGAAACAAGGGTATT±3' 210 
NA NA±11±For                                                        
5'± GGTGCGAGATGAATCCAAAT±3' 
NA±1374±Rev                                                  
5'±CCGATCCAGGTTCATTGTCT±3' 1364 
NA NA±1±For                                                          5'±AGCAAAAGCAGGTGCGAGAT±3' 
NA±420±Rev                                                    
5'±GAGAGCAAAGGACCAGCAAT±3' 420 
NA NA±1220±For                                                    5'±ATTGGTCAGGCTATTCAGG±3' 
NA±1453±Rev                                                       
5'±TAGAGTAGTAGAAACAAGGTGG±3' 234 
M M±1±For                                                        5'±AGCAAAAGCAGGTAGATATTG±3' 
M±999±Rev                                                        
5'±GCTCTATGTTGACAAAATGACC±3' 999 
M M±857±For                                                    5'±AATGCATTTATCGTCGCCT±3' 
M±1027±Rev                                                        
5'±TAGAGTAGTAGAAACAAGGTAGT±3' 171 
NS NS±20±For                                                         5'±AWACATAATGGAYTCCAACAC±3' 
NS±677±Rev                                                    
5'±CTTTGGAGGGAGTGGAG±3' 658 
NS NS±575±For                                                         5'-GGACTTGAATGGAATGATAACAC-3' 
NS±890±Rev                                                    
5'±TAGAGTAGTAGAAACAAGGGTG±3' 316 
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5.3.1.2 PCR conditions  
For amplifying each of the 8 viral genes, SuperScript® III one step RT±PCR system with 
platinum® Taq high fidelity was used. Both cDNA synthesis and PCR amplification 
were performed in a single tube using this system. Gene±specific primers (Table 5.3±1) 
were used for cDNA synthesis and PCR amplification. Starting material of viral RNA 
used in cDNA synthesis of all genes was 100 ng/µl, and the final concentration of Mg+2 
ions (which is included in the 2X reaction mix) was 1.2 mM. The volumes and final 
concentrations of components used in the PCR are shown in Table 5.3±2. 
 
Table 5.3±2 One±step RT-PCR reaction.  
Table showing list of components used to perform one±step RT±PCR.  The amount of viral RNA used in 
the reaction was 100 ng/µl. Reaction mix consisted of a proprietary buffer system, deoxyribonucleotide 
phosphate (dNTPs), magnesium ions (Mg+2), and stabilizers. Enzyme mix consisted of SuperScript® III 
Reverse Transcriptase and Platinum® Taq DNA Polymerase High Fidelity. 
 
The tube was capped and then placed in a thermal cycler (XP cycler), and the following 
program was used for RNA transcription (cDNA synthesis) and PCR amplification:    
1) For amplicons more than 400 bp, PCR conditions were: cDNA synthesis at 55ƕC for 30 
min, initial denaturation at 95ƕC for 2 min followed by 35 cycles of: denaturation at 95ƕC 
for 30 s, annealing at 58ƕC for 40 s, extension at 68ƕC for 2 min. The reaction was then 
held at 68ƕC for 10 min, and then cooled down at 4ƕC for 5 min. The extension time of 2 
Component            Volume       Final Concentration 
2X Reaction Mix 25 µl  1X 
Template RNA n  µl (100 ng)  ± 
Sense primer 1 µl  0.2 µM 
Anti±sense primer 1 µl  0.2 µM 
Enzyme mix 1 µl  1.0 unit 
PCR grade water To 50  µl  ± 
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min in PCR cycles was employed to increase the yield of the large (polymerase) genes. 
The above concentrations and PCR conditions were employed for all viral gene 
amplicons more than 400 bp with differences in the annealing temperature for NS and 
PB2 genes which were 53ƕC and 62ƕC, respectively.   
2) For amplicons less than 400 bp, PCR conditions were: cDNA synthesis at 55ƕC for 10 
min, initial denaturation at 95ƕC for 2 min followed by 35 cycles of: denaturation at 95ƕC 
for 15 s, annealing at 57ƕC for 30 s, extension at 68ƕC for 30 s. The reaction was then 
held at 68ƕC for 1 min, and then cooled to 4ƕC for 5 min. The above concentrations and 
PCR conditions were employed for all viral gene amplicons less than 400 bp with a 
difference in the annealing temperature for M gene, which was 55ƕC instead of 57ƕC.   
 
5.3.1.3 Agarose gel electrophoresis 
The amplified PCR products were detected using 1% (w/v) agarose gel prepared with 
agarose (Sigma) in TAE buffer. The mixture was stirred well and melted in a microwave 
oven, and mixed once or twice during microwaving. The gel was then cooled to 55ƕC, 
and one microgram per milliliter of Nancy±520 (Sigma) was added. The gel was then 
poured into a gel casting tray, and a 10 well gel comb was inserted, and then left for 30 
to 45 min to set. The comb was then carefully pulled out and the gel was placed in the 
electrophoresis tank. Running buffer was added into the tank up to 2 to 3 mm over the 
gel. The sample was then prepared for loading on the gel by adding 8.5 µl of PCR 
product and 1.5 µl of 6X loading dye (New England BioLabs). A 1 kb or 100 bp DNA 
ladder (New England BioLabs) was loaded in one of the side well. The lid was placed on 
the gel box and the electrical current was connected for around 1 hr with 90 V. The gel 
was then carefully removed from the tray and examined under a UV trans±illuminator 
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(ImageQuant 300 imager, GE healthcare, UK). The size of the gene was estimated by 
comparison with the standard DNA ladder.   
 
5.3.2 Sequencing 
5.3.2.1 PCR purification and determination of DNA concentration 
PCR products were cleaned up using QIAquick PCR purification kit (Qiagen) according 
WRPDQXIDFWXUHU¶VLQVWUXFWLRQV$SSHQGL[,9. The volume of the DNA elution buffer (10 
mM Tris Cl, pH 8.5) was ȝO. The concentration of cleaned up DNA was determined 
using NanoDrop8000 spectrophotometer (Thermo Scientific, UK) by UV absorption. 
The purified PCR products were sent for sequencing. 
 
5.3.2.2 Nucleotide sequencing 
One nanogram per microliter per 100 bp of purified DNA with 3.2 pml/µl of forward and 
reverse primers that were used to amplify the viral genes was sent to Source BioScience 
LifeSciences for sequencing. Additional primers for polymerase (PB1, PB2, and PA) 
genes (Table 5.3±3) were also used to obtain full coverage of these genes.  The 
sequences were edited using Chromas Lite software and then were assembled and 
aligned by Geneious Inspirational Software for Biologists (www.geneious.com).  
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Gene Forward primer Reverse primer 
PB2 
PB2±738_For (seq)                                           
5'±AGCGAAAGCAGGTCAAATA±3' 
PB2±1501_Rev (seq)                                        
5'±AATTCGACACTAATTGATGGC±3' 
PB1 
PB1±784_For (seq)                                           
5'±ATGGATGTCAATCCGACTTTAC±3' 
PB1±1585_Rev  (seq)                                  
5'±CTATTTCTGCCGTCTGAG±3' 
PA 
PA±712_For (seq)                                             
5'±AGCGAAAGCAGGTACTGA±3' 
PA±1404_Rev (seq)                                       
5'±TTTTGGACAGTATGGATAGC±3' 
 
Table 5.3±3 3ULPHUVGHVLJQHGIRUVHTXHQFLQJWKH³PLGGOH´RIWKHSRO\PHUDVHJHQHVRI+1DYLDQ
influenza A.  
 
5.3.2.3 Amino acid sequences 
The assembled sequences were translated to amino acids using the same software 
(Geneious Inspirational Software for Biologists). Sequence differences were identified 
by alignment of the amino acid sequences (chicken± and duck±produced genes) and also 
by comparison with amino acid sequences available from GenBank.  
 
5.3.3 Cloning 
5.3.3.1 Cloning of PCR products into a plasmid vector 
For cloning the amplified influenza A virus PB1 and PB2 genes, TOPO® TA Cloning 
system for Sequencing (Invitrogen), a specialized cloning kit designed for Taq 
polymerase±amplified PCR products was used. The plasmid vector (pCRTM 4±TOPO®) is 
3956 bp and supplied linearized ZLWKVLQJOH¶WK\PLGLQH7UHVLGXHRYHUKDQJVDOORZLQJ
any PCR product with any adenosine (A) residues overhanging to be ligated into the 
vector. Topoisomerase is also covalently bound to the vector. The cloning reaction was 
performed IROORZLQJ WKH PDQXIDFWXUHU¶V instructions. Fresh PCR product was first 
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purified as described in 5.3.2.1, and the DNA concentration was determined by 
NanoDrop quantification. Fifteen to twenty nanograms of purified PCR product, 1 µl of 
TOPO vector, 1 µl of salt solution (containing 1.2 M NaCl and 0.06 M MgCl2) and water 
(to a final volume of 6 µl) were added to a 0.5 mL centrifuge tube and mixed gently. The 
mixture was incubated at room temperature for 5 min, and then was placed on ice. 
The amount of purified PCR product needed for the cloning reaction was calculated 
using the following formula: 
 
10 ng/ vector X kb insert
Kb vector (3956)
X
3
1 =
ng of PCR needed
 
 
5.3.3.2 Transformation of bacteria with plasmid 
Four microlitres of TOPO cloning reaction were added into one vial of One Shot® 
TOP10 chemically competent E. coli and mixed gently. The contents were then 
incubated on ice for 30 min. The cells were then subjected to heat shock for 30 s at 42ƕC 
in a water bath without shaking and then immediately moved on to ice. Two hundred and 
fifty microlitres of pre±warmed S.O.C medium (0.5 g of tryptose, 5 g of yeast extract and 
200 Mm glucose in 1 L of sterile distilled water) was added to the tube. The tube was 
incubated at 37ƕC for 1 hr in an orbital shaker at 225 rpm. Following incubation, 100±
200 µl from each transformation were spread on pre±warmed Luria±Bertani (LB) agar 
(Thermo Scientific) supplemented with 50 µg/mL kanamycin and incubated overnight at 
37ƕC. Single clones were transferred to 8 mL of LB broth (Thermo Scientific) 
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supplemented with 50 µg/mL kanamycin and incubated overnight at 37ƕC in an orbital 
shaker at 150 rpm prior to isolation of plasmid DNA.  
 
5.3.3.3 Plasmid DNA purification 
Plasmid purification was performed using PureLink® Quick Plasmid DNA Miniprep 
V\VWHP ,QYLWURJHQ IROORZLQJ WKH PDQXIDFWXUHU¶V LQVWUXFWLRQV (Appendix IV). The 
volume of the plasmid elution buffer (10 mM Tris±HCl, pH8.0; 0.1 mM EDTA) was 75 
ȝO. The Concentration of DNA from purified plasmid was determined using 
NanoDrop8000 spectrophotometer (Thermoscientific, UK) by UV absorption.  
 
5.3.3.4  Restriction digestion 
To determine the insert size of transformants, plasmid DNA was digested with the 
restriction enzyme EcoRI. Two micrograms of plasmid DNA was mixed with 1 µl of 
EcoRI (Invitrogen) and 2 µl of 10x reaction buffer REACT®3 (Invitrogen) and PCR grade 
water for a final volume of 20 µl. The mixture was incubated in water bath at 37ƕC for 1 
hr. The reaction was stopped by adding 3 µl of loading buffer (New England BioLabs) 
and then was run on an agarose gel as described in 5.3.1.3 using a 1 kb ladder (New 
England BioLabs) to determine the sizes of the bands. Samples containing inserts of the 
appropriate size were then used for sequencing. 
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5.3.3.5  Plasmid sequencing 
Plasmids were sent to Source Bioscience for sequencing. Fifteen positive plasmids of 
each gene were used for this purpose. One hundred microgram per microlitre of plasmid 
with 3.2 pml/µl of M13 Forward µ±GTAAAACGACGGCCAG±¶ DQG 03 Reverse 
µ±CAGGAAACAGCTATGAC±¶ ZKLFK DUH VXSSOLHG DV D SDUW RI WKH 7232±TA 
cloning system (Invitrogen), were used for sequencing. The sequence data was edited 
using Chromas Lite software and the area of differences determined using Geneious 
Inspirational Software for Biologists. 
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Figure 5.3±1 pCRTM 4±TOPO® vector map.  
The map shows the features of pCRTM 4±TOPO® that was used for cloning and sequencing of influenza 
PB1 and PB2. After cloning the vector was digested at EcoRI restriction sites (red boxes) in order to 
confirm gene ligation onto the vector. Forward and reverse M13 priming sites (green boxes) were used for 
sequencing. The yellow box indicates the site where PB1 and PB2 were inserted. 
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5.4 Results 
5.4.1 Gene amplification 
All viral genes were successfully amplified by using one step RT±PCR. Genes were 
amplified using one or more sets of primers in order to cover the whole genome. All 
results showed single and clear bands following loading of 10 µl of the product stained 
with 1 µg/mL of Nancy±520. Figure 5.4±1, A and B shows the largest amplicons of all 
viral genes; product sizes were determined by comparison with 1 kb ladder. Figure 5.4±2 
shows the small DNA amplicons which are located at the ends of viral genes, and the 
sizes were detected using 100 bp ladder.  
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Figure 5.4±1 PCR products of large DNA amplicons of influenza virus visualized by Nancy±520 
stained agarose gel electrophoresis.  
The PCR products were separated using a 1% agarose gel pre±stained with 1 µg/mL Nancy±520. (A) 
Amplification of PB1, PB2, NS, and M genes from chicken and duck produced viruses /C and /D. (B) 
Amplification of HA, NA, PA, and NP genes from chicken and duck produced viruses /C and /D.  
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Figure 5.4±2 PCR products of small DNA amplicons of influenza virus following Nancy±520 stained 
agarose gel electrophoresis.  
The PCR products were separated using 1% agarose gel pre±stained with 1 µg/mL Nancy±520. The genes 
were amplified from chicken and duck produced viruses (/C and /D). (A) Amplification at the 5´ and 3´ 
ends of PB2 and PB1. The bands represent amplicons located at the 5´ (1 and 2) and the 3´ ends (3 and 4) 
of PB2, and also the 5´ (5 and 6) and the 3´ ends (7 and 8) of PB1 of chicken and duck produced viruses 
(/C and /D). (B) Amplification of the 3´ end of HA (1 and 2), NP (3 and 4), NA (7 and 8) and also the 5´ 
end of NA (5 and 6) of chicken and duck produced viruses (/C and /D). (C) Amplification of the 3´ end of 
M (1 and 2) and NS (3 and 4) of chicken and duck produced viruses (/C and /D). 
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5.4.2 PCR sequencing 
Compared with nucleotide sequences of the H2N3 virus (A/mallard 
duck/England/7277/06) that was used to infect chicken and duck fibroblasts, six of the 
viral genes (PA, HA, NA, M, NS, and NP) showed identical sequences between viruses 
produced from chicken and duck cells. The PB1 and PB2 nucleotide sequences from 
viruses grown on chicken and duck cells were aligned and compared with nucleotide 
sequence of the parent virus (A/mallard duck/England/7277/06). The alignment 
identified some nucleotide differences distributed throughout the gene sequence. 
However, all these differences were a consequence of non±specific amplification during 
PCR reaction rather than genuine mutations (Figure 5.4±3 and 5.4±4).  
 
 
Figure 5.4±3 Polymerase basic 2 (PB2) gene alignments between chicken and duck cell grown 
viruses.  
The figure shows a 54 nt region of the PB2 section alignment. Although, some nucleotide differences 
between the PB2 sequence of chicken and duck virus genes are seen, the traces show that these changes are 
a consequence of mixed sequence.  
PB2/C: Polymerase basic 2 gene sequenced from H2N3 grown on chicken cells.   
PB2/D: Polymerase basic 2 gene sequenced from H2N3 grown on duck cells.  
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Figure 5.4±4 Polymerase basic 1 (PB1) gene alignments between chicken and duck cell grown 
viruses.  
The figure shows a 50 nt region of the PB1 section alignment. Although, some nucleotide differences 
between the PB1 sequence of chicken and duck virus genes are seen, the traces show that these changes are 
a consequence of mixed sequence.  
PB1/C: Polymerase basic 1 gene sequenced from H2N3 grown on chicken cells.   
PB1/D: Polymerase basic 1 gene sequenced from H2N3 grown on duck cells.  
 
5.4.3 Plasmid digestion  
Ligation of PB1 and PB2 into pCRTM 4±TOPO vector was confirmed by digestion with 
the restriction enzyme EcoRI. Clones with inserts of the appropriate size were detected 
by loading samples on 1% agarose in TAE buffer pre±stained with Nancy±520 (Figure 
5.4±5). A single band was observed for PB1, however it was slightly smaller than the 
expected size because of the presence of EcoRI target sequence at position 2030 of the 
PCR amplicon. Double bands were observed for PB2 indicating the presence of an 
EcoRI site within the viral sequence. 
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Figure 5.4±5 pCRTM 4±TOPO digestion.  
Restriction digestion products were analysed on a 1% agarose gel in TAE buffer, pre±stained with 1 
µg/mL Nancy±520, and the sizes of vector and digested products were measured by using 1 kb ladder. The 
plasmid was digested with EcoRI and the original size of the plasmid vector (3956 bp) is clearly shown 
following digestion. The PB1 inserts are shown with at about 2030 bp of 2274 bp (the original amplicon 
size) because of the presence of the target sequence of EcoRI at position 2030 of the amplicon, while the 
PB2 inserts show two bands of about 1100 and 1200 bp because of the presence of the target sequence for 
EcoRI in the middle of the PB2 amplicon. 
 
5.4.4 Plasmid sequencing  
Fifteen plasmids of the PB1 and PB2 inserted genes of both chicken and duck viruses 
were sequenced and aligned. The results showed very few nucleotide changes with a 
similar number in both chicken and duck genes. Alignment with the parent sequences 
obtained from viruses propagated in chicken eggs also showed no obvious difference 
except very few changes in some clones, which were more likely to be PCR±generated 
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mutations. These results confirmed that there was no fundamental difference between 
chicken and duck produced PB1 and PB2, and the few nucleotide differences that had 
been observed after PCR sequencing were due to the presence of non±specific PCR 
products within the sequencing reaction.  
In addition, running the gel with 30 to 40 µl of PB1 and PB2 PCR products, non±specific 
bands are clearly observed in both reactions (Figure 5.4±6). Interestingly, the sizes of the 
non±specific bands correspond to the length of the genes observed in sequence 
chromatograms where multiple peaks were observed.  
               
Figure 5.4±6 PCR product of PB1 and PB2 DNA amplicons visualized by Nancy±520 stained agarose 
gel electrophoresis.  
Forty microlitres of the PCR products were separated using 1% agarose gel pre±stained with 1 µg/mL 
Nancy±520. Secondary bands (indicated by arrows) with similar sizes of the secondary sequences were 
clearly observed from both reactions. (A) Amplification of PB1 from chicken and duck produced viruses C 
and D. (B) Amplification of PB2 from chicken and duck produced viruses C and D. 
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5.5 Discussion 
The nucleotide sequence of the influenza H2N3 produced in chicken and duck 
fibroblasts was analysed by direct sequencing, using the PCR product as a template. PB1 
and PB2 sequences were confirmed by cloning of the viral genes into a vector, followed 
by sequencing. The overall results showed that there was no significant difference in the 
sequence of any of the viral genes produced from cells of the two host species.  
The polymerase chain reaction (PCR) is widely used to amplify a specific region in the 
gene or the whole genome, to prepare products for DNA sequencing. The production of 
specific PCR product must be assessed by agarose electrophoresis before sequencing in 
order to ensure sequence specificity (Leonard et al., 1998). Detection of PCR results 
after applying 10 µl of the PCR products on Nancy±20±stained gel had shown single and 
clear bands for all the viral genes. Such a PCR product can be sequenced directly without 
the need for extracting bands from the gel. The initial sequencing results showed no 
difference in six of the virus genes (PA, HA, NP, NA, M, and NS) of viruses produced 
from chicken and duck cells, however, some differences were observed in PB1 and PB2 
between the two host species. 
There are many important factors affect virus infectivity. Mutations and deletions in any 
of virus genes may play a role in changing the protein structure and in eventually 
decreasing viral infectivity and changing the virus morphology. For example, changes in 
polymerase gene sequences may disrupt the functional polymerase protein and reduce 
viral RNA cap±snatching, endonuclease or polymerase function and consequently the 
infectivity of the virus (Boivin et al., 2010). In addition, deletions in the cytoplasmic tail 
of the M2 protein might inhibit the genome packaging and the production of infectious 
viruses (McCown and Pekosz, 2005). Furthermore, mutations in the M1 protein 
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(Burleigh et al., 2005) and deletions in the cytoplasmic tail of the HA and NA proteins 
(Jin et al., 1997) have been shown to play a substantial role in modulating virus 
morphology. These results showed that there were no mutations in any of these genes, 
suggesting that other factors play a role in decreasing virus infectivity in H2N3 virus 
derived from duck cells. 
Minor nucleotide changes in influenza viruses can occur normally regardless of the type 
of host due to the lack of proofreading ability of the RNA polymerase, leading to 
incorrect ribonucleotide insertion during replication, which is termed µantigenic 
drift¶(Zambon, 1999). Therefore, viral polymerase plays an important role in the 
evolution and spread of the influenza A virus (Gabriel et al., 2013). However, no 
changes were detected after sequencing the whole genome of the virions.  In addition, it 
has been shown that the amplification of DNA by thermostable polymerases using 
standard conditions produces errors of about 5.5 x 10±4 mutations per basepair (Spee et 
al., 1993). However, PCR±generated mutations are usually not detectable following 
sequencing of a PCR product directly. The reason for this is the presence of a large 
number of templates in the reaction and a mutation introduced in one PCR product in the 
first cycle of amplification will only be found in that one product out of thousands 
formed by the reaction. This means that the error is swamped by the majority of correct 
sequences in the PCR product and thus is not seen. As the reaction proceeds, the 
mutation is amplified, but so is the percentage of the non±mutated sequence at the same 
place in other templates. Hence, the error still only exists at a very low occurrence and is 
not detectable. 
To conclude, according to these findings, it seems that the reduction of infectious virus 
production and the difference in the morphology between chicken and duck cell derived 
virions are most likely related to host cellular factors rather than viral genetic factors. 
Firas Al ?Mubarak 2014 Chapter 5: Molecular analysis of influenza A virus 
140 
 
Further investigation is required to focus on the impact of the host cell in producing 
different levels of infectious viruses. 
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6.1   Summary 
In this chapter, virus budding and morphology were investigated by 
immunofluorescence. Madin Darby canine kidney (MDCK), chicken embryo fibroblast 
(CEF), and duck embryo fibroblast (DEF) cells were infected or mock infected with 
avian H2N3. A known filamentous equine influenza A H3N8 strain was used as a positive 
control. Cells were incubated for 8 hr in the absence or presence of 0.5 µg/mL or 5 
µg/mL of cytochalasin D to inhibit actin. Following infection, cells were fixed with 4% 
paraformaldehyde and then stained with specific antiserum to detect viral HA antigen 
and with phalloidin to detect cellular actin. Following infecting cells with H2N3 in the 
presence or absence of actin inhibitor, MDCK and CEF cells produced spherical virions 
while DEF produced short filament particles. Following infecting the cells with H3N8 in 
the absence of an actin inhibitor, all produced filamentous viruses, and in the presence 
of the inhibitor, the majority of virions produced from MDCK and CEF cells were 
spherical while DEF cells were not markedly affected and still produced filamentous 
particles. These findings suggest that actin is not only the cellular factor that determines 
the differing morphology between viruses grown in CEF or DEF. According to a very 
recent published study, Microtubule±associated protein 1A/1B±light chain 3 (LC3) can 
play a role in the assembly of filamentous viruses. Therefore, cells were transfected with 
a green fluorescent protein (GFP) ± LC3 expression vector and then infected or mock±
infected with avian H2N3. Initial results showed that virus morphology changed from 
spherical to short filaments followed transfection of CEF cells with GFP±LC3. This 
suggests that autophagy which occurs more readily in duck cells than chicken cells might 
play a role in the production of filamentous virions. However, further confirmation, such 
as observing budding viruses under an electron microscope, is required. 
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6.2 Introduction 
6.2.1 Host cell dependence of influenza virus morphology 
The morphology of influenza virions varies considerably, ranging from spherical with a 
diameter of 80±120 nm to filamentous particles with a similar diameter but vastly 
elongated (up to 30 µm in length). They assemble and bud from the apical plasma 
membrane of infected epithelial cells (Nayak et al., 2004).  The variation in virus 
morphology can be because of viral genetic factors such as differences in haemagglutinin 
(HA), neuraminidase (NA), matrix 1 and 2 (M1 and M2) proteins (Bourmakina and 
Garcia-Sastre, 2003). However, sequence analysis of viruses grown in chicken and duck 
embryo fibroblast cells did not reveal any gene changes that could explain the 
differences in morphology (Chapter 5). Host cell factors have been shown to play an 
important role in determining virus morphology, in particular, the filamentous form. 
Epithelial cells such as Madin Darby canine kidney (MDCK) cells tend to produce more 
filamentous particles than fibroblasts, and intact actin cytoskeleton is important for 
filamentous but not spherical particle formation (Roberts and Compans, 1998, Simpson-
Holley et al., 2002). Actin is found inside the virions of some viruses such as the measles 
virus, but not in the influenza virus (Bohn et al., 1987). However, a previous study has 
demonstrated that both viral M1 and NP proteins interact with the actin cytoskeleton in 
influenza±infected MDCK cells (Avalos et al., 1997). The sensitivity of influenza 
filamentous virus budding to actin inhibitors such as cytochalasin D suggests that their 
formation depends on an intact actin cytoskeleton (Roberts and Compans, 1998). 
Furthermore, disruption of actin by different actin inhibitors leads to reorganization of 
HA, M1, and RNP proteins into annular cell±surface structures formed around a core of 
aggregated actin underlying the plasma membrane which results in the reduction of 
filamentous virion production (Simpson-Holley et al., 2002). 
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6.2.2 Immunofluorescence 
Immunofluorescence is a histochemical laboratory staining technique that is performed 
to detect specific target antigens using fluorescently±labelled antibodies. It has been 
widely used both in clinical laboratories and scientific research. Antibodies used in this 
technique are tagged (labelled) with fluorescent dye such as Alexa fluor, fluorescein 
isothiocyanate (FITC) or tetramethyl rhodamine isothiocyanate (TRITC). They react 
with a specific antigen (directly or indirectly) forming an antigen±antibody complex, 
which is visualized using fluorescent microscopy. Some cellular components, however, 
can be detected using specific fluorescently±labelled compounds such as phalloidin to 
detect actin and ¶±Diamidino±2±phenylindole (DAPI) to visualize the nucleus. These 
compounds can directly interact with the cellular components without the need of 
antibodies. The fluorescent signals can be quantified using an automated imaging 
instrument, flow cytometer, or array scanner.  
Two main immunofluorescence methods have been documented: primary (direct) and 
secondary (indirect). The primary method uses a single fluorescent±tagged antibody that 
interacts directly with the antigen of interest, while the secondary method employs two 
antibodies; the primary antibody (unlabelled) which specifically binds to the target 
protein, and a secondary antibody (labelled), which recognizes the primary antibody and 
binds to it (Figure 6.2±1). 
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Figure 6.2±1 Schematic diagram of direct and indirect immunofluorescence.  
Figure shows the mechanism of indirect (on the right) and direct (on the left) immunofluorescence. In the 
direct method, the primary antibody which binds to the target protein is conjugated with a fluorophore for 
detection by fluorescence. In the indirect method, a secondary labelled antibody with specificity against 
the primary antibody is employed to amplify the primary signal.     
 
Although the direct process does not need a further step of adding labelled secondary 
antibody, the detection of signal may be difficult if the protein is found in small 
quantities. The main reason for this is because the signal is not amplified. In indirect 
detection, there is an amplification of the fluorescent signal as more than one labelled 
secondary antibody can attach to the primary antibody. Therefore, indirect 
immunofluorescence has been more frequently used in laboratory research because of 
greater sensitivity than direct immunofluorescence.  
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6.2.3 Immunofluorescence and influenza A virus 
Immunofluorescence has been used for the detection of viral respiratory infection 
including influenza A virus (Blaskovic and Labzoffsky, 1973, Orstavik et al., 1984). 
Based on the diversity of influenza A virus surface antigens, the indirect 
immunofluorescence assay can be used for typing and subtyping of virus strains using 
specific monoclonal antibodies against surface glycoproteins, HA and NA (Johnson et 
al., 2012). In addition, indirect immunofluorescence can be used to detect filamentous 
virus budding from host cell surfaces using purified antiserum against haemagglutinin 
(Cox et al., 1980). Furthermore, the role of the host cell in determining the virion 
morphology, in particular the filamentous form, has also been observed using this 
technique (Roberts and Compans, 1998, Simpson-Holley et al., 2002).  
 
6.2.4 Hypothesis 
Cellular factors, for example actin, might be responsible for the morphological 
differences between influenza viruses grown in chicken and duck cells. 
 
6.2.5 Aim and objectives 
To study the role of host cell factors in determining virus morphology. 
For this objective, chicken, duck, and MDCK cells were infected with filamentous and 
spherical virus strains (equine H3N8 and avian H2N3, respectively). Differences in 
morphology of progeny virions produced from all cells were observed via 
immunofluorescence microscopy, in the presence or absence of an actin inhibitor. 
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6.3 Materials and methods 
6.3.1 Viruses 
Two viral strains were used in this technique, with filamentous and spherical 
morphology. Influenza A/equine/Newmarket/5/03 (H3N8) was selected as a filamentous 
strain and avian influenza H2N3 A/mallard duck/England/7277/06 as a spherical strain. 
Viruses were grown in KHQ¶V eggs as described in 2.2.2.  
 
6.3.2 Cells  
Chicken and duck fibroblasts were extracted and grown following the procedure 
described in 2.2.3.1. MDCK cells were also used as a control and they were grown as 
described in 2.2.3.3.  
 
6.3.3 Virus infection of cells  
6.3.3.1  Actin disruption 
MDCK, chicken and duck embryo fibroblast cells were grown on glass coverslips (19 
mm in diameter) in 12±well plates in DMEM with 10% FCS and antibiotics, and then 
incubated at 37ƕC until confluent. The cells were then infected either with the 
filamentous virus strain (A/equine/Newmarket/5/03 (H3N8)) or with the spherical strain 
(A/mallard duck/England/7277/06 (H2N3)) in serum±IUHH +DP¶V  FRQWDLQLQJ 
Ultroser G, 500 ng/mL TPCK trypsin and 1% antibiotics at a multiplicity of infection 
(MOI) of 1.0 for 2 hr. Control cells were incubated in serum±IUHH+DP¶VRQO\&HOOV
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were then washed three times with PBS and fresh media was added either with 
cytochalasin D (5 µg/mL or 0.5 µg/mL) or without it, and further incubated for 6 hr at 
37ƕC. They were washed three times with PBS, and incubated with 4% 
paraformaldehyde for 10 min, and then washed again three times with PBS. They were 
either kept in 4ƕC or processed directly for immunological staining. 
 
6.3.3.2  LC3 transfection 
Chicken and duck fibroblast cells were grown on glass coverslip (19 mm in diameter) in 
12±well plates in 1 mL DMEM containing 10% FCS and antibiotics, and then incubated 
at 37ƕC until they reached 60 to 80% confluency. The medium was then removed and 1 
mL of fresh media was added. In a sterile tube, 1 µg of human GFP±LC3 expression 
vector or GFP control vector (Cell Biolabs) was diluted in 100 µl of jetprime buffer 
(Polyplus transfection) and mixed by vortexing. Two microlitres of jetprime DNA 
transfection reagent (Polyplus transfection) were added and mixed. The mixture was 
spun down and incubated for 10 min at room temperature. One hundred microlitres of 
transfection mix were added to each well dropwise on to the cells. The plate was gently 
rocked back and forth and from side±to±side to distribute the complexes evenly. Two 
wells were left without any treatment as a control. The transfection medium was replaced 
after 4 hr by growth medium and the plate was then returned to the incubator. At about 
40 hr after transfection, cells were infected or mock±infected with avian H2N3 
(A/mallard duck/England/7277/06) in serum±IUHH+DP¶VFRQWDLQLQJ8OWURVHU*
500 ng/mL TPCK trypsin and 1% antibiotics at MOI of 1.0 for 2 hr. Cells were then 
washed three times with PBS and fresh media, and further incubated for 6 hr at 37ƕC. 
They were washed and fixed as described above. 
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6.3.4 Immunological detection and imaging 
Cells were first blocked with 1% bovine serum albumin (BSA, Fisher Scientific) in 
phosphate buffer saline (PBS) for 1 hr at room temperature. Blocking buffer was then 
carefully aspirated, and without washing, cells were incubated with 300 µl of primary 
antibodies (antibodies were typically diluted 1:500 in 1% BSA) specific to the H2 
antigen (chicken H2N3 antiserum, a kind gift from Dr Ian Brown, Veterinary Laboratory 
Agency, UK) or specific to the H3 antigen (rabbit H3N8 antiserum, a kind gift from Dr 
Debra Elton, Animal Health Trust, UK) for 1 hr at room temperature. They were gently 
washed three times in PBS for 5 min each. Cells were then incubated in the dark for 1 hr 
at room temperature with a 300 µl of diluted secondary antibodies (either with goat anti±
chicken or anti±rabbit IgG antibody, Invitrogen) which are labelled with green 
fluorescent Alexa Fluor® 488. After washing three times, cells were incubated in the dark 
for 1 hr with 300 µl of Alexa Fluor® 546 Phalloidin (Invitrogen) for actin staining. Cells 
were then washed three times with PBS, and the coverslips were removed from the wells 
using a combination of a curved end long needle and a pair of fine tweezers and placed 
facing up on a white paper towel for air drying. A spot of about 20 µl of Prolong® Gold 
Anti±Fade Reagent with 4',6±diamidino±2±phenylindole DAPI (Life technologies) was 
put on a clean glass slide; the cover slip was inverted facing down onto the mountant, 
and the mountant was allowed to fully spread. Coverslips were sealed by surrounding 
with clear nail varnish to stop the coverslip moving and prevent the cells drying out over 
time. They were kept at 4ƕC protected from light. Slides were viewed under Leica DM 
5000B epifluorescence imaging system and cells were visualized and images were 
captured at high resolution.  
 
For LC3±transfected cells, cells were blocked and incubated with antibodies specific for 
H2 antigen as described above. They were incubated in the dark for 1 hr at room 
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temperature with a 300 µl of diluted secondary antibody (goat anti chicken IgG antibody, 
Invitrogen) which is labelled with red fluorescent Alexa Fluor® 546 dye. They were 
washed three times with PBS, mounted with Prolong® Gold Anti±Fade Reagent with 
4',6±diamidino±2±phenylindole DAPI (Life technologies), and viewed as described 
above.  
  
6.4 Results 
6.4.1 Virus morphology in the presence and absence of actin inhibitor 
Surface HA and internal actin were examined by fluorescent microscopy. Photographs 
were taken in three steps, detection of viral HA (H2 or H3), actin imaging (disrupted or 
not disrupted), and then were merged with DAPI. Using 0.5 µg/mL of Cyt.D was 
sufficient to disrupt the actin without causing complete collapse of the actin cytoskeleton 
and rounding of the cells. The mock±infected cells showed very low levels of non±
specific antibody binding of the HA±stained samples, with specific actin staining with 
phalloidin, in the presence or absence of cytochalasin D. The phalloidin±stained actin in 
untreated cells was distributed as a layer underlying the plasma membrane, while drug±
treated cells showed loss of the cortical actin web which aggregated in clumps, 
distributed across the cell (Figures 6.4±1, 6.4±2, and 6.4±3).  
In the absence of an actin inhibitor, all cells infected with H3N8 produced distinctive 
HA±stained filamentous structures on the cell surface which reached several microns in 
diameter and were distributed regularly on the cell surface. In the presence of the 
inhibitor, the MDCK and CEF cells produced spherical virions, while in the DEF cells, 
the virus morphology changed from filamentous to short filaments (Figures 6.4±4, 6.4±5, 
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and 6.4±6). Treatment of duck cells with a high dose of drug (5 µg/mL) showed 
rounding of the cells and actin collapse, although short filaments were still produced 
(Figure 6.3±7). Following infection of MDCK and CEF cells with H2N3, spherical 
virions were produced in the presence or absence of the drug with no obvious 
filamentous virus present. Following infection of DEF, striking short filaments were 
produced in the presence of the drug and elongated to pleomorphic structures were 
produced in the presence of 0.5 µg/ mL of the drug (Figures 6.4±8, 6.4±9 and 6.4±10).  
Following treatment of duck cells with a high dose of drug (5 µg/mL), some elongated 
virions were still produced from the cell surface (Figure 6.4±11).  
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Figure 6.4±1 Effect of cytochalasin D treatment (0.5 µg/mL) on the actin of uninfected MDCK cells.  
The cells were mock±infected and incubated for 8 hr with or without cytochalasin D (+Cyt.D and ±Cyt.D, respectively), and stained for surface HA (green), actin (red±
orange), and DNA (blue). Immunofluorescence photographs show a clear difference between the disrupted and non±disrupted actin. Scale bar 10 µm.  
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Figure 6.4±2 Effect of cytochalasin D treatment (0.5 µg/mL) on the actin of uninfected chicken embryo fibroblast cells.  
The cells were mock±infected and incubated for 8 hr with or without cytochalasin D (+Cyt.D and ±Cyt.D, respectively), and stained for surface HA (green), actin (red±
orange), and DNA (blue). Immunofluorescence photographs show a clear difference between the disrupted and non±disrupted actin. Scale bar 10 µm. 
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Figure 6.4±3 Effect of Cytochalasin D treatment (0.5 µg/mL) on the actin of uninfected duck embryo fibroblast cells.  
The cells were mock±infected and incubated for 8 hr with or without cytochalasin D (+Cyt.D and ±Cyt.D, respectively), and stained for surface HA (green), actin (red±
orange), and DNA (blue). Immunofluorescence photographs show a clear difference between the disrupted and non±disrupted actin. Scale bar 10 µm. 
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Figure 6.4±4 Differences in H3N8 morphology in MDCK cells either untreated or treated with 0.5 µg/mL of cytochalasin D. The cells were infected with the virus in 
the presence or absence of cytochalasin D (+Cyt.D and ±Cyt.D) and stained for surface HA (green), actin (red±orange), and DNA (blue). Filamentous virions were observed 
on the surface of untreated cells, while spherical virions were observed following treatment (indicated by arrows). Scale bar 10 µm. 
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Figure 6.4±5 Differences in H3N8 morphology in chicken embryo fibroblast cells either untreated or treated with 0.5 µg/mL of cytochalasin D.  
The cells were infected with the virus in the presence or absence of cytochalasin D (+Cyt.D and ±Cyt.D) and stained for surface HA (green), actin (red±orange), and 
DNA (blue). Filamentous virions were observed on the surface of untreated cells, while significant reduction in filamentous form and increase the spherical virion 
production was observed following treatment (indicated by arrows). Scale bar 10 µm. 
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Figure 6.4±6 Differences in H3N8 morphology in duck embryo fibroblast cells either untreated or treated with 0.5 µg/mL of cytochalasin D. The cells were infected 
with the virus in the presence or absence of cytochalasin D (+Cyt.D and ±Cyt.D) and stained for surface HA (green), actin (red±orange), and DNA (blue). Filamentous 
virions were observed on the surface of treated cells and short filaments were clearly noticed in untreated (indicated by arrows). Scale bar 10 µm.  
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Figure 6.4±7 H3N8 morphology in duck embryo fibroblast cells treated with 5 µg/mL of cytochalasin D.  
The cells were infected with the virus in the presence cytochalasin D (5 µg/mL) and stained for surface HA (green), actin (red±orange), and DNA (blue). Both elongated 
and short filament virions were appeared following infection of cells with the virus (indicated by arrows). Scale bar 10 µm. 
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Figure 6.4±8 H2N3 morphology in untreated and treated MDCK cells with 0.5 µg/mL of cytochalasin D.  
The cells were infected with the virus in the presence or absence of cytochalasin D (+Cyt.D and ±Cyt.D) and stained for surface HA (green), actin (red±orange), and DNA 
(blue). Spherical virions were observed on the surface of treated and untreated cells (indicated by arrows). Scale bar 10 µm. 
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Figure 6.4±9 H2N3 morphology in untreated and treated chicken embryo fibroblast cells with 0.5 µg/mL of cytochalasin D.  
The cells were infected with the virus in the presence or absence of cytochalasin D (+Cyt.D and ±Cyt.D) and stained for surface HA (green), actin (red±orange), and DNA 
(blue). Spherical virions were observed on the surface of treated and untreated cells (indicated by arrows). Scale bar 10 µm. 
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Figure 6.4±10 Differences in H2N3 morphology in untreated and treated duck embryo fibroblast cells with 0.5 µg/mL of cytochalasin D.  
The cells were infected with the virus in the presence or absence of cytochalasin D (+Cyt.D and ±Cyt.D) and stained for surface HA (green), actin (red±orange), and 
DNA (blue). Short filament and elongated virions appeared following infection of cells even after actin inhibition (indicated by arrows). Scale bar 10 µm. 
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Figure 6.4±11 H2N3 morphology in treated duck embryo fibroblast cells with 5 µg/mL of cytochalasin D.  
The cells were infected with the virus in the presence cytochalasin D (5 µg/mL) and stained for surface HA (green), actin (red±orange), and DNA (blue). Some elongated 
and pleomorphic virions also appeared following infection of cells (indicated by arrows). Scale bar 10 µm. 
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6.4.2 Virus morphology before and after transfection of cells with LC3 
The viral HA antigen of viruses budding from the surface of chicken and duck cells was 
examined by immunofluorescence microscopy following the infection of cells 
transfected with GFP±LC3, or GFP alone as a control. Infected cells without any 
transfection were also examined. The results revealed that cells were transfected 
successfully before infection with virus (Figure 6.4.12), with some colocalization of LC3 
in the perinuclear region and in the cell periphery following infection, particularly the 
infected chicken cells. The overall results showed a difference in virus shape before and 
after transfection of chicken cells with GFP±LC3. Viruses released from the 
untransfected chicken and duck cells were spherical and short filament, respectively, 
while short filaments were produced from both cells following transfection with GFP±
LC3 (Figures 6.4.13, and 6.4.14).  
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Figure 6.4.12 Transfection of uninfected chicken and duck fibroblasts with LC3 plasmid vector.   
The figure shows the transfection of GFP±LC3 and GFP±Control 40 hr post transfection of the uninfected chicken and duck fibroblasts. There is a clear difference 
between cells transfected with GFP±LC3 and GFP±Control. Untransfected cells showed no colour. Scale bar 10 µm. 
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Figure 6.4.13 H2N3 morphology in GFP±LC3±transfected and untransfected chicken embryo 
fibroblasts. GFP±LC3 and GFP±Control transfected, and untransfected cells were infected with H2N3 for 
8 hr and stained for surface HA (red) and DNA (blue), while the evidence of transfection appeared with 
green fluorescence. The virus morphology was detected by an immunofluorescence microscope. Spherical 
virions (red) were observed on the surface of untransfected cells, while short filaments were observed on 
the surface of transfected cells (indicated by arrows). Scale bar 10 µm.  
Firas Al ?Mubarak 2014 Chapter 6: Cellular factors influencing virus morphology 
166 
 
GFP MergeHA (H2)
N
o
 
tr
an
sf
ec
tio
n
G
FP
-
C
o
n
tr
o
l
GFP-LC3
 
Figure 6.4.14 H2N3 morphology in GFP±LC3±transfected and untransfected duck embryo fibroblasts.  
GFP±LC3 and GFP±Control transfected, and untransfected cells were infected with H2N3 for 8 hr and 
stained for surface HA (red) and DNA (blue), while the evidence of transfection appeared with green 
fluorescence. The virus morphology was detected by an immunofluorescence microscope. Short filament or 
elongated virions (red) were observed on the surface of all cells (indicated by arrows). Scale bar 10 µ m.  
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Figure 6.4.15 H2N3 morphology in GFP±LC3±transfected and untransfected chicken and duck 
embryo fibroblasts.  
The figure shows a comparison between the morphology of H2N3 virions budding from chicken and duck 
fibroblasts at a high magnification.  Untransfected and transfected duck cells with GFP±LC3 produce short 
filaments (indicated by arrows). Untransfected chicken cells produce spherical virions, while following 
transfection with GFP±LC3, the virus morphology shifted from spherical to short filaments (indicated by 
arrows). Scale bar 10 µm. DEF: duck embryo fibroblasts. CEF: chicken embryo fibroblasts. 
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6.5 Discussion 
Differences in the morphology of influenza viruses budding from different hosts (CEF, 
DEF, and MDCK cells) were studied by immunofluorescence. Two virus strains were 
used to infect cells, spherical strain (avian H2N3) and filamentous strain (equine H3N8). 
The extensive production of filamentous particles by the equine influenza H3N8 strain 
was observed in all the infected cells. In contrast, short filament budding was restricted 
to DEF cells following infection with H2N3 strain, while chicken embryo fibroblasts and 
MDCK cells produced spherical virions, and filament formation was rarely seen. 
Although filamentous influenza virion assembly was proposed to depend on the actin 
cytoskeleton, based on their sensitivity to actin inhibitor, cytochalasin D (Roberts and 
Compans, 1998), duck embryo fibroblasts produced short filament virions, following 
infection with H3N8 and short filaments or elongated particles, following infection with 
H2N3, even after actin disruption.  
The actin cytoskeleton has been shown to influence virus morphology. Cytochalasin D 
prevents actin polymerization via binding to the boarded ends of actin filaments and 
blocking the addition of soluble (G)±actin monomers (Schliwa, 1982). A previous study 
showed that cytochalasin D inhibits the production of the filamentous form of 
A/Udorn/72 (H3N2) virus, but not the spherical A/PR/8/34 (H1N1) virus suggesting that 
the assembly of filamentous particles requires an intact actin cytoskeleton (Roberts and 
Compans, 1998). In addition, Simpson±Holley et al. (2002) tested the effect of other 
actin inhibitors, jasplakinolide and latrunculin A following infecting cells with the 
filamentous strain A/Udorn/72 (H3N2) and the spherical strain A/PR/8/34 (H1N1). 
These drugs are mechanistically different inhibitors of actin. Jasplakinolide binds to F±
actin and inhibits actin depolymerization (Bubb et al., 1994) and latrunculin A inhibits 
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actin polymerisation by sequestering G±actin monomers (Coue et al., 1987). These drugs 
have only been previously used to inhibit the actin cytoskeleton of MDCK cells and all 
were found to prevent the assembly of filamentous but not spherical virus particles. 
Although the use of a high dose of cytochalasin D (5 µg/mL) showed cell rounding and 
actin collapse, following the treatment of duck cells, short filaments were still produced, 
suggesting that the effect of the drug on virus morphology was not dose dependent. 
Using different actin inhibitors, in particular, jasplakinolide might produce a different 
form of disruption and might demonstrate a role for actin in changing virus shape. 
Arcangeletti et al. (2008) investigated a clear difference in the fate of influenza virus 
infection using the same cell type from two different mammalian species, MDCK and  
Rhesus monkey kidney (LLC±MK2) epithelial cell lines. These cells were infected with 
human influenza A virus NWS/33 strain (H1N1) and the actin was disrupted using 
cytochalasin D. Treatment of LLC±MK2 with cytochalasin D following infection with 
the virus was shown to enhance virus progression and accumulation in the nuclear 
compartment which resulted in an increase in infection efficacy and yield of infectious 
virus at 24 hr post infection. On the other hand, treatment of MDCK cells with 
cytochalasin D had a detrimental effect on virus replication and reduced the delivery of 
NP to the nucleus which was accompanied by a significant decrease in virus titre at 24 hr 
post infection. Based on these findings, it seems that the actin cytoskeleton could play a 
role in the modulation of host permissiveness to viral infection; therefore, further study is 
required to determine the level of infectious virus produced from cells, following 
disruption of actin in infected CEF and DEF cells. 
Following transfection of chicken cells with GFP±LC3, virus morphology shifted from 
spherical to short filaments. Macroautophagy, or self±eating, is considered an important 
defence process against influenza A infection. LC3 protein plays a critical role in 
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macroautophagy and is considered a suitable marker for this process (Zhou et al., 2009). 
However, viruses must evade autophagocytic degradation, so they can manipulate 
autophagy, via the interaction with LC3. This interaction is mediated by a highly 
conserved LC3 interacting region (LIR) motif in M2 which is required for the 
redistribution of LC3 to the plasma membrane in cells infected with influenza. The LC3±
M2 LIR interaction supports the stability of the filamentous viruses, and mutations in M2 
might inhibit LC3 interaction causing instability of virions (Beale et al., 2014). The 
current sequencing results showed that M2 protein sequence is identical between chicken 
and duck derived virions (Chapter 5). During autophagosome formation, LC3 I is 
converted to LC3 II. LC3±II has been shown to be rapidly upregulated in DEF cells, but 
only transiently upregulated in CEF cells following infection with H2N3 (Donna 
Fountain, personal communication). However, the higher levels of the LC3II protein 
could contribute to the formation of autophagosomes and eventually lyse the pathogens 
through lysosomes; this might support the release of filamentous particles in duck cells. 
The accumulation of LC3 at the cell periphery might represent the virus mobilizing lipid 
resources for virus budding (Beale et al., 2014). Protein colocalization was seen in the 
plasma membrane of the infected cells particularly chicken cells following transfection 
with GFP±LC3 plasmid. These preliminary results showed that virus shape changed 
from spherical to short filaments following transfection of chicken cells with LC3. 
Autophagy, which is more marked in infected duck cells than chicken cells following 
influenza infection (Donna Fountain, personal communication) could increase the 
production of filamentous virions. However, electron microscopy of infected cells is 
required for further confirmation of the initial observations using immunofluorescence, 
possibly using immunogold labelling to identify budding virions or LC3. 
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Chapter 7 
General Discussion
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7.1 General Discussion 
One of the major determinants of influenza virus infection in the host is the presence of 
virus receptors on the host cell surface to which viral haemagglutinin can bind. Avian 
influenza A viruses bind to sialic acid 6$Į±Gal) receptors (Connor et al., 1994). A 
recent study has shown that these receptors are distributed at a similar level in chicken 
and duck embryo fibroblasts (CEF and DEF) essentially giving them a similar affinity to 
infection with avian influenza viruses. Low pathogenic avian influenza (LPAI) H2N3 
virus produces a comparable level of infection in both cell types (Kuchipudi, 2010). 
Accordingly, these cells were chosen to identify differences in the host±pathogen 
interaction and its impact on the nature of the virus. The aim of this research project was 
to elucidate the molecular and morphological differences of viruses produced from two 
different avian host cells, chicken and duck, following infection with low pathogenic 
avian influenza (LPAI) H2N3 virus. It has been shown that influenza A virus can infect a 
wide range of hosts, including wild and domestic birds and some mammals. Little is 
known about the role of the host cell type in producing different level of infectious 
viruses and different virus morphology following infection with the same virus strain.  
It was previously reported that rapid cell death in duck cells following infection with 
H2N3 virus was accompanied by a reduction in the production of infectious virions but 
not viral RNA (Kuchipudi et al., 2011). The viral output was tested by measuring the 
matrix (M) gene copy number using absolute quantitative real±time PCR. This 
investigation may not be adequate to understand the reason behind the variation in 
infectious virus production between chicken and duck fibroblasts. Therefore, further 
techniques were employed to investigate the possible differences in the structure of 
viruses produced from chicken and duck cells. In the first part of this thesis, infectious 
virus production was extensively studied by the detection at different time points 2, 4, 6, 
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8, 24, and 48 hr post infection. The viruses collected from two of these time points (8 
and 24 hr post infection) were used to detect the matrix protein expression of viruses 
produced from chicken and duck cells. These time points were selected as representative 
of the significant and non±significant differences in infectious virus production from 
chicken and duck cells.  
The major part of this study was to determine the differences in virus morphology. 
Chicken and duck cells infected with the virus were observed by electron microscopy 
(EM), to determine the difference in virus morphology budding from those cells. Culture 
supernatants collected from chicken and duck cells infected with the virus were also 
observed under an electron microscope and a clear difference in virus morphology was 
detected. All viral genes of viruses produced from chicken and duck cells were 
sequenced and aligned to study the impact of any possible change in gene sequences on 
modulation of virus morphology and reduction in the virus titre. The role of the host cell 
in determining virus morphology was also studied using different virus strains 
(filamentous and non±filamentous) and different cell types (fibroblasts and MDCK 
cells). 
The production of fewer infective viruses from the infected duck cells at 24 and 48 hr 
post infection might be the result of rapid cell death, which is an important marker 
induced following infection of duck cells with influenza viruses (Kuchipudi et al., 2011). 
However, influenza matrix gene copy number measurement by RT±PCR of viral RNA 
and protein expression measurement by western blotting of culture supernatants were 
similar between chicken and duck derived virions at this time point. The level of 
expression of the other genes and proteins is still unknown. The matrix protein of 
influenza A virus has been shown to play a major role in mediating budding of virus±like 
particles (VLPs), which are non±infectious and non±replicating particles. The expression 
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of M1 protein alone is sufficient to drive the formation of spikeless virus±like particles, 
which can be released from the surface of the infected fibroblast±like COS±1 African 
green monkey kidney cells (Gomez-Puertas et al., 2000). In addition, Latham and 
Galarza (2001) have reported that VLPs can be assembled and released from the surface 
of sf9 insect cells following expression of only four viral proteins, HA, NA, M1, and 
M2. The VLPs were very similar to the size and morphology of influenza virions and 
contained the fine structure of the surface spikes. Therefore, in future, measuring the 
level of all viral proteins derived from the two host species is strongly recommended. 
Furthermore, identification of the types and levels of incorporated cellular proteins in 
purified virions derived from both hosts also needs to be addressed. 
To highlight the expected difference in virus assembly from chicken and duck 
fibroblasts, EM was employed to observe virus budding from those cells and also 
examine viruses from culture supernatants. Interestingly, there was a clear difference in 
the morphology of budding viruses with longer and pleomorphic viruses seen from duck 
cells in comparison with chicken cells which produced spherical virions. It is well known 
that influenza virus morphology can be affected by different factors. Sample preparation 
processes might result in the production of pleomorphic structures (Choppin et al., 1961, 
Sugita et al., 2011).  Further, genetic factors represented by changes in M1, M2, and NA 
amino acid sequence (Bourmakina and Garcia-Sastre, 2003, Elleman and Barclay, 2004, 
Burleigh et al., 2005) or deletions in the cytoplasmic tail of HA or NA amino acid 
sequence (Jin et al., 1997, Zhang et al., 2000) could affect virus morphology. In addition, 
cellular factors play an important role in influenza virus morphogenesis.    
One study has shown that influenza virus morphology is significantly affected by 
ultracentrifugation, which is often used to concentrate virus prior to EM. It showed that 
spherical or ovoid virions sometimes changed to irregular morphology following 
Firas Al ?Mubarak 2014  Chapter 7: General Discussion 
175 
 
ultracentrifugation of unfixed influenza A viruses (Sugita et al., 2011). Therefore, in the 
current study, viruses collected from culture supernatants were concentrated directly 
using an alternative system, Amicon® Ultra 100K NMWL (National Molecular Weight 
Limit) Centrifugal Filter Device, which should maintain virus morphology. This method 
was evaluated by comparing the morphology of viruses observed from the concentrated 
and the non±concentrated supernatants. The morphology of concentrated and non±
concentrated viruses was similar. Such a procedure is recommended to be used in the 
future to concentrate viruses for determining virus morphology using EM. 
Cellular factors such as cell polarity and actin cytoskeleton network play an important 
role in influenza virus morphogenesis. Polarized cells have been shown to support the 
production of filamentous particles up to 30 µm following infection with a filamentous 
A/Udorn/72 virus, while spherical to slightly elongated particles are usually observed 
after infection of non±polarized cells (Roberts and Compans, 1998). However, DEFs 
used in this study supported the production of short filaments after infecting with a non±
filamentous strain (H2N3) while CEFs produced only spherical virions. Although 
fibroblasts are not typical host cells for influenza virus replication in vivo, primary 
fibroblasts derived from avian embryos are commonly used for culture and assay of 
avian influenza viruses. 
In this thesis, all viral genes of the viruses derived from chicken and duck cells were 
amplified, sequenced, and aligned to determine whether there was a genetic basis for 
difference in virus morphology or to address the reason behind the reduction of 
infectious virus production from duck cells. However, the sequence alignments showed 
identical amino acid sequences of all viral genes between chicken and duck produced 
viruses.  
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Mutations and deletions in the viral genome have been shown to play a critical role in 
decreasing virus infectivity and changing the morphology of the virus. Minor nucleotide 
changes in influenza viruses can occur normally due to the lack of proofreading ability of 
the RNA polymerase. Here the overall results of gene sequencing were identical between 
the chicken and duck derived viruses. A study has shown that changes in the nucleotides 
of the polymerase genes might disrupt the formation of the polymerase complex protein 
and inhibit the polymerase functions, eventually reducing the infectivity of the virus 
(Boivin et al., 2010). In the current study, changes were initially detected in PB1 and 
PB2 following sequencing, but these were due to the presence of a secondary amplicon 
rather than real mutations.  
The results of gene sequencing suggested that the difference in virus infectivity and 
morphology between chicken and duck derived viruses was due to cellular factors rather 
than genetic factors. Whilst much attention will be placed on the role of the host cell in 
modulating virus morphology, the potential importance of the role of virus genes in 
reducing output of infectious virus should not be overlooked. A high mutation frequency 
of RNA viral replication is ³GDQJHURXV´IRU a virus because it might result in nonviable 
individuals.  On the other hand, it could create complex quasispecies populations (mutant 
clouds) with potentially beneficially mutations that enable the virus to evolve and adapt 
to new environments during infection (Domingo et al., 2012). Using chemical 
mutagenesis to expand quasispecies diversity of the high±fidelity polio virus, analysing 
viruses provided direct evidence for complementation in sequences between members in 
the quasispecies. This indicates that the selection indeed occurs at the population level 
rather than on individual variants (Vignuzzi et al., 2006). Therefore, due to the high 
mutation rate of influenza A viruses, further work is required to investigate the possible 
changes in the viral genome which might play a role in reducing the infectivity of the 
Firas Al ?Mubarak 2014  Chapter 7: General Discussion 
177 
 
virus. For this purpose, deep sequencing of the complete genome can be a very valuable 
tool. Deep sequencing provides a direct way to evaluate the genome characteristics by 
generating massive amounts of genetic information which could be used to reveal and 
quantify mutations (Bidzhieva et al., 2014). 
For further evaluation of the differences in virus morphology, CEF and DEF were 
infected with the avian H2N3 and equine H3N8 viruses. MDCK cells were also infected 
as a control, as most published work on influenza virus morphology is conducted in this 
type of cell. The principal aim was to investigate the possible role of the actin 
cytoskeleton in the modulation of virus morphogenesis following in vitro infection with 
the virus. In the absence of actin inhibitor, DEF cells produced filamentous or short 
filament particles following infection with both strains, while CEF and MDCK cells 
produced filamentous virions following infection with H3N8 and almost spherical 
particles following infection with H2N3. The assembly of filamentous particles is 
reported to require an intact actin cytoskeleton (Roberts and Compans, 1998). Unlike 
CEF and MDCK cells, DEF cells produced filaments even after disruption of actin with 
actin inhibitor, cytochalasin D (Cyt.D). Using other actin inhibitors such as 
jasplakinolide, a mechanistically different inhibitor of actin treadmilling on influenza 
virus infection, might produce a different form of disruption and might demonstrate a 
role for actin in changing virus shape. In addition, Arcangeletti et al. (2008) have 
reported that treatment of epithelial mammalian cells with an actin inhibitor using Cyt.D 
could be either advantageous or disadvantageous for virus replication following infection 
with human influenza A/NWS/33 virus (H1N1). The study showed treatment with the 
drug significantly increased the infection effectiveness in LLC±MK2 cells, while a 
harmful effect was detected in the MDCK cell line, which was accompanied by a 
significant increase or decrease in virus titre respectively. Hence, further studies are 
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required to explain the differential effect of Cyt.D on infection efficacy in the two avian 
model CEF and DEF cells.  
A very recent study has shown that autophagy, which is a consequence of influenza virus 
infection, is manipulated by the virus itself for its benefit. This manipulation is mediated 
by the interaction of matrix 2 (M2) ion channel protein directly with the essential 
autophagy protein, LC3 (Beale et al., 2014). This interaction is mediated by a highly 
conserved LC3±interaction region (LIR) with M2. The M2 LIR motif causes the 
redistribution of LC3 to the plasma membrane at the time of virus budding. This subverts 
autophagy for the benefit of the virus to provide suitable resources for viral budding and 
to enhance virion stability. The study also showed that mutations in M2 protein 
abolished LC3 binding, which resulted in reduced virion stability of the filamentous 
influenza (Beale et al., 2014). Currently, M2 protein sequencing results are identical 
between chicken and duck produced viruses (Chapter 5). In addition, LC3 has been 
shown to be rapidly upregulated in DEF cells, but transiently upregulated in CEF cells 
following infection with H2N3 (Donna Fountain, personal communication). In this 
thesis, the preliminary findings demonstrated that transfection-mediated LC3 
upregulation in CEF cells supported the production of short filaments compared with the 
untransfected control, which produced only spherical particles. However, observation of 
infected cells under an electron microscope should present a clearer image with more 
details about the differences in virus morphology following the transfection of cells with 
LC3. In addition, using high pathogenic virus strains, or a filamentous virus strain, to 
infect cells following transfection with LC3 could lead to new findings which will help 
to understand this mechanism in more detail. How this process supports the production 
of filaments is still not clear. However, the higher prevalence of autophagy in DEF cells, 
in which LC3 is a key player, could play a role in supporting filamentous virus budding. 
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Hence, further work may give more insights into viral morphogenesis in avian cells and 
possibly identify new cellular factor(s). 
There is also a role for cellular Rab11 (a small GTP±binding protein involved in 
endocytic recycling) and Rab11±family interacting protein 3 (FIP3, which plays a role in 
PHPEUDQH WUDI¿FNLQJ DQG UHJXODWLRQ RI DFWLQ G\QDPLFV SURWHLQV LQ LQIOXHQ]D YLUXV
budding and morphogenesis (Bruce et al., 2010). This study showed that both Rab11 and 
),3SURWHLQVDUHUHTXLUHGWRVXSSRUWWKHIRUPDWLRQRI¿ODPHQWRXVSDUWLFOHVZKLOH5DE
is additionally involved in the final budding step of spherical virions. The reduction of 
Rab11 and FIP3 proteins in human embryonic kidney cells (293T) by treatment with 
small interfering RNA (siRNA) showed an almost complete absence of filaments 
following infection with the filamentous virus PR8 MUd.  The level and the structure of 
these proteins in chicken and duck embryo fibroblasts and their impact on regulating 
influenza virus morphology have not been studied yet. Hence, such a study is required to 
address the effect these proteins may have on modulating virus morphogenesis in 
chicken and duck cells. 
Although the embryonic chicken and duck fibroblasts are considered a good cell model 
to study influenza virus infection in vitro, they might have different growth kinetics to 
support the production of the influenza virus. Such a variation is also found in epithelial 
continuous cell lines, for example MDCK and Vero cells have different viral growth 
kinetics and play a role in supporting different levels of influenza virus replication (Youil 
et al., 2004). Further, epithelial cells of the crypts of Lieberkuhn in the large intestine of 
ducks represent the primary target site for replication of LPAI (Webster et al., 1978) and 
the epithelial cells of the upper and lower respiratory tract are the main target of virus 
replication in chickens (Shalaby et al., 1994, Swayne and Slemons, 1994). Although the 
results of this thesis affirm similar levels of virus infection in chicken and duck cells (as 
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evidenced by detection of viral nucleoprotein by immunohistochemical staining), there 
might be some differences in the growth kinetics between cells which result in the 
production of different levels of infective viruses. Using different cell types such as 
respiratory, kidney and intestinal cells of both chicken and duck is important to evaluate 
the role of those cells in supporting virus replication. In addition, the use of other virus 
strains such as highly pathogenic avian influenza (HPAI) strains to infect the same cell 
type of different hosts is also recommended. 
 
7.2 Conclusions and future work 
In summary, based on the findings gained from this thesis, it appears plausible that 
cellular factors rather than viral strain or genetic factors might play a major role in 
producing different titres of infectious avian H2N3 and in modulating virus morphology 
following the infection of embryonic fibroblasts from chickens and ducks. The 
hypothesis of this project was: the different outcomes of H2N3 infection in chicken 
versus duck cells, which are accompanied by a reduction in infectious virus titre from 
duck cells, may be due to changes in virus morphology, defects in the viral structure, or 
host cell factors. Accordingly, these findings upheld one hypothesis of this project ³the 
role of host cell factors´. However, further studies are required to identify the cellular 
factors, in particular the role of autophagy in modulating virus morphology. In addition, 
determining the level of cellular Rab11 and FIP3 in both chicken and duck fibroblasts 
would be worthwhile. For these purposes, using virus strains of different morphology 
and observation of infected cells under an electron microscope is recommended. This 
may further indicate some level of divergence in the mechanisms responsible for 
VSKHULFDO DQG ¿ODPHQWRXV YLULRQ PRUSKRJHQHVLV Furthermore, studying the effect of 
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different actin inhibitors on virus morphogenesis and their impact on the replication of 
viruses is required. 
On the other hand, it will be interesting to study the structure of the progeny virions in 
more detail, and in particular determine the level of all viral proteins following infection 
of CEF and DEF with the virus. This will further help in appreciating the relationship 
between rapid cell death which follows the infection of duck cells and the production of 
defective virions. At the level of the investigation conducted and findings in this thesis, 
no differences in virus genome were detected; however, deep sequencing of the whole 
virus genome may be required to reveal and quantify any possible mutations which 
might decrease the infectivity of the duck derived virions. Moreover, it is necessary to 
examine other cell types such as epithelial cells to observe the differences of virus 
outcome following infection. Further, the use of other virus strains such as HPAI might 
produce different levels of virus titre. 
The kinds of approaches outlined above may lead to the potentially new findings which 
will help to understand the impact of the host cell on influenza virus production in more 
detail. 
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Appendix±I: Buffers and media formulation 
Tris Acetate EDTA buffer (TAE) 50X 
7ULVEDVH«««««««««««««««««««.««««««««« g 
*ODFLDODFHWLFDFLG«««««««««««««..««««««......«««mL 
0.5 0('7$S+««««««««««««««««««««« mL 
Make up the volume to 1 litre with distilled water. It can be stored at room temperature 
for long time. 
 
Tris buffered saline (TBS) 10X  
The following are dissolved in 800mL of distilled water 
6RGLXPFKORULGH1D&O«««««««««««««««......««««« g 
7ULV7UL]PDEDVH««««««««««««««««««««««« g 
Adjust the pH to 7.4 with HCl and make up the volume to one liter with distilled water. 
 
Cell culture medium 
'0(0*OXWD0D[«««««««««««««««««««..«««« mL 
)HWDOFDOIVHUXP)&6««««««««««««««««««««.«« mL 
Penicillin±streptomycin ««««««««««««««««.««.«...«« mL 
 
Infection medium (IM) 
DMEM with Gluta 0D[DQG+DP¶V)««««««««.««..««« mL 
8OWURVHU*VHUXPUHSODFHPHQW««««««««««««««««««« mL 
3HQVWUHS««««««««««««««««««««««««....««« ȝO 
73&.WU\SVLQ«««««««««««««««««««««««««««ȝO 
 
Media used for egg infection  
Phosphate EXIIHU6DOLQH3%6«««««««««««««««..«««« mL 
Tryptose phosphate broth ««««««««...««««««.«««««« mL 
Penicillin Streptomycin (Pen Strep) ««.««««««.«««««««««« mL 
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Appendix±II Influenza virus gene sequences and primer sites 
Below, there are 8 viral genome sequences with their accession numbers obtained from 
an influenza research database (http://www.fludb.org/brc/home.do?decorator=influenza). 
The top and bottom yellow highlighted fragments were used for designing forward and 
reverse primers, respectively, to amplify the large amplicon of each gene. The forward 
and reverse of the start (top) of each gene are highlighted with green, while the forward 
and reverse of the end (bottom) are highlighted with blue. The forward and reverse 
primer sites used only to sequence the middle part of PB1, PB2, and PA are highlighted 
with red. 
 
CY003943|A/mallard duck/ALB/353/1988 PB2 gene  
AGCGAAAGCAGGTCAAATATATTCAATATGGAGAGAATAAAAGAACTAAGAGATCTAATG 
TCGCAGTCCCGCACCCGCGAGATACTCACTAAGACCACTGTGGACCATATGGCCATAATC 
AAAAAGTACACATCAGGAAGGCAAGAGAAGAACCCCGCACTCAGAATGAAGTGGATGATG 
GCAATGAAATACCCAATTACAGCAGACAAGAGAATAATGGAAATGATTCCTGAGAGGAAT 
GAACAAGGGCAAACCCTCTGGAGCAAAACAAACGATGCTGGCTCAGACCGAGTGATGGTA 
TCACCTCTGGCCGTAACATGGTGGAATAGGAATGGACCGACAACAAGTACAGTTCACTAC 
CCGAAGGTATATAAAACTTATTTCGAAAAAGTCGAAAGGTTAAAACATGGTACTTTTGGC 
CCCGTCCACTTCAGAAATCAAGTTAAGATAAGAAGGAGAGTTGACATAAACCCTGGTCAC 
GCAGATCTCAGTGCCAAGGAGGCACAGGATGTGATCATGGAAGTCGTTTTCCCAAATGAA 
GTGGGAGCAAGAATACTAACATCAGAGTCACAGCTGACAATAACAAAAGAGAAGAAAGAA 
GAGCTCCAGGATTGCAAAATTGCTCCCTTGATGGTAGCATACATGCTAGAAAGAGAGTTG 
GTCCGCAAAACGAGGTTCCTCCCAGTGGCTGGTGGGACAAGCAGTGTTTATATTGAGGTG 
CTGCATTTAACCCAGGGGACATGCTGGGAGCAGATGTACACTCCAGGAGGAGAAGTGAGA 
AATGATGATATTGACCAAAGTTTGATTATCGCTGCTAGGAACATAGTAAGAAGAGCAACG 
GTCTCAGCAGACCCATTAGCGTCTCTCTTGGAAATGTGCCATAGCACACAGATTGGAGGG 
ATAAGGATGGTGGACATCCTTAGACAGAATCCAACAGAGGAACAAGCCGTAGACATATGC 
AAGGCAGCAATGGGGTTGAGGATTAGCTCATCTTTCAGCTTCGGTGGGTTCACTTTCAAA 
AGAACAAGCGGATCGTCAGTCAAGAAAGAAGAAGAAGTGCTCACGGGCAACCTTCAAACA 
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CTGAAAATAAGAGTACATGAAGGGTATGAAGAATTCACAATGGTCGGGAGAAGAGCAACA 
GCTATTCTCAGAAAGGCAACCAGGAGATTGATCCAGCTAATAGTAAGTGGGAGAGACGAG 
CAGTCAATTGCTGAGGCAATAATCGTGGCCATGGTATTTTCACAAGAGGATTGCATGATC 
AAGGCAGTTCGGGGCGATCTGAACTTTGTCAATAGGGCAAACCAACGATTGAATCCCATG 
CATCAACTCCTGAGACATTTCCAAAAAGATGCAAAAGTGCTTTTCCAGAACTGGGGAATT 
GAACCTATCGACAATGTGATGGGAATGATCGGAATATTGCCCGATATGACCCCAAGTACA 
GAGATGTCGCTGAGGGGAATAAGAGTCAGCAAAATGGGAGTAGATGAATACTCCAGCACG 
GAGAGAGTGGTGGTGAGCATTGACCGATTTTTGAGGGTTCGGGATCAACGGGGAAATGTA 
CTATTGTCTCCCGAAGAAGTCAGCGAGACACAAGGAACGGAGAAACTGACAATAACTTAT 
TCGTCATCAATGATGTGGGAGATCAATGGTCCTGAGTCGGTGCTGGTCAATACTTATCAG 
TGGATCATCAGGAACTGGGAGACTGTGAAAATTCAATGGTCACAAGATCCCACGATGTTG 
TACAATAAAATGGAATTCGAACCATTTCAGTCTCTTGTCCCCAAGGCAGCCAGAAGTCAA 
TACAGCGGATTCGTGAGGACACTGTTCCAGCAAATGCGAGATGTGCTTGGAACATTTGAC 
ACTGTTCAAATAATAAAACTTCTCCCCTTTGCTGCTGCTCCACCAGAACAGAGTAGGATG 
CAGTTCTCCTCACTAACTGTGAATGTGAGAGGGTCAGGGATGAGGATACTGGTAAGAGGC 
AATTCTCCAGTGTTCAATTACAACAAGGCAACCAAAAGGCTTACAGTTCTTGGAAAGGAT 
GCAGGTGCATTGACCGAAGATCCAGATGAAGGCACAGCTGGGGTGGAGTCTGCTGTTCTG 
AGAGGATTCCTCATTCTGGGCAAAGAAGACAAGAGATATGGCCCAGCATTGAGCATCAAT 
GAACTGAGCAATCTTGCAAAAGGGGAGAAGGCTAATGTGCTAATTGGACAAGGAGACGTA 
GTGTTGGTAATGAAACGGAAACGGGACTCTAGCATACTTACTGACAGCCAGACAGCGACC 
AAAAGAATTCGGATGGCCATCAATTAGTGTCGAATTGTTTAAAAACGACCTTGTTTCTAC 
T 
 
CY003942|A/mallard duck/ALB/353/1988 PB1 gene  
AGCGAAAGCAGGCAAACCATTTGAATGGATGTCAATCCGACTTTACTTTTCTTGAAAGTT 
CCAGCGCAAAATGCCATAAGCACCACATTCCCATATACAGGAGATCCTCCATACAGCCAT 
GGAACAGGAACAGGATACACCATGGACACAGTCAATAGAACACATCAATATTCAGAAAAG 
GGAAAATGGACAACAAACACAGAAACTGGAGCACCCCAACTTAACCCAATTGATGGACCA 
TTACCTGAGGATAATGAGCCAAGTGGATATGCACAAACAGACTGTGTCCTGGAAGCAATG 
GCTTTCCTTGAAGAGTCCCACCCAGGAATCTTTGAAAACTCGTGTCTTGAAACGATGGAA 
GTTGTTCAACAAACAAGAGTGGACAAGCTGACCCAAGGGCGCCAGACCTATGATTGGACA 
TTAAACAGGAATCAGCCGGCTGCAACTGCATTAGCTAATACTATAGAGGTCTTCAGATCG 
AACGGTTTAACGGCTAATGAATCAGGAAGGCTAATAGATTTCCTCAAGGATGTGATGGAA 
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TCAATGGATAAAGAGGAAATGGAAATAACAACGCACTTCCAAAGAAAAAGAAGAGTAAGG 
GACAACATGACCAAGAAAATGGTCACACAAAGAACAATAGGAAAGAAGAAACAGAGACTA 
AACAAGAGAAGCTATCTAATAAGAGCACTGACACTGAACACAATGACAAAAGACGCTGAA 
AGAGGCAAATTAAAAAGAAGAGCAATTGCAACACCCGGAATGCAAATCAGAGGGTTTGTG 
TATTTTGTTGAAACATTGGCGAGGAGCATTTGTGAGAAACTTGAACAATCTGGACTTCCA 
GTTGGAGGCAATGAAAAGAAGGCTAAACTGGCAAATGTTGTGAGAAAAATGATGACTAAT 
TCACAGGATACAGAGCTCTCTTTCACAATCACTGGAGACAACACCAAATGGAATGAAAAT 
CAGAACCCTAGGATGTTCCTGGCAATGATAACATACATAACAAGAAACCAACCTGAATGG 
TTTAGGAATGTTTTGAGCATTGCACCTATAATGTTCTCAAACAAAATGGCAAGGCTAGGA 
AAAGGGTACATGTTTGAAAGTAAGAGCATGAAACTTCGAACACAGATACCAGCAGAGATG 
CTAGCAAATATTGACCTGAAATATTTCAATGAGTCAACAAGAAAAAAAATAGAGAAAATA 
AGGCCTCTTCTAATAGATGGTACAGCCTCATTGAGTCCTGGAATGATGATGGGTATGTTC 
AATATGCTAAGTACAGTTTTAGGAGTCTCAATCCTAAATCTAGGACAGAAGAGATATACA 
AAAACAACATACTGGTGGGACGGGCTCCAATCCTCTGATGACTTTGCTCTCATCGTGAAT 
GCACCGAATCATGAAGGAATACAAGCAGGAGTAGATAGATTCTATAGAACCTGCAAGCTA 
GTCGGAATCAATATGAGCAAGAAGAAGTCCTACATAAACAGAACAGGGACATTTGAATTC 
ACAAGCTTTTTCTATCGCTATGGGTTTGTAGCCAACTTTAGCATGGAACTGCCCAGCTTT 
GGAGTGTCTGGGATTAATGAATCGGCTGACATGAGCATTGGGGTAACAGTGATAAAGAAC 
AACATGATAAACAATGACCTTGGACCAGCGACGGCTCAAATGGCTCTTCAGCTGTTCATC 
AAGGATTACAGGTACACGTATCGGTGTCACAGAGGGGACACACAAATTCAGACGAGGAGG 
TCATTCGAGCTGAAGAAGTTGTGGGAACAAACCCGCTCAAAGGCAGGACTGCTGGTTTCA 
GATGGAGGACCAAACTTATACAATATTCGGAATCTCCACATCCCGGAAGTCTGCCTGAAA 
TGGGAGCTAATGGACGAAGACTATCAAGGAAGGCTTTGTAACCCATTGAACCCATTTGTC 
AGCCATAAGGAGATAGAGTCTGTAAACAATGCTGTGGTGATGCCAGCTCATGGCCCAGCC 
AAGAGCATGGAATATGATGCTGTTGCTACTACACATTCCTGGATCCCCAAGAGGAACCGC 
TCCATCCTCAACACAAGCCAAAGGGGAATCCTTGAAGACGAACAGATGTACCAAAAGTGC 
TGCAATCTATTCGAGAAATTCTTCCCTAGCAGTTCATACAGGAGACCGGTTGGAATTTCC 
AGCATGGTGGAGGCCATGGTGTCTAGGGCCCGAATTGATGCACGAATTGACTTCGAGTCT 
GGACGGATTAAGAAGGAGGAGTTTGCTGAGATCATGAAGATCTGTTCCACCATTGAAGAG 
CTCAGACGGCAGAAATAGTGAATTTAGCTTGTCCTTCATGAAAAAATGCCTTGTTTCTAC 
T 
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CY003997|A/mallard/Alberta/79/2003 PA gene  
AGCGAAAGCAGGTACTGATTCAAAATGGAAGATTTTGTGCGACAATGCTTCAATCCAATG 
ATCGTCGAGCTTGCGGAAAAGGCAATGAAAGAATATGGGGAAGATCCAAAAATCGAGACA 
AACAAATTTGCTGCAATATGCACACACTTAGAAGTGTGTTTCATGTATTCAGATTTCCAT 
TTCATTGATGAACGAGGTGAGTCGATAATCGTGGAGTCTGGCGATCCAAATGCACTCCTA 
AAACACCGATTTGAAATAATTGAAGGGAGAGATCGTACTATGGCCTGGACAGTAGTGAAC 
AGTATTTGCAACACCACAGGAGTTGAAAAACCCAAATTTCTCCCGGATTTATACGATTAC 
AAAGAGAATCGTTTCATTGAAATTGGAGTAACCAGGAGGGAGGTCCATATATACTATTTA 
GAAAAGGCCAATAAGATAAAGTCTGAGAAGACACACATCCACATCTTTTCATTCACTGGG 
GAAGAAATGGCTACTAAAGCAGACTACACTCTTGATGAAGAAAGTAGAGCGAGGGTCAAA 
ACCAGACTATTCACCATAAGACAAGAGATGGCCAGTAGAGGCCTCTGGGATTCCTTTCGT 
CAGTCCGAGAGAGGCGAAGAGACAATTGAAGAAAGATTTGAAATTACAGGAACCATGCGC 
AGGCTCGCCGACCAAAGTCTCCCACCGAACTTCTCCAGCCTTGAAAACTTTAGAGCCTAT 
GTGGATGGATTCGAACCGAACGGCTGCATTGAGGGCAAGCTTTCTCAAATGTCCAAAGAA 
GTAAACGCAAGAATTGAACCATTTTTGAAGACAACACCACGCCCCCTGAGATTACCGGAA 
GGGCCTCCTTGCTCTCAGCGGTCGAAATTTCTGCTGATGGATGCTCTGAAGCTTAGCATT 
GAAGACCCGAGTCATGAAGGCGAGGGGATACCGCTGTATGATGCGATCAAATGCATGAAG 
ACCTTTTTCGGCTGGAAAGAGCCTAACATTGTTAAGCCACATGAAAAGGGCATAAACCCC 
AATTATCTCCTGGCTTGGAAGCAAGTGCTAGCAGAGCTACAGGATATTGAAAACGAGGAG 
AAGATTCCAAAAACGAAGAACATGAAGAAAACAAGCCAATTGAAGTGGGCACTTGGTGAA 
AACATGGCACCAGAGAAAGTGGACTTTGAAGATTGCAAGGATGTCAGCGATTTGAGGCAG 
TATGACAGCGATGAGCCTGAGCAAAGATCACTAGCAAGTTGGATTCAAAGTGAGTTCAAC 
AAAGCTTGTGAATTGACTGACTCAAGTTGGATAGAACTCGATGAAATAGGGGAGGACGTT 
GCCCCAATCGAACACATTGCAAGCATGAGGAGGAATTACTTTACAGCTGAAGTGTCTCAC 
TGCAGGGCAACAGAATACATAATGAAGGGAGTATACATAAACACAGCTTTGCTCAATGCT 
TCTTGTGCGGCAATGGATGATTTTCAGCTGATCCCAATGATAAGCAAATGCAGAACCAAG 
GAAGGGCGGCGGAAGACAAATCTGTATGGGTTCATAATAAAGGGAAGATCTCATTTGAGG 
AACGATACTGATGTAGTGAATTTTGTGAGCATGGAGTTTTCTCTTACTGATCCTAGACTA 
GAGCCACATAAATGGGAGAAATACTGTGTCCTTGAAATAGGGGACATGCTCCTGCGGACT 
GCAATAGGCCAAGTATCGAGACCCATGTTTCTGTATGTGAGGACCAATGGAACTTCCAAG 
ATCAAAATGAAATGGGGTATGGAGATGAGGCGTTGTCTTCTTCAATCCCTTCAGCAAATT 
GAAAGCATGATTGAGGCCGAGTCCTCTGTCAAAGAGAAAGACATGACCAAAGAATTCTTT 
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GAAAACAAATCAGAGACATGGCCCATTGGGGAATCACCCAAAGGAGTAGAAGAAGGTTCC 
ATTGGAAAGGTGTGCAGGACTCTGCTGGCAAAATCTGTATTCAACAGCTTGTATGCATCT 
CCACAACTAGAGGGATTTTCAGCTGAGTCGAGAAAGCTGCTCCTCATTGTTCAGGCACTT 
AGGGACAACCTGGAACCTGGTACCTTCGATCTTGGAGGGCTATATGAAGCAATTGAGGAG 
TGCCTGATTAATGATCCCTGGGTTTTGCTTAACGCATCTTGGTTCAACTCCTTCCTCACA 
CATGCACTGAAATAGTTGTGGCAATGCTACTATTTGCTATCCATACTGTCCAAAAAAGTA 
CCTTGTTTCTACT 
 
 
CY003992|A/mallard/Alberta/79/2003 HA gene 
AGCAAAAGCAGGGGTTATACCATAGACAACCGAACAAAGACAATGACCATCACTTTTCTC 
ATCCTCCTGTTCACAGTAGTGAAAGGGGACCAAATATGTATCGGATACCATGCCAACAAT 
TCCACAGAAAAAGTTGACACAATCTTGGAACGAAACGTCACCGTGACTCATGCCAAGGAC 
ATTCTTGAAAAAACGCATAATGGAAAGTTGTGCAGATTAAGCGGGATCCCTCCACTGGAA 
CTGGGGGATTGCAGCATTGCAGGTTGGCTCCTTGGAAATCCGGAATGTGACCGGCTCTTA 
AGTGTACCTGAATGGTCCTATATAGTGGAAAAGGAAAACCCGGTGAATGGTCTGTGCTAC 
CCAGGCAGTTTCAATGATTATGAGGAATTGAAACATCTCCTCACCAGTGTGACACACTTT 
GAGAAAGTTAAGATTCTGCCCAGAGATCAATGGACTCAGCACACAACAACTGGTGGTTCT 
CGGGCCTGTGCAGTGTCTGGAAACCCGTCATTCTTTAGGAACATGGTTTGGCTTACAAAG 
AAGGGGTCAAACTACCCAATTGCTAAAAGGTCATACAACAACACAAGTGGGGAGCAAATG 
CTGGTAATCTGGGGGATACATCATCCCAATGACGATGCGGAACAAAGGACACTGTACCAG 
AATGTGGGAACATATGTTTCCGTTGGGACATCAACACTAAATAAGAGGTCAATCCCTGAA 
ATAGCAACAAGGCCCAAAGTCAATGGACAAGGAGGGAGAATGGAATTCTCTTGGACTCTA 
TTGGAGACATGGGATGTCATAAATTTTGAGAGCACTGGTAATTTAATTGCACCAGAATAC 
GGATTCAAAATATCAAAGAGAGGAAGCTCAGGAATTATGAAGACAGAGAAAACACTTGAA 
AATTGTGAAACCAAATGTCAGACCCCCTTGGGGGCAATAAATACAACATTGCCCTTTCAC 
AACATTCACCCATTGACAATAGGTGAGTGCCCCAAGTATGTAAAGTCAGACAGACTGGTT 
TTGGCAACAGGACTAAGAAATGTCCCTCAGATTGAATCAAGGGGATTGTTTGGAGCAATA 
GCTGGGTTTATAGAAGGCGGATGGCAAGGGATGGTTGATGGCTGGTATGGGTATCATCAC 
AGCAATGATCAAGGATCAGGATATGCAGCAGACAAAGAATCCACTCAAAAGGCAATTGAT 
GGGATAACTAACAAAGTAAATTCTGTGATTGAAAAGATGAACACTCAGTTTGAGGCTGTT 
GGGAAAGAGTTCAACAATCTAGAGAGAAGACTAGAAAACTTAAATAAAAAGATGGAAGAT 
GGATTTCTTGATGTATGGACATATAATGCCGAACTCCTAGTTCTAATGGAGAATGAGAGG 
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ACACTTGATTTCCATGACTCTAATGTGAAGAATCTGTACGATAAGGTCAGAATGCAATTA 
AGAGACAATGCTAAGGAAATAGGGAACGGATGCTTTGAGTTTTATCATAAATGTGATGAT 
GAATGCATGAATAGTGTCAGGAATGGAACATATGATTATCCCAAATATGAGGAAGAGTCC 
AAGCTGAACAGGAACGAAATAAAAGGACTGAAATTGAGCAATATGGGGGTCTATCAAATA 
CTTGCTATATACGCTACAGTTGCAGGCTCCTTGTCACTGGCAATCATGATAGCTGGGATT 
TCTTTCTGGATGTGTTCTAATGGGTCTCTGCAATGCAGAATTTGCATATGACTGTAAGTC 
AATTTGTAATTAAAAACACCCTTGTTTCTACT 
 
CY003995|A/mallard/Alberta/79/2003 NP gene 
AGCAAAAGCAGGGTAGATAATCACTCACCGAGTGACATCCACATCATGGCGTCTCAAGGC 
ACCAAACGATCTTATGAACAGATGGAAACTGGTGGAGAACGCCAGAATGCAACTGAAATC 
AGAGCATCTGTTGGGAGAATGGTTGGTGGAATCGGAAGGTTCTACATACAGATGTGCACT 
GAACTCAAGCTCAGTGACTATGAAGGGAGGCTGATCCAAAACAGCATCACAATAGAGAGA 
ATGGTTCTCTCAGCATTTGATGAGAGGAGAAACAAATATCTGGAGGAGCATCCCAGTGCT 
GGAAAAGACCCTAAGAAGACTGGAGGTCCAATCTACAGGAGGAGAGATGGGAAATGGATG 
AGAGAATTGATCCTATATGATAAAGAGGAGATCAGAAGGATTTGGCGTCAAGCGAATAAT 
GGAGAAGACGCAACTGCCGGCCTCACCCATTTGATGATCTGGCACTCCAATCTGAATGAT 
GCCACCTATCAGAGGACGAGGGCACTTGTGCGTACTGGAATGGATCCCAGGATGTGTTCT 
CTGATGCAAGGCTCGACTCTTCCGAGGAGGTCTGGAGCTGCTGGAGCAGCAGTGAAAGGA 
GTTGGAACAATGGTGATGGAATTGATCCGAATGATCAAGCGAGGGATCAATGATCGGAAT 
TTCTGGAGAGGCGAAAATGGGCGGAGGACAAGAATTGCTTATGAGAGAATGTGCAACATC 
CTCAAAGGGAAGTTTCAAACAGCGGCACAAAGAGCAATGATGGACCAGGTGAGGGAAAGC 
CGGAATCCTGGGAATGCTGAAATTGAAGATCTCATCTTTCTCGCACGGTCTGCTCTCATT 
CTGAGGGGATCAGTGGCTCATAAGTCTTGCCTGCCTGCTTGTGTGTATGGACTTGCTGTG 
GCCAGTGGATACGACTTTGAAAGAGAGGGATACTCCCTAGTCGGAATCGATCCTTTCCGT 
CTGCTCCAAAACAGTCAAGTCTTCAGTCTCATCAGACCAAACGAAAACCCAGCACATAAA 
AGTCAGCTGGTATGGATGGCATGCCACTCTGCAGCTTTTGAAGATCTGAGAGTGTCAAGC 
TTCATTAGAGGAACAAGAGTAGTCCCAAGAGGACAGCTATCCACCAGAGGAGTTCAGATT 
GCTTCAAATGAGAACATGGAGACAATGGACTCCAGTACTCTTGAACTGAGGAGCAGATAC 
TGGGCTATAAGGACCAGAAGTGGAGGAAACACTAACCAGCAGAGAGCATCCGCAGGGCAA 
ATCAGCGTACAGCCCACATTCTCTGTACAGAGGAACCTCCCATTCGAGAGAGCAACCATT 
ATGGCGGCATTTACAGGGAACACTGAAGGCAGAACTTCAGACATGAGAACAGAAATCATA 
AGGATGATGGAAAATGCCAGACCTGAGGATGTGTCTTTCCAGGGGCGGGGAGTCTTCGAG 
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CTCTCAGACGAAAAGGCAACGAACCCGATCGTGCCTTCCTTTGACATGAGTAACGAAGGA 
TCTTATTTCTTCGGAGACAATGCAGAGGAGTATGACAATTAAAAAAAGAAAAATACCCTT 
GTTTCTACT 
 
CY003946|A/mallard/ALB/201/1996 NA gene  
The area which is highlighted with yellow and green is a region of overlapping between 
the two forward primers. 
 
AGCAAAAGCAGGTGCGAGATGAATCCAAATCAGAAGATAATAACAATCGGGGTAGTGAAC 
ACCACTCTGTCAACAATAGCCCTTCTCATTGGAGTGGGAAATTTAGTTTTCAACACAGTC 
ATACATGAGAAAATAGGAGACCACCAAACAGTGATCCACCCAACAATAACGACCCCTGCA 
GTACCGAACTGCAGTGACACTATAATAACATACAATAACACTGTGATAAACAACATAACA 
ACAACAATAATAACTGAAGCGGAAAGGCCTTTCAAGCCTCCACTACCGCTGTGCCCCTTC 
AGAGGATTCTTCCCTTTTCACAAGGACAATGCAATACGGCTGGGTGAGAACAAAGACGTC 
ATAGTCACAAGGGAGCCTTATGTTAGCTGCGATAATGACAATTGCTGGTCCTTTGCTCTC 
GCACAAGGAGCATTGCTAGGGACTAAACATAGCAATGGGACCATTAAAGACAGAACACCA 
TATAGGTCTCTAATCCGATTCCCAATAGGAACAGCTCCAGTACTAGGAAATTACAAGGAG 
ATATGCATTGCTTGGTCGAGCAGCAGTTGCTTTGACGGGAAAGAGTGGATGCATGTATGC 
ATGACAGGGAACGATAATGATGCAAGTGCCCAGATAATATATGCAGGGAGAATGACAGAC 
TCCATTAAATCATGGAGAAAGGACATACTGAGAACTCAGGAGTCCGAATGTCAGTGCATC 
GGCGGGATTTGTGTTGTTGCTGTCACAGATGGCCCTGCTGCTAATAGTGCAGATCACAGG 
ATTTACTGGATACGGGAGGGAAGAATAATGAAGTATGAAAATGTCCCCAAAACAAAGATA 
CAACACTTAGAAGAGTGTTCCTGCTATGTGGACATTGATGTTTACTGTATATGTAGGGAT 
AATTGGAAGGGTTCTAACAGACCTTGGATGAGAATCAACAACGAGACTATACTGGAAACA 
GGGTATGTGTGTAGTAAATTTCACTCAGACACCCCCAGGCCAGCTGATCCCTCAACAATA 
TCATGTGACTCCCCAAGCAATGTCAATGGAGGACCCGGAGTAAAGGGATTTGGTTTCAAA 
GCCGGCAATGATGTATGGTTGGGTAGAACAGTGTCAACTAGTGGTAGATCGGGCTTTGAA 
ATTATCAAAGTTACAGAGGGGTGGATCAACTCTCCCAATCATGCCAAATCAATTACACAA 
ACACTGGTGTCCAACAATGATTGGTCAGGCTATTCAGGTAGCTTCATTGTCAAAACCAAG 
GACTGTTTTCAGCCCTGTTTTTATGTCGAGCTTATACGAGGGAGGCCCAACAAGAATGAT 
GATGTCTCTTGGACAAGCAATAGTATAGTTACTTTCTGTGGACTAGACAATGAACCTGGA 
TCGGGAAATTGGCCGGATGGTTCTAACATTGGGTTTATGCCCAAGTAACAGAAAAAAGCA 
CCTTGTTTCTACT 
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CY003945|A/mallard/ALB/201/1996 M gene 
Pink areas represent the sites of the forward and reverse primers that were used for 
qPCR. Grey area represents the site of the probe.  
 
AGCAAAAGCAGGTAGATATTGAAAGATGAGTCTTCTAACCGAGGTCGAAACGTACGTTCT 
CTCTATCGTCCCGTCAGGCCCCCTCAAAGCCGAGATCGCGCAGAGACTTGAAGATGTCTT 
TGCAGGAAAGAACACAGATCTTGAGGCACTCATGGAATGGCTAAAGACAAGACCAATCCT 
GTCACCTCTGACTAAGGGGATTTTAGGATTTGTGTTCACGCTCACCGTGCCCAGTGAGCG 
AGGACTGCAGCGTAGACGCTTTGTCCAGAATGCTCTTAATGGGAATGGAGATCCAAACAA 
CATGGACAGGGCAGTCAAACTGTATAGGAAGCTCAAAAGGGAAATTACATTCCATGGGGC 
CAAAGAGGTAGCACTCAGTTATTCCACTGGTGCACTTGCCAGTTGCATGGGCCTCATATA 
CAACAGGATGGGAACAGTGACCACCGAAGTGGCATTTGGACTGGTGTGCGCCACATGTGA 
GCAGATTGCTGACTCCCAGCATCGGTCTCACAGGCAGATGGTGACAACAACCAACCCACT 
GATCAGACATGAGAACAGGATGGTACTGGCTAGTACTACGGCTAAAGCCATGGAGCAGAT 
GGCAGGGTCGAGCGAACAAGCAGCAGAGGCTATGGAGGTTGCCAGTCAGGCTAGGCAGAT 
GGTGCAGGCAATGAGGACCATTGGGACTCATCCTAGCTCCAGTGCCGGTCTAAAAGATGA 
TCTTCTTGAAAATTTGCAGGCCTACCAGAAACGAATGGGAGTGCAAATGCAGCGATTCAA 
GTGATCCTCTCGTTATTGCCGCAAGTATCATTGGGATCTTGCACTTGATATTGTGGATTC 
TTGATCGTCTTTTTTTCAAATGCATTTATCGTCGCCTTAAATACGGATTGAAAAGAGGGC 
CTTCTACGGAAGGAGTGCCTGAGTCTATGAGGGAAGAATATCGGCAGGAACAGCAGAGTG 
CTGTGGATGTTGACGATGGTCATTTTGTCAACATAGAGCTGGAGTAAAAAACTACCTTGT 
TTCTACT 
 
CY003980|A/mallard/ALB/226/1998 NS gene 
AGCAAAAGCAGGGTGACAAAAACATAATGGATTCCAACACTGTGTCAAGCTTTCAGGTAG 
ACTGCTTTCTTTGGCATGTCCGCAAACGATTTGCAGACCAAGAACTGGGTGATGCCCCAT 
TCCTTGACCGGCTTCGCCGAGATCAAAAATCTCTAAGAGGAAGAGGCAGCACTCTTGGTC 
TGGATATCGAAACAGCCACTCGCTCTGGAAAGCAGATAGTGGAGAGGATTCTGGAGGAAG 
AATCCGACGAGGCACTCAAAATGACTATTGCCTCTGTACCTGCTTCACGCTACCTAACTG 
ACATGACTCTTGAAGAGATGTCAAGAGACTGGTTCATGCTCATGCCCAAACAAAAAGTGG 
CAGGTTCCCTCTGTATCAGAATGGACCAGGCGATCATGGATAAGAATATTATACTGAAAG 
CGAATTTCAGTGTGATCTTCGATCGGCTGGAGACACTAATACTACTCAGAGCTTTCACTG 
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AAGAAGGAGCAATTGTCGGCGAAATTTCACCATTGCCTTCTCTTCCAGGACATACTGATG 
AGGATGTCAAAAATGCAATTGGGGTCCTCATCGGAGGACTTGAATGGAATGATAACACAG 
TTCGAGTCTCTGAAACTCTACAGAGATTCGCTTGGAGAAGCTGTAATGAGGATGGGAGAC 
CTCCACTCCCTCCAAAGCAGAAACGGAAAATGGCGAGAACAATTGAGTCAGAAGTTTGAG 
GAAATAAGGTGGCTAATTGAAGAGGTGCGACATAGACTAAAGGTTACAGAGAATAGTTTT 
GAACAAATAACATTTATGCAAGCCTTACAACTACTGCTTGAAGTGGAGCAAGAGATAAGA 
ACTTTCTCGTTTCAGCTTATTTAATGATAAAAAACACCCTTGTTTCTACT 
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Appendix±III Nucleotide sequence alignments  
Below, the final nucleotide sequences of the eight H2N3 viral genes of both CEF and 
DEF cell produced viruses. The sequences of each gene were assembled and aligned by 
Geneious Inspirational Software for Biologists. 
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Figure III±1 Polymerase basic 2 (PB2) gene alignment between chicken and duck cell grown viruses. The figure shows identical sequences between the two PB2 genes.   
PB2/C: Polymerase basic 2 gene sequenced from H2N3 grown on chicken cells.   
PB2/D: Polymerase basic 2 gene sequenced from H2N3 grown on duck cells. 
PB2 
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Figure III±2 Polymerase basic 1 (PB1) gene alignment between chicken and duck cell grown viruses. The figure shows identical sequences between the two PB1 genes.   
PB1/C: Polymerase basic 1 gene sequenced from H2N3 grown on chicken cells.   
PB1/D: Polymerase basic 1 gene sequenced from H2N3 grown on duck cells.
PB1 
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Figure III±3 Polymerase acidic (PA) gene alignment between chicken and duck cell grown viruses. The figure shows identical sequences between the two PA genes.   
PA/C: Polymerase acidic gene sequenced from H2N3 grown on chicken cells.   
PA/D: Polymerase acidic gene sequenced from H2N3 grown on duck cells. 
PA 
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Figure III±4 Haemagglutinin (HA) gene alignment between chicken and duck cell grown viruses. The figure shows identical sequences between the two HA genes.    
HA/C: Haemagglutinin gene sequenced from H2N3 grown on chicken cells.                                                                                                                                                                     
HA/D: Haemagglutinin gene sequenced from H2N3 grown on duck cells. 
HA 
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Figure III±5 Nucleoprotein (NP) gene alignment between chicken and duck cell grown viruses. The figure shows identical sequences between the two NP genes.   
NP/C: Nucleoprotein gene sequenced from H2N3 grown on chicken cells.   
NO/D: Nucleoprotein gene sequenced from H2N3 grown on duck cells.
NP 
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Figure III±6 Neuraminidase (NA) gene alignment between chicken and duck cell grown viruses. The figure shows identical sequences between the two NA genes.    
NA/C: Neuraminidase gene sequenced from H2N3 grown on chicken cells.                                                                                                                                                                       
NA/D: Neuraminidase gene sequenced from H2N3 grown on duck cells. 
NA 
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Figure III±7 Matrix (M) gene alignment between chicken and duck cell grown viruses. The figure shows identical sequences between the two M genes.                  
M/C: Matrix gene sequenced from H2N3 grown on chicken cells.   
M/D: Matrix gene sequenced from H2N3 grown on duck cells. 
 
M 
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Figure III±8 Non±structural (NS) gene alignment between chicken and duck cell grown viruses. The figure shows identical sequences between the two NS genes.                  
NS/C: Non±structural gene sequenced from H2N3 grown on chicken cells.   
NS/D: Non±structural gene sequenced from H2N3 grown on duck cells. 
NS 
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$SSHQGL[,90DQXIDFWXUHU¶VSURWRFROV 
 
1. Viral RNA extraction 
Viral RNA was extracted using QIAamp® Viral RNA Mini Kit (Qiagen) following the 
manufacturer¶V instUXFWLRQV)LYHKXQGUHGVL[W\ȝORI$9/±carrier RNA was moved into 
a 1.5 mL FHQWULIXJHWXEHȝORIDOODQWRLFIOXLGor culture supernatant was added to the 
mixture and the contents were mixed well by pulse vortexing for 15 s. The mixture was 
then incubated at room temperature (15 ± 25ƕC) for 10 min. The tube was briefly 
FHQWULIXJHGDQGȝORIHWKDQRO± 100%) was added to the sample, mixed by pulse 
vortexing for 15 s.  
)URPWKLVPL[WXUHȝOZDVWUDQVIHUUHGWR WKHKLJKILOWHU4,$DPS0LQLFROXPQand 
then centrifuged at 6000 xg for 1 min. The tube was placed into a clean 2 mL collection 
tube, and the tube containing the filtrate was discarded, then the above step was repeated. 
7KHQȝORI$:EXIIHUZDVDGGHGWRWKH4,$DPS0LQLFROXPQFHQWULIXJed for 1 
min at 6000 xg, then the column was placed in a clean 2 mL collection tube, and the tube 
FRQWDLQLQJ WKH ILOWUDWH ZDV GLVFDUGHG 7KHQ  ȝO RI EXIIHU $: ZDV DGGHG WR WKH
column and centrifuged at highest speed (20,000 xg) for 3 min to remove any residual 
wash buffers. The QIAamp Mini column was then inserted in a clean 1.5 mL 
PLFURFHQWULIXJHWXEHDQGYLUDO51$ZDVHOXWHGE\DGGLQJȝORIEXIIHU$9(DQGWKHQ
was centrifuged at 6000 xg for 1 min. The concentration of purified RNA was 
determined using a NanoDrop8000 spectrophotometer (Thermoscientific, UK) by UV 
absorption. Eluted viral RNA samples were stored at ±Û&XQWLOIXUWKHUXVH 
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2. PCR purification 
PCR product was purified using QIAquick PCR Purification Kit (Qiagen) following the 
manufactXUHU¶V LQVWUXFWLRQV )LYH volumes of buffer PB were transferred to 1 volume 
PCR reaction into a 1.5 mL centrifuge tube, followed by adding 10 ȝORI M sodium 
acetate, pH5, to the mixture. The provided 2 mL collection tube was placed into a 
QIAquick column, and then the sample was added. For DNA binding, the QIAquick 
column containing the sample was centrifuged at 20,000 xg for 30 to 60 s. For washing, 
0.75 mL of buffer PE was added to the QIAquick column, and then centrifuged at 20,000 
xg for 30 to 60 s. The QIAquick column was placed in a clean 1.5 mL microcentrifuge 
WXEH)RU'1$HOXWLRQȝORIEXIIHU(%P07ULV&OS+ZDVDGGHG WR WKH
centre of the QIAquick membrane and then the column centrifuged at 20,000 xg for 1 
min. The Concentration of cleaned up DNA was determined using NanoDrop8000 
spectrophotometer (Thermo Scientific, UK) by UV absorption.  
 
3. Plasmid purification 
Plasmid purification was performed using PureLink® Quick Plasmid DNA Miniprep 
V\VWHP ,QYLWURJHQ IROORZLQJ WKH PDQXIDFWXUHU¶V LQVWUXFWLRQV )LYH millilitres of the 
overnight LB culture was centrifuged at 500 xg for 5 min and the medium was removed 
from the tube. The pellet was re±suspended thoroughly by adding 250 µl of resuspension 
buffer (R3; 50 mM Tris±HCl, pH 8.0, 10 mM EDTA) with RNase A. The bacteria were 
lysed by adding 250 µl of pre±warmed lysis buffer (L7; 200 mM NaOH, 1% w/v SDS), 
mixed gently by inverting the capped tube five times and incubated at room temperature 
for 5 min. Three hundred and fifty microlitres of precipitation buffer were then added 
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and the suspension was mixed immediately by vigorously shaking the tube until the 
mixture was homogenous, and then centrifuged at 14000 xg for 10 min. The supernatant 
was then loaded onto a spin column in a 2 mL wash tube and centrifuged at 12000 xg for 
1 min, the filtrate was discarded and the column was placed back into the wash tube. 
Five hundred microlitre of washing buffer (W10) with ethanol were uploaded into the 
column and centrifuged at 12000 xg for 1 min, the filtrate was discarded and the column 
was placed back into the washing tube. The column was then washed with W9 and 
ethanol by centrifuging at 12000 xg for 1 min, the filtrate was discarded and the column 
was centrifuged again at 12000 xg for 1 min. The spin column was then placed in a clean 
1.5 mL recovery tube and 75 µl of TE buffer (10 mM Tris±HCl, pH8.0; 0.1 mM EDTA) 
was added to the center of the column, and incubated for 1 min at room temperature. To 
extract the purified plasmid, the column was centrifuged at 12000 xg for 2 min. The 
concentration of DNA from purified plasmid was determined using a NanoDrop8000 
spectrophotometer (Thermoscientific, UK) by UV absorption.  
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Appendix V:  List of reagents used with catalogue numbers 
Reagent Supplier and catalogue number 
100 bp DNA ladder  New England BioLabs, Cat. No. N3231S 
10X REACT®3 Invitrogen, Cat. No. 16303±018 
1Kb DNA ladder New England BioLabs, Cat. No. N3232S 
Agar 100  Agar Scientific, Cat. No. 1043 
Agarose, powder Fisher Scientific, Cat. No. BP1356±100 
Alexa Fluor® 488 Goat Anti±Chicken IgG (H+L) Antibody Invitrogen, Cat. No. A±11039 
Alexa Fluor® 488 Goat Anti±Rabbit IgG (H+L) Antibody Invitrogen, Cat. No. A±11008 
Alexa Fluor® 546 Goat Anti±Rabbit IgG (H+L) Antibody Invitrogen, Cat. No. A11040 
Alexa Fluor® 546 Phalloidin Invitrogen, Cat. No. A22283 
Amersham ECL Prime Western Blotting Detection Reagent Scientific Laboratory, Cat. No. RPN2232  
Anti±Influenza A Virus Nucleoprotein antibody (AA5H)  Abcam, Cat. No. ab20343 
Anti±mouse IgG antibody, HRP±linked (for western blotting) Cell Signaling Technology, Cat. No. 7076S 
Araldite CY212 resin TAAB, Cat. No. E006 
Chloroform  Fisher Scientific, Cat. No. C/4960/PB17 
Cytochalasin D Sigma±Aldrich, Cat. No. C8273 
Dibutyl phthalate  Agar Scientific, Cat. No. R1071 
Dimethyl sulfoxide (DSMO), for analysis Fisher Scientific, Cat. No. D/4121/PB08 
D±MEM/F±12 (1X) Invitrogen, Cat. No. 11039±047 
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Reagent Supplier and catalogue number 
DMP±30 TAAB, Cat. No. E035 
Dodecenylsuccinic anhydride (DDSA) TAAB, Cat. No. E025 
'XOEHFFR¶V0RGLILHG(DJOH0HGLXP'±MEM±1X) Invitrogen, Cat. No. 31966±047 
'XOEHFFR¶VSKRVSKDWHEXIIHUed saline (DPBS) Invitrogen, Cat. No. 31966±047 
EcoRI Invitrogen, Cat. No. 15202±013 
EnVisionTM + Kit HRP, Mouse (DAB+) Dako, Cat. No. K4007 
Ethidium bromide solution Fisher Scientific Cat. No. 10375700 
Fetal calf serum (FCS), qualified, heat inactivated Invitrogen. Cat. No. 10100±147 
Gel Loading Dye, Blue (6X) New England BioLabs, Cat. No. B7021S 
Glutardehyde±cocodylate buffer Agar Scientific, Cat. No. R1010 
Influenza A Matrix Protein Antibody (for western blotting) ABD serotec, Cat. No. MCA401 
JetPRIME® buffer, sterile filter 0.2 µm Polyplus transfection, Cat No. 712±60 
JetPRIMETM, DNA transfection reagent Polyplus transfection, Cat No. 114±01 
Methanol Fisher Scientific, Cat. No. M/4056/17 
Nancy±520 DNA gel stain Sigma±Aldrich, Cat. No. 01494 
Novex® 14% Tris±Glycine Gels 1.0 mm, 10 well Invitrogen, Cat. No. EC6485BOX 
Novex® Tris±Glycine SDS Running Buffer (10X) Invitrogen, Cat. No. LC2675 
Nuclease±free water Invitrogen, Cat. No. AM9937 
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Reagent Supplier and catalogue number 
Nutrient agar, dehydrated culture media (powder) Thermo Scientific, Cat. No. CM0003 
Nutrient broth, dehydrated culture media (powder) Thermo Scientific, Cat. No. CM0001 
Paraformaldehyde, granules Fisher Scientific, Cat. No. P/0840/53 
pCMV±GFP control vector Cell Biolabs, Cat. No. CBA±401 
pCMV±GFP±LC3 expression vector Cell Biolabs, Cat. No. CBA±401 
Penicillin±Streptomycin (penstrep), liquid Invitrogen, Cat. No. 15140±122 
Phosphate buffered saline (PBS), 1X liquid Invitrogen, Cat. No. 10010056 
Phosphate buffer saline, tablets Invitrogen, Cat. No.18912±014 
Phosphotungstic acid (2%) Sigma, Cat. No. HT152 
Prolong® Gold antifade reagent with DAPI Invitrogen, Cat. No. P36935  
Pure Link TM Quick Plasmid meniprep kit Invitrogen, Cat. No. K210011 
QIA amp® viral RNA mini kit  Qiagen, Cat. No. 52906 
QIAquick PCR Purification Kit Qiagen, Cat. No. 28104 
Reynolds lead citrate Agar Scientific, Cat. No. R1217 
SeeBlue® Pre±Stained Standard (1X) Invitrogen, Cat. No. LC5625 
SuperScript® III Platinum® One±Step Quantitative PCR System  Invitrogen, Cat. No. 11732±020 
SuperScript® III Platinum® One±Step RT±PCR System with Platinum Tag High Fidelity  Invitrogen, Cat. No. 12574±030 
TOPO® TA Cloning® Kit for Sequencing, with One Shot® TOP10 Chemically Competent E. coli Invitrogen, Cat. No. K4575±J10 
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Reagent Supplier and catalogue number 
Tris Glycine SDS sample buffer (2X) Invitrogen, Cat. No. LC2676 
Tris Glycine SDS transfer buffer (25X) Invitrogen, Cat. No. LC3675 
Trypsin from bovine pancreas TPCK treated Sigma±Aldrich, Cat. No. T1426 
Trypsin, 2.5% (10X), liquid Invitrogen, Cat. No. 15090±046 
Tryptose phosphate broth solution Sigma±Aldrich, Cat. No. T8159 
Tween 20 Fisher Scientific, Cat. No. C58H114O26 
Ultroser G, lyophilized Pall Biosepra, Cat. No.15950±017 
Urenyle acetate AnalaR, Cat. No. 10288 
Water, '1DVH51DVH3URWHDVHIUHHȝPILOWHUHG Sigma±Aldrich, Cat. No. W4502 
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